Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of ERBB3 signaling pathway.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle clearance.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mannose stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mannose stimulus.
Any apoptotic process in an outer hair cell.
Any apoptotic process in an outer hair cell.
Any apoptotic process in an outer hair cell.
Any process that modulates the frequency, rate or extent of outer hair cell apoptotic process.
Any process that modulates the frequency, rate or extent of outer hair cell apoptotic process.
Any process that modulates the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of outer hair cell apoptotic process.
Any plant-type cell wall modification that is involved in stomatal movement.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-arginine import across plasma membrane.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a fibronectin fibril.
Any process that modulates the frequency, rate or extent of optical nerve axon regeneration.
Any process that stops, prevents or reduces the frequency, rate or extent of optical nerve axon regeneration.
Any process that stops, prevents or reduces the frequency, rate or extent of optical nerve axon regeneration.
Any process that stops, prevents or reduces the frequency, rate or extent of optical nerve axon regeneration.
Any process that stops, prevents or reduces the frequency, rate or extent of optical nerve axon regeneration.
Any process that activates or increases the frequency, rate or extent of optical nerve axon regeneration.
Any process that activates or increases the frequency, rate or extent of optical nerve axon regeneration.
Any process that activates or increases the frequency, rate or extent of optical nerve axon regeneration.
Any process that activates or increases the frequency, rate or extent of optical nerve axon regeneration.
Interacting selectively and non-covalently with resveratrol.
Any process that modulates the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that modulates the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein particle receptor binding.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that activates or increases the frequency, rate or extent of low-density lipoprotein receptor activity.
Any process that modulates the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that modulates the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that modulates the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that modulates the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Any process that modulates the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that activates or increases the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that activates or increases the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that activates or increases the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that activates or increases the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that activates or increases the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that activates or increases the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that activates or increases the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that activates or increases the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that activates or increases the frequency, rate or extent of maintenance of permeability of blood-brain barrier.
Any process that modulates the frequency, rate or extent of presynapse assembly.
Any process that modulates the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of presynapse assembly.
Any process that activates or increases the frequency, rate or extent of smooth muscle cell-matrix adhesion.
Any process that activates or increases the frequency, rate or extent of smooth muscle cell-matrix adhesion.
Any process that activates or increases the frequency, rate or extent of smooth muscle cell-matrix adhesion.
Any process that activates or increases the frequency, rate or extent of smooth muscle cell-matrix adhesion.
Any process that modulates the frequency, rate or extent of mRNA cap binding.
Any process that stops, prevents or reduces the frequency, rate or extent of mRNA cap binding.
Any process that stops, prevents or reduces the frequency, rate or extent of mRNA cap binding.
Any process that stops, prevents or reduces the frequency, rate or extent of mRNA cap binding.
Any process that stops, prevents or reduces the frequency, rate or extent of mRNA cap binding.
Any process that activates or increases the frequency, rate or extent of mRNA cap binding.
Any process that activates or increases the frequency, rate or extent of mRNA cap binding.
Any process that activates or increases the frequency, rate or extent of mRNA cap binding.
Any process that activates or increases the frequency, rate or extent of mRNA cap binding.
Any process that modulates the frequency, rate or extent of developmental vegetative growth.
Any process that stops, prevents or reduces the frequency, rate or extent of developmental vegetative growth.
Any process that stops, prevents or reduces the frequency, rate or extent of developmental vegetative growth.
Any process that stops, prevents or reduces the frequency, rate or extent of developmental vegetative growth.
Any process that stops, prevents or reduces the frequency, rate or extent of developmental vegetative growth.
Any process that activates or increases the frequency, rate or extent of developmental vegetative growth.
Any process that activates or increases the frequency, rate or extent of developmental vegetative growth.
Any process that activates or increases the frequency, rate or extent of developmental vegetative growth.
Any process that activates or increases the frequency, rate or extent of developmental vegetative growth.
Any process that modulates the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that modulates the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that modulates the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that modulates the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that modulates the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that modulates the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that modulates the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that activates or increases the frequency, rate or extent of miRNA mediated inhibition of translation.
Any process that modulates the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that modulates the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that modulates the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that activates or increases the frequency, rate or extent of alpha-(1->3)-fucosyltransferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of leaf development.
Any process that stops, prevents or reduces the frequency, rate or extent of leaf development.
Any process that stops, prevents or reduces the frequency, rate or extent of leaf development.
Any process that stops, prevents or reduces the frequency, rate or extent of leaf development.
Any process that activates or increases the frequency, rate or extent of leaf development.
Any process that activates or increases the frequency, rate or extent of leaf development.
Any process that activates or increases the frequency, rate or extent of leaf development.
Any process that activates or increases the frequency, rate or extent of leaf development.
Any process that modulates the frequency, rate or extent of L-methionine import across plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of L-methionine import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-methionine import across plasma membrane.
Any process that modulates the frequency, rate or extent of serotonin biosynthetic process.
Any process that modulates the frequency, rate or extent of serotonin biosynthetic process.
Any process that modulates the frequency, rate or extent of serotonin biosynthetic process.
Any process that modulates the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glyceraldehyde stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glyceraldehyde stimulus.
A process in which a protein is transported to, or maintained in, a location within an euchromatin.
A process in which a protein is transported to, or maintained in, a location within an euchromatin.
A process in which a protein is transported to, or maintained in, a location within an euchromatin.
The directed movement of a protein to a specific location in an euchromatin.
The directed movement of a protein to a specific location in an euchromatin.
The directed movement of a protein to a specific location in an euchromatin.
Any process that modulates the frequency, rate or extent of protein localization to chromatin.
The aggregation, arrangement and bonding together of a set of components to form a FACT complex.
The aggregation, arrangement and bonding together of a set of components to form a FACT complex.
The aggregation, arrangement and bonding together of a set of components to form a FACT complex.
Any process that activates or increases the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding.
Any process that activates or increases the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding.
Any process that activates or increases the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding.
Any process that activates or increases the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding.
Any process that modulates the frequency, rate or extent of mitochondrial mRNA catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial mRNA catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial mRNA catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial mRNA catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial mRNA catabolic process.
Any process that activates or increases the frequency, rate or extent of mitochondrial mRNA catabolic process.
Any process that activates or increases the frequency, rate or extent of mitochondrial mRNA catabolic process.
Any process that activates or increases the frequency, rate or extent of mitochondrial mRNA catabolic process.
Any process that activates or increases the frequency, rate or extent of mitochondrial mRNA catabolic process.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an acetaldehyde stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an acetaldehyde stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA methylation.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA methylation.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA methylation.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA methylation.
Any process that activates or increases the frequency, rate or extent of DNA methylation.
Any process that activates or increases the frequency, rate or extent of DNA methylation.
Any process that activates or increases the frequency, rate or extent of DNA methylation.
Any process that activates or increases the frequency, rate or extent of DNA methylation.
Any process that modulates the frequency, rate or extent of FACT complex assembly.
Any process that modulates the frequency, rate or extent of FACT complex assembly.
Any process that modulates the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
Any process that activates or increases the frequency, rate or extent of FACT complex assembly.
The directed movement of proline from outside of a cell into the cytoplasmic compartment.
The directed movement of proline from outside of a cell into the cytoplasmic compartment.
Any process that modulates the frequency, rate or extent of shell calcification.
Any process that stops, prevents or reduces the frequency, rate or extent of shell calcification.
Any process that stops, prevents or reduces the frequency, rate or extent of shell calcification.
Any process that stops, prevents or reduces the frequency, rate or extent of shell calcification.
Any process that stops, prevents or reduces the frequency, rate or extent of shell calcification.
Any process that activates or increases the frequency, rate or extent of shell calcification.
Any process that activates or increases the frequency, rate or extent of shell calcification.
Any process that activates or increases the frequency, rate or extent of shell calcification.
Any process that activates or increases the frequency, rate or extent of shell calcification.
Any process that modulates the frequency, rate or extent of artery morphogenesis.
Any process that modulates the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that activates or increases the frequency, rate or extent of artery morphogenesis.
Any process that modulates the frequency, rate or extent of artery smooth muscle contraction.
Any process that stops, prevents or reduces the frequency, rate or extent of artery smooth muscle contraction.
Any process that stops, prevents or reduces the frequency, rate or extent of artery smooth muscle contraction.
Any process that stops, prevents or reduces the frequency, rate or extent of artery smooth muscle contraction.
Any process that stops, prevents or reduces the frequency, rate or extent of artery smooth muscle contraction.
Any process that activates or increases the frequency, rate or extent of artery smooth muscle contraction.
Any process that activates or increases the frequency, rate or extent of artery smooth muscle contraction.
Any process that activates or increases the frequency, rate or extent of artery smooth muscle contraction.
Any process that activates or increases the frequency, rate or extent of artery smooth muscle contraction.
The aggregation, arrangement and bonding together of a set of components to form a mitotic checkpoint complex.
The aggregation, arrangement and bonding together of a set of components to form a mitotic checkpoint complex.
The aggregation, arrangement and bonding together of a set of components to form a mitotic checkpoint complex.
Any process that modulates the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.
Any process that modulates the frequency, rate or extent of calcium ion import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion import across plasma membrane.
Any process that modulates the frequency, rate or extent of protein localization to endosome.
Any process that modulates the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
Any process that activates or increases the frequency, rate or extent of protein localization to endosome.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The aggregation, arrangement and bonding together of a set of components to form a TORC1 complex.
The disaggregation of a TORC2 complex into its constituent components.
The disaggregation of a TORC2 complex into its constituent components.
The disaggregation of a TORC2 complex into its constituent components.
The disaggregation of a TORC2 complex into its constituent components.
The disaggregation of a TORC2 complex into its constituent components.
Any process that modulates the frequency, rate or extent of lysosome organization.
Any process that modulates the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that activates or increases the frequency, rate or extent of lysosome organization.
Any process that modulates the frequency, rate or extent of adaptive immune memory response.
Any process that stops, prevents or reduces the frequency, rate or extent of adaptive immune memory response.
Any process that stops, prevents or reduces the frequency, rate or extent of adaptive immune memory response.
Any process that stops, prevents or reduces the frequency, rate or extent of adaptive immune memory response.
Any process that stops, prevents or reduces the frequency, rate or extent of adaptive immune memory response.
Any process that activates or increases the frequency, rate or extent of adaptive immune memory response.
Any process that activates or increases the frequency, rate or extent of adaptive immune memory response.
Any process that activates or increases the frequency, rate or extent of adaptive immune memory response.
Any process that activates or increases the frequency, rate or extent of adaptive immune memory response.
Any process that modulates the frequency, rate or extent of adaptive immune effector response.
Any process that stops, prevents or reduces the frequency, rate or extent of adaptive immune effector response.
Any process that stops, prevents or reduces the frequency, rate or extent of adaptive immune effector response.
Any process that stops, prevents or reduces the frequency, rate or extent of adaptive immune effector response.
Any process that stops, prevents or reduces the frequency, rate or extent of adaptive immune effector response.
Any process that activates or increases the frequency, rate or extent of adaptive immune effector response.
Any process that activates or increases the frequency, rate or extent of adaptive immune effector response.
Any process that activates or increases the frequency, rate or extent of adaptive immune effector response.
Any process that activates or increases the frequency, rate or extent of adaptive immune effector response.
Any process that modulates the frequency, rate or extent of innate immunity memory response.
Any process that stops, prevents or reduces the frequency, rate or extent of innate immunity memory response.
Any process that stops, prevents or reduces the frequency, rate or extent of innate immunity memory response.
Any process that stops, prevents or reduces the frequency, rate or extent of innate immunity memory response.
Any process that stops, prevents or reduces the frequency, rate or extent of innate immunity memory response.
Any process that activates or increases the frequency, rate or extent of innate immunity memory response.
Any process that activates or increases the frequency, rate or extent of innate immunity memory response.
Any process that activates or increases the frequency, rate or extent of innate immunity memory response.
Any process that activates or increases the frequency, rate or extent of innate immunity memory response.
The disaggregation of a peroxisome into its constituent components.
Any process that modulates the frequency, rate or extent of plasma membrane repair.
Any process that stops, prevents or reduces the frequency, rate or extent of plasma membrane repair.
Any process that stops, prevents or reduces the frequency, rate or extent of plasma membrane repair.
Any process that stops, prevents or reduces the frequency, rate or extent of plasma membrane repair.
Any process that stops, prevents or reduces the frequency, rate or extent of plasma membrane repair.
Any process that activates or increases the frequency, rate or extent of plasma membrane repair.
Any process that activates or increases the frequency, rate or extent of plasma membrane repair.
Any process that activates or increases the frequency, rate or extent of plasma membrane repair.
Any process that activates or increases the frequency, rate or extent of plasma membrane repair.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that modulates the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.
The disaggregation of a nucleus into its constituent components.
The disaggregation of a lipid particle into its constituent components.
The disaggregation of a lipid particle into its constituent components.
The disaggregation of a lipid particle into its constituent components.
The disaggregation of a lipid particle into its constituent components.
The disaggregation of an endoplasmic reticulum into its constituent components.
Any process that modulates the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of polysome binding.
Any process that stops, prevents or reduces the frequency, rate or extent of polysome binding.
Any process that stops, prevents or reduces the frequency, rate or extent of polysome binding.
Any process that stops, prevents or reduces the frequency, rate or extent of polysome binding.
Any process that stops, prevents or reduces the frequency, rate or extent of polysome binding.
Any process that stops, prevents or reduces the frequency, rate or extent of polysome binding.
Any process that stops, prevents or reduces the frequency, rate or extent of polysome binding.
Any process that stops, prevents or reduces the frequency, rate or extent of polysome binding.
Any process that stops, prevents or reduces the frequency, rate or extent of polysome binding.
Any process that stops, prevents or reduces the frequency, rate or extent of polysome binding.
Any process that activates or increases the frequency, rate or extent of polysome binding.
Any process that activates or increases the frequency, rate or extent of polysome binding.
Any process that activates or increases the frequency, rate or extent of polysome binding.
Any process that activates or increases the frequency, rate or extent of polysome binding.
Any process that activates or increases the frequency, rate or extent of polysome binding.
Any process that activates or increases the frequency, rate or extent of polysome binding.
Any process that activates or increases the frequency, rate or extent of polysome binding.
Any process that activates or increases the frequency, rate or extent of polysome binding.
Any process that activates or increases the frequency, rate or extent of polysome binding.
Any process that modulates the frequency, rate or extent of drug transmembrane export.
Any process that stops, prevents or reduces the frequency, rate or extent of drug transmembrane export.
Any process that stops, prevents or reduces the frequency, rate or extent of drug transmembrane export.
Any process that stops, prevents or reduces the frequency, rate or extent of drug transmembrane export.
Any process that stops, prevents or reduces the frequency, rate or extent of drug transmembrane export.
Any process that activates or increases the frequency, rate or extent of drug transmembrane export.
Any process that activates or increases the frequency, rate or extent of drug transmembrane export.
Any process that activates or increases the frequency, rate or extent of drug transmembrane export.
Any process that activates or increases the frequency, rate or extent of drug transmembrane export.
Any process that modulates the frequency, rate or extent of inhibitory synapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of inhibitory synapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of inhibitory synapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of inhibitory synapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of inhibitory synapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of inhibitory synapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of inhibitory synapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of inhibitory synapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of inhibitory synapse assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of inhibitory synapse assembly.
Any process that activates or increases the frequency, rate or extent of inhibitory synapse assembly.
Any process that activates or increases the frequency, rate or extent of inhibitory synapse assembly.
Any process that activates or increases the frequency, rate or extent of inhibitory synapse assembly.
Any process that activates or increases the frequency, rate or extent of inhibitory synapse assembly.
Any process that activates or increases the frequency, rate or extent of inhibitory synapse assembly.
Any process that activates or increases the frequency, rate or extent of inhibitory synapse assembly.
Any process that activates or increases the frequency, rate or extent of inhibitory synapse assembly.
Any process that activates or increases the frequency, rate or extent of inhibitory synapse assembly.
Any process that activates or increases the frequency, rate or extent of inhibitory synapse assembly.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a paclitaxel stimulus.
Any process that modulates the frequency, rate or extent of mitochondrial ATP synthesis coupled proton transport.
Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial ATP synthesis coupled proton transport.
Any process that modulates the location, frequency, rate or extent of cell morphogenesis involved in conjugation with cellular fusion.
Any process that modulates the location, frequency, rate or extent of cell morphogenesis involved in conjugation with cellular fusion.
Any process that stops, prevents or reduces the frequency, rate or extent of the passage or uptake of molecules by a membrane.
Any process that activates or increases the frequency, rate or extent of the passage or uptake of molecules by a membrane.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phosphatidylethanolamine stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phosphatidylethanolamine stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phosphatidylethanolamine stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phosphatidylethanolamine stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phosphatidylethanolamine stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phosphatidylethanolamine stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phosphatidylethanolamine stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phosphatidylethanolamine stimulus.
Any process that modulates the frequency, rate or extent of cornification.
Any process that stops, prevents or reduces the frequency, rate or extent of cornification.
Any process that stops, prevents or reduces the frequency, rate or extent of cornification.
Any process that stops, prevents or reduces the frequency, rate or extent of cornification.
Any process that stops, prevents or reduces the frequency, rate or extent of cornification.
Any process that activates or increases the frequency, rate or extent of cornification.
Any process that activates or increases the frequency, rate or extent of cornification.
Any process that activates or increases the frequency, rate or extent of cornification.
Any process that activates or increases the frequency, rate or extent of cornification.
A process in which a protein is transported to, or maintained in, a location within the perinuclear region of the cytoplasm.
A process in which a protein is transported to, or maintained in, a location within the perinuclear region of the cytoplasm.
A process in which a protein is transported to, or maintained in, a location within the perinuclear region of the cytoplasm.
A process in which a protein is transported to, or maintained in, a location within the perinuclear region of the cytoplasm.
Any microtubule bundle that is part of a cytoplasm.
Any microtubule bundle that is part of a cytoplasm.
Any microtubule end that is part of a mitotic spindle astral microtubule.
Any process that modulates the frequency, rate or extent of trypanothione biosynthetic process.
Any process that modulates the frequency, rate or extent of trypanothione biosynthetic process.
Any process that modulates the frequency, rate or extent of trypanothione biosynthetic process.
Any process that modulates the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
Any process that activates or increases the frequency, rate or extent of trypanothione biosynthetic process.
A process in which a protein is transported to, or maintained in, a location at a microtubule end.
Any process that modulates the frequency, rate or extent of L-proline import across plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of L-proline import across plasma membrane.
Any process that activates or increases the frequency, rate or extent of L-proline import across plasma membrane.
Any mitochondrial calcium release that is involved in positive regulation of presynaptic cytosolic calcium concentration.
Any mitochondrial calcium release that is involved in positive regulation of presynaptic cytosolic calcium concentration.
A protein complex which is capable of Ras guanyl-nucleotide exchange factor activity.
Any mitochondrial calcium uptake that is involved in negative regulation of presynaptic cytosolic calcium concentration.
Any mitochondrial calcium uptake that is involved in negative regulation of presynaptic cytosolic calcium concentration.
Any process that modulates the frequency, rate or extent of mRNA cis splicing, via spliceosome.
Any process that modulates the frequency, rate or extent of mRNA cis splicing, via spliceosome.
Any process that modulates the frequency, rate or extent of mRNA cis splicing, via spliceosome.
Any process that stops, prevents or reduces the frequency, rate or extent of mRNA cis splicing, via spliceosome.
Any process that activates or increases the frequency, rate or extent of mRNA cis splicing, via spliceosome.
Any process that stops, prevents or reduces the frequency, rate or extent of saliva secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of saliva secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of saliva secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of saliva secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of saliva secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of saliva secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of saliva secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of saliva secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of saliva secretion.
The developmental process by which a hard palate is generated and organized.
Any process that modulates the frequency, rate or extent of endosome to plasma membrane protein transport.
Any process that stops, prevents or reduces the frequency, rate or extent of endosome to plasma membrane protein transport.
Any process that stops, prevents or reduces the frequency, rate or extent of endosome to plasma membrane protein transport.
Any process that stops, prevents or reduces the frequency, rate or extent of endosome to plasma membrane protein transport.
Any process that stops, prevents or reduces the frequency, rate or extent of endosome to plasma membrane protein transport.
Any process that activates or increases the frequency, rate or extent of endosome to plasma membrane protein transport.
Any process that activates or increases the frequency, rate or extent of endosome to plasma membrane protein transport.
Any process that activates or increases the frequency, rate or extent of endosome to plasma membrane protein transport.
Any process that activates or increases the frequency, rate or extent of endosome to plasma membrane protein transport.
Any process that modulates the frequency, rate or extent of argininosuccinate synthase activity.
Any process that modulates the frequency, rate or extent of argininosuccinate synthase activity.
Any process that modulates the frequency, rate or extent of argininosuccinate synthase activity.
Any process that modulates the frequency, rate or extent of argininosuccinate synthase activity.
Any process that modulates the frequency, rate or extent of argininosuccinate synthase activity.
Any process that modulates the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any process that activates or increases the frequency, rate or extent of argininosuccinate synthase activity.
Any nucleus that is part of a ascospore-type prospore.
Any nucleus that is part of a ascospore-type prospore.
A process in which a protein is transported to, or maintained in, a location within a cytoplasmic microtubule.
Any process that modulates the frequency, rate or extent of primary cell septum biogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of primary cell septum biogenesis.
Any process that activates or increases the frequency, rate or extent of primary cell septum biogenesis.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule that is part of a post-anaphase microtubule array.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Any microtubule end that is part of a post-anaphase array microtubule.
Interacting selectively and non-covalently with a SCF ubiquitin ligase complex.
Interacting selectively and non-covalently with a SCF ubiquitin ligase complex.
Interacting selectively and non-covalently with a SCF ubiquitin ligase complex.
Interacting selectively and non-covalently with a SCF ubiquitin ligase complex.
Interacting selectively and non-covalently with a SCF ubiquitin ligase complex.
Interacting selectively and non-covalently with a SCF ubiquitin ligase complex.
Interacting selectively and non-covalently with a SCF ubiquitin ligase complex.
Interacting selectively and non-covalently with a CCR4-NOT complex.
Interacting selectively and non-covalently with a MTREC complex.
Any process that modulates the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that stops, prevents or reduces the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that stops, prevents or reduces the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that stops, prevents or reduces the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that stops, prevents or reduces the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that stops, prevents or reduces the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that stops, prevents or reduces the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that stops, prevents or reduces the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that stops, prevents or reduces the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that stops, prevents or reduces the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that activates or increases the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that activates or increases the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that activates or increases the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that activates or increases the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that activates or increases the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that activates or increases the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that activates or increases the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that activates or increases the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that activates or increases the frequency, rate or extent of protection from non-homologous end joining at telomere.
Any process that modulates the frequency, rate or extent of double-stranded telomeric DNA binding.
Any process that stops, prevents or reduces the frequency, rate or extent of double-stranded telomeric DNA binding.
Any process that stops, prevents or reduces the frequency, rate or extent of double-stranded telomeric DNA binding.
Any process that stops, prevents or reduces the frequency, rate or extent of double-stranded telomeric DNA binding.
Any process that stops, prevents or reduces the frequency, rate or extent of double-stranded telomeric DNA binding.
Any process that activates or increases the frequency, rate or extent of double-stranded telomeric DNA binding.
Any process that activates or increases the frequency, rate or extent of double-stranded telomeric DNA binding.
Any process that activates or increases the frequency, rate or extent of double-stranded telomeric DNA binding.
Any process that activates or increases the frequency, rate or extent of double-stranded telomeric DNA binding.
Any process that modulates the frequency, rate or extent of mesodermal cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesodermal cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesodermal cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesodermal cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesodermal cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesodermal cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesodermal cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesodermal cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesodermal cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesodermal cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesodermal cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesodermal cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesodermal cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesodermal cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesodermal cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesodermal cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesodermal cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesodermal cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesodermal cell differentiation.
Interacting selectively and non-covalently with 8-hydroxy-2'-deoxyguanosine an oxidized purine residue found in damaged DNA.
Any process that modulates the frequency, rate or extent of DNA helicase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA helicase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA helicase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA helicase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA helicase activity.
Any process that activates or increases the frequency, rate or extent of DNA helicase activity.
Any process that activates or increases the frequency, rate or extent of DNA helicase activity.
Any process that activates or increases the frequency, rate or extent of DNA helicase activity.
Any process that activates or increases the frequency, rate or extent of DNA helicase activity.
Any process that modulates the frequency, rate or extent of exonuclease activity.
Any process that stops, prevents or reduces the frequency, rate or extent of exonuclease activity.
Any process that stops, prevents or reduces the frequency, rate or extent of exonuclease activity.
Any process that stops, prevents or reduces the frequency, rate or extent of exonuclease activity.
Any process that stops, prevents or reduces the frequency, rate or extent of exonuclease activity.
Any process that stops, prevents or reduces the frequency, rate or extent of exonuclease activity.
Any process that stops, prevents or reduces the frequency, rate or extent of exonuclease activity.
Any process that stops, prevents or reduces the frequency, rate or extent of exonuclease activity.
Any process that stops, prevents or reduces the frequency, rate or extent of exonuclease activity.
Any process that stops, prevents or reduces the frequency, rate or extent of exonuclease activity.
Any process that activates or increases the frequency, rate or extent of exonuclease activity.
Any process that activates or increases the frequency, rate or extent of exonuclease activity.
Any process that activates or increases the frequency, rate or extent of exonuclease activity.
Any process that activates or increases the frequency, rate or extent of exonuclease activity.
Any process that activates or increases the frequency, rate or extent of exonuclease activity.
Any process that activates or increases the frequency, rate or extent of exonuclease activity.
Any process that activates or increases the frequency, rate or extent of exonuclease activity.
Any process that activates or increases the frequency, rate or extent of exonuclease activity.
Any process that activates or increases the frequency, rate or extent of exonuclease activity.
Any process that modulates the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
Any process that activates or increases the frequency, rate or extent of phosphatidylserine exposure on apoptotic cell surface.
The disaggregation of a CENP-A containing nucleosome into its constituent components.
The disaggregation of a CENP-A containing nucleosome into its constituent components.
The disaggregation of a CENP-A containing nucleosome into its constituent components.
Any process that modulates the frequency, rate or extent of anaphase-promoting complex-dependent catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of anaphase-promoting complex-dependent catabolic process.
Any process that activates or increases the frequency, rate or extent of anaphase-promoting complex-dependent catabolic process.
Any process that modulates the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that modulates the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that modulates the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that modulates the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that modulates the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that modulates the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that activates or increases the frequency, rate or extent of detection of mechanical stimulus involved in sensory perception of touch.
Any process that modulates the frequency, rate or extent of mechanosensory behavior.
Any process that modulates the frequency, rate or extent of mechanosensory behavior.
Any process that modulates the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
Any process that activates or increases the frequency, rate or extent of mechanosensory behavior.
A process in which a protein is transported to, or maintained in, a location within a pericentriolar material.
A process in which a protein is transported to, or maintained in, a location within a pericentriolar material.
A process in which a protein is transported to, or maintained in, a location within a pericentriolar material.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a puromycin stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a puromycin stimulus.
Any process that modulates the frequency, rate or extent of intraciliary anterograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary anterograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary anterograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary anterograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary anterograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary anterograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary anterograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary anterograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary anterograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary anterograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary anterograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary anterograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary anterograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary anterograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary anterograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary anterograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary anterograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary anterograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary anterograde transport.
Any process that modulates the frequency, rate or extent of intraciliary retrograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary retrograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary retrograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary retrograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary retrograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary retrograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary retrograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary retrograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary retrograde transport.
Any process that stops, prevents or reduces the frequency, rate or extent of intraciliary retrograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary retrograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary retrograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary retrograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary retrograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary retrograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary retrograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary retrograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary retrograde transport.
Any process that activates or increases the frequency, rate or extent of intraciliary retrograde transport.
Any process that modulates the frequency, rate or extent of cellular response to manganese ion.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to manganese ion.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to manganese ion.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to manganese ion.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to manganese ion.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to manganese ion.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to manganese ion.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to manganese ion.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to manganese ion.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to manganese ion.
Any process that activates or increases the frequency, rate or extent of cellular response to manganese ion.
Any process that activates or increases the frequency, rate or extent of cellular response to manganese ion.
Any process that activates or increases the frequency, rate or extent of cellular response to manganese ion.
Any process that activates or increases the frequency, rate or extent of cellular response to manganese ion.
Any process that activates or increases the frequency, rate or extent of cellular response to manganese ion.
Any process that activates or increases the frequency, rate or extent of cellular response to manganese ion.
Any process that activates or increases the frequency, rate or extent of cellular response to manganese ion.
Any process that activates or increases the frequency, rate or extent of cellular response to manganese ion.
Any process that activates or increases the frequency, rate or extent of cellular response to manganese ion.
The disaggregation of an excitatory synapse into its constituent components.
The disaggregation of an excitatory synapse into its constituent components.
The disaggregation of an excitatory synapse into its constituent components.
The disaggregation of an excitatory synapse into its constituent components.
Any process that modulates the frequency, rate or extent of synapse pruning.
Any process that modulates the frequency, rate or extent of synapse pruning.
Any process that modulates the frequency, rate or extent of synapse pruning.
Any process that modulates the frequency, rate or extent of synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse pruning.
Any process that activates or increases the frequency, rate or extent of synapse pruning.
Any process that activates or increases the frequency, rate or extent of synapse pruning.
Any process that activates or increases the frequency, rate or extent of synapse pruning.
Any process that activates or increases the frequency, rate or extent of synapse pruning.
Any process that activates or increases the frequency, rate or extent of synapse pruning.
Any process that activates or increases the frequency, rate or extent of synapse pruning.
Any process that activates or increases the frequency, rate or extent of synapse pruning.
Any process that activates or increases the frequency, rate or extent of synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse organization.
Any process that modulates the frequency, rate or extent of excitatory synapse pruning.
Any process that modulates the frequency, rate or extent of excitatory synapse pruning.
Any process that modulates the frequency, rate or extent of excitatory synapse pruning.
Any process that modulates the frequency, rate or extent of excitatory synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of excitatory synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of excitatory synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of excitatory synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of excitatory synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of excitatory synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of excitatory synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of excitatory synapse pruning.
Any process that stops, prevents or reduces the frequency, rate or extent of excitatory synapse pruning.
Any process that modulates the frequency, rate or extent of motor neuron axon guidance.
Any process that modulates the frequency, rate or extent of motor neuron axon guidance.
Any process that modulates the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that activates or increases the frequency, rate or extent of motor neuron axon guidance.
Any process that modulates the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that modulates the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that modulates the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that stops, prevents or reduces the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that activates or increases the frequency, rate or extent of dorsal/ventral axon guidance.
Any process that modulates the frequency, rate or extent of chromosome separation.
Any process that modulates the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome separation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that activates or increases the frequency, rate or extent of chromosome condensation.
Any process that modulates the frequency, rate or extent of mitotic sister chromatid arm separation.
Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid arm separation.
Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid arm separation.
Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid arm separation.
Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid arm separation.
Any process that activates or increases the frequency, rate or extent of mitotic sister chromatid arm separation.
Any process that activates or increases the frequency, rate or extent of mitotic sister chromatid arm separation.
Any process that activates or increases the frequency, rate or extent of mitotic sister chromatid arm separation.
Any process that activates or increases the frequency, rate or extent of mitotic sister chromatid arm separation.
Any process that modulates the frequency, rate or extent of selenocysteine metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.
Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.
Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.
Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.
Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.
Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.
Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.
Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.
Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.
Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.
Any process that modulates the frequency, rate or extent of prostaglandin catabolic process.
Any process that modulates the frequency, rate or extent of prostaglandin catabolic process.
Any process that modulates the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that activates or increases the frequency, rate or extent of prostaglandin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that activates or increases the frequency, rate or extent of spindle assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule nucleation.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule nucleation.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule nucleation.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule nucleation.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pyrimidine ribonucleotide stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pyrimidine ribonucleotide stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a triterpenoid stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a triterpenoid stimulus.
Any process that modulates the frequency, rate or extent of telomeric D-loop disassembly.
Any process that stops, prevents or reduces the frequency, rate or extent of telomeric D-loop disassembly.
Any process that stops, prevents or reduces the frequency, rate or extent of telomeric D-loop disassembly.
Any process that stops, prevents or reduces the frequency, rate or extent of telomeric D-loop disassembly.
Any process that stops, prevents or reduces the frequency, rate or extent of telomeric D-loop disassembly.
Any process that activates or increases the frequency, rate or extent of telomeric D-loop disassembly.
Any process that activates or increases the frequency, rate or extent of telomeric D-loop disassembly.
Any process that activates or increases the frequency, rate or extent of telomeric D-loop disassembly.
Any process that activates or increases the frequency, rate or extent of telomeric D-loop disassembly.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxidopamine stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxidopamine stimulus.
Any process that modulates the frequency, rate or extent of cellular response to gamma radiation.
Any process that modulates the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of cellular response to gamma radiation.
Any process that modulates the frequency, rate or extent of cellular response to oxidopamine.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to oxidopamine.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to oxidopamine.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to oxidopamine.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to oxidopamine.
Any process that activates or increases the frequency, rate or extent of cellular response to oxidopamine.
Any process that activates or increases the frequency, rate or extent of cellular response to oxidopamine.
Any process that activates or increases the frequency, rate or extent of cellular response to oxidopamine.
Any process that activates or increases the frequency, rate or extent of cellular response to oxidopamine.
Any process that stops, prevents or reduces the frequency, rate or extent of forward locomotion.
Any process that stops, prevents or reduces the frequency, rate or extent of forward locomotion.
Any process that stops, prevents or reduces the frequency, rate or extent of forward locomotion.
Any process that stops, prevents or reduces the frequency, rate or extent of forward locomotion.
Any process that activates or increases the frequency, rate or extent of forward locomotion.
Any process that activates or increases the frequency, rate or extent of forward locomotion.
Any process that activates or increases the frequency, rate or extent of forward locomotion.
Any process that activates or increases the frequency, rate or extent of forward locomotion.
Any process that stops, prevents or reduces the frequency, rate or extent of backward locomotion.
Any process that stops, prevents or reduces the frequency, rate or extent of backward locomotion.
Any process that stops, prevents or reduces the frequency, rate or extent of backward locomotion.
Any process that stops, prevents or reduces the frequency, rate or extent of backward locomotion.
Any process that activates or increases the frequency, rate or extent of backward locomotion.
Any process that activates or increases the frequency, rate or extent of backward locomotion.
Any process that activates or increases the frequency, rate or extent of backward locomotion.
Any process that activates or increases the frequency, rate or extent of backward locomotion.
Any process that modulates the frequency, rate or extent of heparan sulfate binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate binding.
Any process that stops, prevents or reduces the frequency, rate or extent of pentose-phosphate shunt.
Any process that activates or increases the frequency, rate or extent of pentose-phosphate shunt.
Any process that modulates the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that stops, prevents or reduces the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate proteoglycan binding.
Any process that activates or increases the frequency, rate or extent of heparan sulfate proteoglycan binding.
The aggregation, arrangement and bonding together of a set of components to form an intranuclear rod.
The aggregation, arrangement and bonding together of a set of components to form an intranuclear rod.
The aggregation, arrangement and bonding together of a set of components to form an intranuclear rod.
A protein complex which is capable of ferroxidase activity.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an invadopodium.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that modulates the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
Any process that activates or increases the frequency, rate or extent of Atg1/ULK1 kinase complex assembly.
The process whose specific outcome is the progression of an epididymis over time, from its formation to the mature structure.
Any process that modulates the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.
Any process that modulates the frequency, rate or extent of protein localization to cell leading edge.
Any process that modulates the frequency, rate or extent of protein localization to cell leading edge.
Any process that modulates the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that activates or increases the frequency, rate or extent of protein localization to cell leading edge.
Any process that modulates the frequency, rate or extent of postsynaptic density organization.
Any process that modulates the frequency, rate or extent of postsynaptic density organization.
Any process that modulates the frequency, rate or extent of postsynaptic density organization.
Any process that modulates the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that stops, prevents or reduces the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
Any process that activates or increases the frequency, rate or extent of postsynaptic density organization.
The aggregation, arrangement and bonding together of a set of components to form an invadopodium.
The disaggregation of an invadopodium into its constituent components.
Any process that modulates the frequency, rate or extent of oogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of oogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of oogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of oogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of oogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of oogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of oogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of oogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of oogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of oogenesis.
Any process that activates or increases the frequency, rate or extent of oogenesis.
Any process that activates or increases the frequency, rate or extent of oogenesis.
Any process that activates or increases the frequency, rate or extent of oogenesis.
Any process that activates or increases the frequency, rate or extent of oogenesis.
Any process that activates or increases the frequency, rate or extent of oogenesis.
Any process that activates or increases the frequency, rate or extent of oogenesis.
Any process that activates or increases the frequency, rate or extent of oogenesis.
Any process that activates or increases the frequency, rate or extent of oogenesis.
Any process that activates or increases the frequency, rate or extent of oogenesis.
Any process that modulates the frequency, rate or extent of triglyceride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.
Any process that activates or increases the frequency, rate or extent of triglyceride transport.
Any process that activates or increases the frequency, rate or extent of triglyceride transport.
Any process that activates or increases the frequency, rate or extent of triglyceride transport.
Any process that activates or increases the frequency, rate or extent of triglyceride transport.
Any process that activates or increases the frequency, rate or extent of triglyceride transport.
Any process that activates or increases the frequency, rate or extent of triglyceride transport.
Any process that activates or increases the frequency, rate or extent of triglyceride transport.
Any process that activates or increases the frequency, rate or extent of triglyceride transport.
Any process that activates or increases the frequency, rate or extent of triglyceride transport.
Any chromatin remodeling that is involved in meiosis I.
Any chromatin remodeling that is involved in meiosis I.
Any chromatin remodeling that is involved in meiosis I.
Any chromatin remodeling that is involved in meiosis I.
The process in which (2R,4S)-2-methyltetrahydrofuran-2,3,3,4-tetrol (autoinducer AI-2) is transported across a membrane. AI-2 is produced by prokaryotes and is believed to play a role in quorum sensing.
The process in which (2R,4S)-2-methyltetrahydrofuran-2,3,3,4-tetrol (autoinducer AI-2) is transported across a membrane. AI-2 is produced by prokaryotes and is believed to play a role in quorum sensing.
The process in which (2R,4S)-2-methyltetrahydrofuran-2,3,3,4-tetrol (autoinducer AI-2) is transported across a membrane. AI-2 is produced by prokaryotes and is believed to play a role in quorum sensing.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that modulates the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.
Any process that modulates the frequency, rate or extent of cellular response to thapsigargin.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to thapsigargin.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to thapsigargin.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to thapsigargin.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to thapsigargin.
Any process that activates or increases the frequency, rate or extent of cellular response to thapsigargin.
Any process that activates or increases the frequency, rate or extent of cellular response to thapsigargin.
Any process that activates or increases the frequency, rate or extent of cellular response to thapsigargin.
Any process that activates or increases the frequency, rate or extent of cellular response to thapsigargin.
Any process that modulates the frequency, rate or extent of cellular response to tunicamycin.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to tunicamycin.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to tunicamycin.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to tunicamycin.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to tunicamycin.
Any process that activates or increases the frequency, rate or extent of cellular response to tunicamycin.
Any process that activates or increases the frequency, rate or extent of cellular response to tunicamycin.
Any process that activates or increases the frequency, rate or extent of cellular response to tunicamycin.
Any process that activates or increases the frequency, rate or extent of cellular response to tunicamycin.
Any process that modulates the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that modulates the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that modulates the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of response to endoplasmic reticulum stress.
Any process that modulates the frequency, rate or extent of smooth muscle tissue development.
Any process that stops, prevents or reduces the frequency, rate or extent of smooth muscle tissue development.
Any process that stops, prevents or reduces the frequency, rate or extent of smooth muscle tissue development.
Any process that stops, prevents or reduces the frequency, rate or extent of smooth muscle tissue development.
Any process that stops, prevents or reduces the frequency, rate or extent of smooth muscle tissue development.
Any process that activates or increases the frequency, rate or extent of smooth muscle tissue development.
Any process that activates or increases the frequency, rate or extent of smooth muscle tissue development.
Any process that activates or increases the frequency, rate or extent of smooth muscle tissue development.
Any process that activates or increases the frequency, rate or extent of smooth muscle tissue development.
Any process that modulates the frequency, rate or extent of mesoderm formation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesoderm formation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesoderm formation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesoderm formation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesoderm formation.
Any process that activates or increases the frequency, rate or extent of mesoderm formation.
Any process that activates or increases the frequency, rate or extent of mesoderm formation.
Any process that activates or increases the frequency, rate or extent of mesoderm formation.
Any process that activates or increases the frequency, rate or extent of mesoderm formation.
The developmental process by which a pharyngeal gland is generated and organized.
The developmental process by which a pharyngeal gland is generated and organized.
Any process that modulates the frequency, rate or extent of amyloid fibril formation.
Any process that modulates the frequency, rate or extent of amyloid fibril formation.
Any process that modulates the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that activates or increases the frequency, rate or extent of amyloid fibril formation.
Any process that modulates the frequency, rate or extent of dauer entry.
Any process that stops, prevents or reduces the frequency, rate or extent of dauer entry.
Any process that stops, prevents or reduces the frequency, rate or extent of dauer entry.
Any process that stops, prevents or reduces the frequency, rate or extent of dauer entry.
Any process that stops, prevents or reduces the frequency, rate or extent of dauer entry.
Any process that stops, prevents or reduces the frequency, rate or extent of dauer entry.
Any process that stops, prevents or reduces the frequency, rate or extent of dauer entry.
Any process that stops, prevents or reduces the frequency, rate or extent of dauer entry.
Any process that stops, prevents or reduces the frequency, rate or extent of dauer entry.
Any process that stops, prevents or reduces the frequency, rate or extent of dauer entry.
Any process that activates or increases the frequency, rate or extent of dauer entry.
Any process that activates or increases the frequency, rate or extent of dauer entry.
Any process that activates or increases the frequency, rate or extent of dauer entry.
Any process that activates or increases the frequency, rate or extent of dauer entry.
Any process that activates or increases the frequency, rate or extent of dauer entry.
Any process that activates or increases the frequency, rate or extent of dauer entry.
Any process that activates or increases the frequency, rate or extent of dauer entry.
Any process that activates or increases the frequency, rate or extent of dauer entry.
Any process that activates or increases the frequency, rate or extent of dauer entry.
Any process that modulates the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that modulates the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that activates or increases the frequency, rate or extent of calcium ion export across the plasma membrane.
Any process that modulates the frequency, rate or extent of cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of cell differentiation involved in phenotypic switching.
Any process that modulates the frequency, rate or extent of CoA-transferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of CoA-transferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of CoA-transferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of CoA-transferase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of CoA-transferase activity.
Any process that activates or increases the frequency, rate or extent of CoA-transferase activity.
Any process that activates or increases the frequency, rate or extent of CoA-transferase activity.
Any process that activates or increases the frequency, rate or extent of CoA-transferase activity.
Any process that activates or increases the frequency, rate or extent of CoA-transferase activity.
Any process that modulates the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that modulates the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that modulates the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that modulates the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of acetylcholine biosynthetic process.
Any process that modulates the frequency, rate or extent of invadopodium assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium assembly.
Any process that activates or increases the frequency, rate or extent of invadopodium assembly.
Any process that activates or increases the frequency, rate or extent of invadopodium assembly.
Any process that activates or increases the frequency, rate or extent of invadopodium assembly.
Any process that activates or increases the frequency, rate or extent of invadopodium assembly.
Any process that activates or increases the frequency, rate or extent of invadopodium assembly.
Any process that activates or increases the frequency, rate or extent of invadopodium assembly.
Any process that activates or increases the frequency, rate or extent of invadopodium assembly.
Any process that activates or increases the frequency, rate or extent of invadopodium assembly.
Any process that activates or increases the frequency, rate or extent of invadopodium assembly.
Any process that modulates the frequency, rate or extent of invadopodium disassembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium disassembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium disassembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium disassembly.
Any process that stops, prevents or reduces the frequency, rate or extent of invadopodium disassembly.
Any process that activates or increases the frequency, rate or extent of invadopodium disassembly.
Any process that activates or increases the frequency, rate or extent of invadopodium disassembly.
Any process that activates or increases the frequency, rate or extent of invadopodium disassembly.
Any process that activates or increases the frequency, rate or extent of invadopodium disassembly.
Any process that modulates the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that modulates the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that modulates the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that modulates the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that modulates the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell differentiation involved in phenotypic switching.
Any process that modulates the frequency, rate or extent of cell fate determination.
Any process that stops, prevents or reduces the frequency, rate or extent of cell fate determination.
Any process that stops, prevents or reduces the frequency, rate or extent of cell fate determination.
Any process that stops, prevents or reduces the frequency, rate or extent of cell fate determination.
Any process that stops, prevents or reduces the frequency, rate or extent of cell fate determination.
Any process that activates or increases the frequency, rate or extent of cell fate determination.
Any process that activates or increases the frequency, rate or extent of cell fate determination.
Any process that activates or increases the frequency, rate or extent of cell fate determination.
Any process that activates or increases the frequency, rate or extent of cell fate determination.
Any process that modulates the frequency, rate or extent of germ cell proliferation.
Any process that stops, prevents or reduces the frequency, rate or extent of germ cell proliferation.
Any process that stops, prevents or reduces the frequency, rate or extent of germ cell proliferation.
Any process that stops, prevents or reduces the frequency, rate or extent of germ cell proliferation.
Any process that stops, prevents or reduces the frequency, rate or extent of germ cell proliferation.
Any process that activates or increases the frequency, rate or extent of germ cell proliferation.
Any process that activates or increases the frequency, rate or extent of germ cell proliferation.
Any process that activates or increases the frequency, rate or extent of germ cell proliferation.
Any process that activates or increases the frequency, rate or extent of germ cell proliferation.
Any process that modulates the frequency, rate or extent of gonad development.
Any process that stops, prevents or reduces the frequency, rate or extent of gonad development.
Any process that stops, prevents or reduces the frequency, rate or extent of gonad development.
Any process that stops, prevents or reduces the frequency, rate or extent of gonad development.
Any process that stops, prevents or reduces the frequency, rate or extent of gonad development.
Any process that stops, prevents or reduces the frequency, rate or extent of gonad development.
Any process that stops, prevents or reduces the frequency, rate or extent of gonad development.
Any process that stops, prevents or reduces the frequency, rate or extent of gonad development.
Any process that stops, prevents or reduces the frequency, rate or extent of gonad development.
Any process that stops, prevents or reduces the frequency, rate or extent of gonad development.
Any process that activates or increases the frequency, rate or extent of gonad development.
Any process that activates or increases the frequency, rate or extent of gonad development.
Any process that activates or increases the frequency, rate or extent of gonad development.
Any process that activates or increases the frequency, rate or extent of gonad development.
Any process that activates or increases the frequency, rate or extent of gonad development.
Any process that activates or increases the frequency, rate or extent of gonad development.
Any process that activates or increases the frequency, rate or extent of gonad development.
Any process that activates or increases the frequency, rate or extent of gonad development.
Any process that activates or increases the frequency, rate or extent of gonad development.
Any process that modulates the frequency, rate or extent of formation of growth cone in injured axon.
Any process that stops, prevents or reduces the frequency, rate or extent of formation of growth cone in injured axon.
Any process that stops, prevents or reduces the frequency, rate or extent of formation of growth cone in injured axon.
Any process that stops, prevents or reduces the frequency, rate or extent of formation of growth cone in injured axon.
Any process that stops, prevents or reduces the frequency, rate or extent of formation of growth cone in injured axon.
Any process that activates or increases the frequency, rate or extent of formation of growth cone in injured axon.
Any process that activates or increases the frequency, rate or extent of formation of growth cone in injured axon.
Any process that activates or increases the frequency, rate or extent of formation of growth cone in injured axon.
Any process that activates or increases the frequency, rate or extent of formation of growth cone in injured axon.
Any process that modulates the frequency, rate or extent of response to calcium ion.
Any process that stops, prevents or reduces the frequency, rate or extent of response to calcium ion.
Any process that stops, prevents or reduces the frequency, rate or extent of response to calcium ion.
Any process that stops, prevents or reduces the frequency, rate or extent of response to calcium ion.
Any process that stops, prevents or reduces the frequency, rate or extent of response to calcium ion.
Any process that stops, prevents or reduces the frequency, rate or extent of response to calcium ion.
Any process that stops, prevents or reduces the frequency, rate or extent of response to calcium ion.
Any process that stops, prevents or reduces the frequency, rate or extent of response to calcium ion.
Any process that stops, prevents or reduces the frequency, rate or extent of response to calcium ion.
Any process that stops, prevents or reduces the frequency, rate or extent of response to calcium ion.
Any process that activates or increases the frequency, rate or extent of response to calcium ion.
Any process that activates or increases the frequency, rate or extent of response to calcium ion.
Any process that activates or increases the frequency, rate or extent of response to calcium ion.
Any process that activates or increases the frequency, rate or extent of response to calcium ion.
Any process that activates or increases the frequency, rate or extent of response to calcium ion.
Any process that activates or increases the frequency, rate or extent of response to calcium ion.
Any process that activates or increases the frequency, rate or extent of response to calcium ion.
Any process that activates or increases the frequency, rate or extent of response to calcium ion.
Any process that activates or increases the frequency, rate or extent of response to calcium ion.
Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + 3',5'-cyclic GMP(in) = ADP + phosphate + 3',5'-cyclic GMP(out).
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion import across plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion import across plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion import across plasma membrane.
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion import across plasma membrane.
Any DNA recombination that takes place in mitochondrion.
Any process that modulates the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of lipid localization.
Any process that activates or increases the frequency, rate or extent of lipid localization.
Any process that activates or increases the frequency, rate or extent of lipid localization.
Any process that activates or increases the frequency, rate or extent of lipid localization.
Any process that activates or increases the frequency, rate or extent of lipid localization.
Any process that activates or increases the frequency, rate or extent of lipid localization.
Any process that activates or increases the frequency, rate or extent of lipid localization.
Any process that activates or increases the frequency, rate or extent of lipid localization.
Any process that activates or increases the frequency, rate or extent of lipid localization.
Any process that activates or increases the frequency, rate or extent of lipid localization.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial tube morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial tube morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial tube morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial tube morphogenesis.
Any process that activates or increases the frequency, rate or extent of endothelial tube morphogenesis.
Any process that activates or increases the frequency, rate or extent of endothelial tube morphogenesis.
Any process that activates or increases the frequency, rate or extent of endothelial tube morphogenesis.
Any process that activates or increases the frequency, rate or extent of endothelial tube morphogenesis.
Any process that modulates the frequency, rate or extent of cellular response to alcohol.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to alcohol.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to alcohol.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to alcohol.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to alcohol.
Any process that activates or increases the frequency, rate or extent of cellular response to alcohol.
Any process that activates or increases the frequency, rate or extent of cellular response to alcohol.
Any process that activates or increases the frequency, rate or extent of cellular response to alcohol.
Any process that activates or increases the frequency, rate or extent of cellular response to alcohol.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)pentan-1-one stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)pentan-1-one stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)pentan-1-one stimulus.
A protein complex which is capable of protein-cysteine S-palmitoyltransferase activity.
A protein complex which is capable of protein-cysteine S-palmitoyltransferase activity.
The process in which a relatively unspecialized cell acquires the specialized features of a glutamatergic neuron.
The generation of amyloid fibrils, insoluble fibrous protein aggregates exhibiting beta sheet structure, from proteins.
The generation of amyloid fibrils, insoluble fibrous protein aggregates exhibiting beta sheet structure, from proteins.
The generation of amyloid fibrils, insoluble fibrous protein aggregates exhibiting beta sheet structure, from proteins.
Any process that prevents the activation of an inactive cysteine-type endopeptidase involved in an apoptotic process.
Catalysis of the reaction: H+ + methylglyoxal + NADPH <=> hydroxyacetone + NADP+.
Catalysis of the reaction: IDP + H2O = IMP + phosphate.
Catalysis of the reaction: IDP + H2O = IMP + phosphate.
Catalysis of the reaction: IDP + H2O = IMP + phosphate.
Catalysis of the reaction: IDP + H2O = IMP + phosphate.
Catalysis of the reaction: XDP + H2O = XMP + phosphate.
A cytoplasmic membrane-bounded vesicle of varying size, but usually larger than 45 nm, with an electron dense granular core, found in noradrenergic and peptidergic cells.
A cytoplasmic membrane-bounded vesicle first described in dendrites, categorized by smooth membranes, electron-lucent interiors and irregular shapes. Sometimes occurs in clumps. Amorphous vesicles have been found to contain material taken up from the extracellular space, therefore suggesting that they may be part of the endosomal pathway.
A configuration of endoplasmic reticulum (ER) found in Purkinje cells in the cerebellum and in axons in the lateral vestibular nucleus, consisting of parallel and interconnecting tubules whose outer surfaces are covered by particles or ringlike structures.
A large cytoplasmic membrane-bounded vesicle with an electron dense granular core, up to 150-200 nm in diameter, found in neurosecretory cells in the hypothalamus.
Any apoptotic process in a retinal cell.
Any apoptotic process in a retinal cell.
Any apoptotic process in a compound eye retinal cell.
Inclusion body characterized by regularly spaced sheets of tubules arranged in a whorl pattern resembling a fingerprint. Laminated bodies have been observed in neurons of the lateral geniculate nucleus.
A cytoplasmic inclusion body found in some lateral geniculate neurons and composed of sheets of tubules (25 nm in diameter) separated by dense material (about 75 nm wide), which together with the tubules whorl give a structure resembling a fingerprint.
A hexagonal array of electron dense particles attached to the cytoplasmic face of the presynaptic membrane.
Square array of closely spaced intramembrane particles, 4-6 nm in size, that form supramolecular aggregates found in the plasma membrane of astrocytes, skeletal muscle and epithelial cells. They have been shown to contain aquaporins (water channels).
Square array of closely spaced intramembrane particles, 4-6 nm in size, that form supramolecular aggregates found in the plasma membrane of astrocytes, skeletal muscle and epithelial cells. They have been shown to contain aquaporins (water channels).
Square array of closely spaced intramembrane particles, 4-6 nm in size, that form supramolecular aggregates found in the plasma membrane of astrocytes, skeletal muscle and epithelial cells. They have been shown to contain aquaporins (water channels).
A cell projection (often from glial cells such as Schwann cells) that surrounds an unmyelinated axon or cell soma.
Elongated portion of a tanycyte that sticks into the periventricular layer of neuropil where it appears to contact a blood vessel; characterized by numerous cytoplasmic extensions. A tanycyte is a specialized elongated ventricular ependymal cell that has processes that extend to the outer, or pial, surface of the CNS.
Portion of a tanycyte that lies within the ependyma and contains the nucleus. A tanycyte is a specialized elongated ventricular ependymal cell that has processes that extend to the outer, or pial, surface of the CNS.
Elongated process of a tanycyte, devoid of cytoplasmic extensions, that courses through the hypothalamic nuclei to form small endfoot processes that terminate either on blood vessels or at the pial surface of the brain. A tanycyte is a specialized elongated ventricular ependymal cell.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a protein storage vacuole, a storage vacuole that contains a lytic vacuole.
Axon collateral that ramifies in the area of the soma of the cell of origin.
Part of axon of a CA3 pyramidal neuron that projects to hippocampal area CA1.
The area in the center of the anaphase spindle consisting of microtubules, microtubule bundling factors and kinesin motors where the spindle microtubules from opposite poles overlap in an antiparallel manner.
Synaptic bouton found in spinal cord on the soma and proximal dendrites of motor neurons.
Synaptic bouton found in the ventral horn of the spinal cord. F boutons range in diameter from 0.5 to 7 um and contain flattened or pleomorphic synaptic vesicles.
Synaptic expansion of hippocampal mossy fiber axon that makes contact with the thorny excrescences of hippocampal CA3 pyramidal cell dendrites.
Synaptic expansion of hippocampal mossy fiber axon that makes contact with the thorny excrescences of hippocampal CA3 pyramidal cell dendrites.
Synaptic expansion of hippocampal mossy fiber axon that makes contact with the thorny excrescences of hippocampal CA3 pyramidal cell dendrites.
Synaptic bouton found in the ventral horn of the spinal cord. S boutons range in diameter from 0.5 to 8 um and contain spherical synaptic vesicles.
Enables the transmembrane transfer of a calcium ion by an intermediate voltage-gated channel. An intermediate voltage-gated channel is a channel whose open state is dependent on intermediate voltage across the membrane in which it is embedded.
The rhythmical contraction and relaxation of arterioles, observed as slow and fast waves, with frequencies of 1-2 and 10-20 cpm.
Ramification of basket cell axon surrounding cell bodies, forming the characteristic pericellular baskets from which the cell class derives its name.
Ramification of basket cell axon surrounding cell bodies, forming the characteristic pericellular baskets from which the cell class derives its name.
Dense plexus formed by the descending collaterals of cerebellar basket cells that wrap around a Purkinje cell axonal initial segment.
A parallel fiber results from the bifurcation of a cerebellar granule cell axon in the molecular layer into two diametrically opposed branches, that are oriented parallel to the long axis of the folium.
The part of a dendritic tree where it branches, giving rise to a dendritic branch.
The directed movement of calcium ions from inside of a cell, across the plasma membrane and into the extracellular region.
The directed movement of calcium ions from inside of a cell, across the plasma membrane and into the extracellular region.
The directed movement of calcium ions into a sarcoplasmic reticulum.
The center portion of a Lewy body. In Parkinson's disease, it contains a matted meshwork of filaments.
The periphery of a Lewy body. In Parkinson's disease, it contains spherical accumulations of filaments arranged in a loose, radiating array.
Specialized part of the smooth endoplasmic reticulum that closely underlies the plasma membrane, usually within 60 nm or closer.
Specialization of the hypolemmal cisterna consisting of either single profiles or closely apposed stacks of endoplasmic reticulum in which the lumen is obliterated, lying 10-20 nm beneath the plasma membrane.
Catalysis of an oxidation-reduction (redox) reaction in which glycerol is converted into glycerone and NAD+ or NADP is reduced.
Catalysis of the endonucleolytic cleavage immediately 5' to pyrimidine dimers to products with 5'-phosphate.
A process in which a protein is transported to, or maintained in, a location on or within a lipid droplet.
A process in which a protein is transported to, or maintained in, a location on or within a lipid droplet.
A process in which a protein is transported to, or maintained in, a location on or within a lipid droplet.
A process in which a protein is transported to, or maintained in, a location on or within a lipid droplet.
A process in which a protein is transported to, or maintained in, a location on or within a lipid droplet.
A process in which a protein is transported to, or maintained in, a location on or within a lipid droplet.
A process in which a protein is transported to, or maintained in, a location on or within a lipid droplet.
The process whose specific outcome is the progression of the sclerotium over time, from its formation to the mature structure. A sclerotium is a mycelial resting body, resistant to adverse environmental conditions.
Merging of two or more mitochondria within a cell to form a single compartment, as a result of a disturbance in cellular homeostasis.
Merging of two or more mitochondria within a cell to form a single compartment, as a result of a disturbance in cellular homeostasis.
Merging of two or more mitochondria within a cell to form a single compartment, as a result of a disturbance in cellular homeostasis.
A proteinaceous, nuclear-derived structure that embeds the microtubule spindle apparatus from pole to pole in a microtubule-independent manner during mitosis.
The directed movement of substances in neuronal dense core vesicles along axonal microtubules towards the presynapse.
The directed movement of substances in neuronal dense core vesicles along axonal microtubules towards the presynapse.
The directed movement of neuronal dense core vesicles along axonal microtubules towards the cell body.
The directed movement of neuronal dense core vesicles along axonal microtubules towards the cell body.
Enables the directed movement of phosphatidic acid into, out of or within a cell, or between cells. Phosphatidic acid refers to a glycophospholipids with, in general, a saturated fatty acid bonded to carbon-1, an unsaturated fatty acid bonded to carbon-2, and a phosphate group bonded to carbon-3.
Any process that initiates the activity of the inactive enzyme protein kinase C.
Any process that initiates the activity of the inactive enzyme protein kinase C.
The directed movement of a lipid from the endoplasmic reticulum (ER) to the chloroplast.
The directed movement of a lipid from the endoplasmic reticulum (ER) to the chloroplast.
Catalysis of the reaction: DNA containing 5-methylcytosine + H2O = DNA with abasic site + 5-methylcytosine. This reaction is the hydrolysis of DNA by cleavage of the N-C1' glycosidic bond between the DNA 5-methylcytosine and the deoxyribose sugar to remove the 5-methylcytosine, leaving an abasic site.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temozolomide stimulus.
Catalyzes the reaction: L-phenylalanine + O2 + H2O -> phenylacetaldehyde + ammonia + hydrogen peroxide + CO2.
The process whose specific outcome is the progression of the fruit replum over time, from its formation to the mature structure. The fruit replum is a portion of fruit placenta tissue that divides a fruit into two or more chambers and develops from a replum.
The process whose specific outcome is the progression of the fruit valve over time, from its formation to the mature structure. The fruit valve is a part of a fruit that splits apart when the fruit dehisces.
Protein complex facilitating ATP-dependent maltose transport through inner cell membrane (periplasm to cytoplasm) in Gram-negative bacteria. In E. coli the system is composed of a periplasmic maltose-binding protein (MBP), two integral membrane proteins, MalF and MalG, and two copies of the cytoplasmic ATP-binding cassette MalK.
Protein complex facilitating ATP-dependent maltose transport through inner cell membrane (periplasm to cytoplasm) in Gram-negative bacteria. In E. coli the system is composed of a periplasmic maltose-binding protein (MBP), two integral membrane proteins, MalF and MalG, and two copies of the cytoplasmic ATP-binding cassette MalK.
The degradosome is a protein complex playing a key role in mRNA degradation and RNA processing. It includes a RNA helicase, a 3'-5' phosphate-dependent PNPase and a RNase E bound-enolase.
A protein complex first characterized in human and comprised of a R2TP module (R2TP complex), a prefoldin-like module (containing both prefoldin-like proteins and canonical prefoldins), WD40 repeat protein Monad/WDR92 and DNA-dependent RNA polymerase subunit RPB5. This complex might have chaperone activity.
Protein complex which is involved in assembly and insertion of beta-barrel proteins into the outer membrane. In E. coli it is composed of BamABCDE, of the outer membrane protein BamA, and four lipoproteins BamB, BamC, BamD and BamE. BamA interacts directly with BamB and the BamCDE subcomplex.
The regionalization process that gives rise to the patterning of the ground tissue.
A protein complex that is involved in the MEP pathway of IPP biosynthesis. It catalyzes the NADP-dependent rearrangement and reduction of 1-deoxy-D-xylulose-5-phosphate (DXP) to 2-C-methyl-D-erythritol 4-phosphate (MEP).
The process by which excess light energy absorbed by chlorophyll and not used to drive photosynthesis is emitted by nonphotochemical quenching or chlorophyll fluorescence.
The process of DNA recombination occurring within a single chromosome.
The seed development process whose outcome is the drying of a maturing seed.
The process of opening of stomata, pores in the epidermis of leaves and stems bordered by two guard cells and serving in gas exchange.
A complex that tethers COPII vesicles at ER-Golgi intermediate compartment. Its role in this part of the vesicular transport may start at the ER exit sites. Binds to a component of the COPII coat. In yeast it includes the following subunits: Bet3 (as homodimer), Bet5, Trs20, Trs23, Trs31, Trs33 which are regarded as the "core subunits" of all TRAPP complexes in yeast.
A complex that mediates intra-Golgi traffic, Golgi exit, endosome-to-Golgi traffic, and the trafficking of autophagy proteins from Golgi to the phagophore assembly site. Binds to a component of the COPI coat. In yeast it includes the following subunits: Bet3 (as homodimer), Bet5, Tca17, Trs20, Trs23, Trs31, Trs33, Trs65, Trs120, Trs130. The whole complex is thought to dimerize with itself.
A complex that functions in anterograde transport at the Golgi and also regulates autophagy. In yeast it includes at least the following subunits: Bet3 (as homodimer), Bet5, Trs20, Trs23, Trs31, Trs33, Trs85. TRAPPIII may include further, as yet undescribed, proteins.
A cell wall part that is the part of a wall of a vessel member and bears one or more openings (perforations).
The chemical reactions and pathways resulting in the breakdown of a messenger RNA (mRNA) molecule, initiated by the enzymatic addition of a sequence of uridylyl residues (polyuridylation) at the 3' end of the target mRNA.
A plasma membrane region adjacent to the base of eukaryotic cilia and flagella that is enriched in endocytosis-associated proteins and vesicles and that appears to regulate ciliary membrane homeostasis.
Any cell wall polysaccharide catabolic process that is involved in abscission.
Any of a family of protein complexes that form at the origin of replication or stalled replication forks and function in replication primer synthesis in all organisms.  Early complexes initiate double-stranded DNA unwinding. The core unit consists of a replicative helicase and a primase. The helicase further unwinds the DNA and recruits the polymerase machinery. The primase synthesizes RNA primers that act as templates for complementary stand replication by the polymerase machinery. The primosome contains a number of associated proteins and protein complexes and contributes to the processes of replication initiation, lagging strand elongation, and replication restart.
A protein complex that inhibits multiple events of replication initiation during one replication cycle.
A tissue homeostatic process involved in the maintenance of an internal equilibrium within cartilage, including control of cellular proliferation and death and control of metabolic function.
A tissue homeostatic process involved in the maintenance of an internal equilibrium within cartilage, including control of cellular proliferation and death and control of metabolic function.
A tissue homeostatic process involved in the maintenance of an internal equilibrium within cartilage, including control of cellular proliferation and death and control of metabolic function.
A tissue homeostatic process involved in the maintenance of an internal equilibrium within cartilage, including control of cellular proliferation and death and control of metabolic function.
A tissue homeostatic process involved in the maintenance of an internal equilibrium within cartilage, including control of cellular proliferation and death and control of metabolic function.
A tissue homeostatic process involved in the maintenance of an internal equilibrium within cartilage, including control of cellular proliferation and death and control of metabolic function.
Combining with the biogenic amine 2-phenylethylamine to initiate a change in cell activity.
Combining with the biogenic amine trimethylamine to initiate a change in cell activity.
A protein complex that inhibits unwinding of DNA at the origin of replication and assembly of the pre-primosome. In E. coli, this complex is composed of DnaA and of the ribosomal protein L2.
A protein complex that inactivates the function of DnaA by inhibiting the phosphorylation of DnaA-ADP to DnaA-ATP and thereby preventing multiple events of replication initiation. In E. coli, this complex is composed of DnaA and Hda.
A protein complex that negatively regulates strand-opening at the origin of replication, thereby interfering with replication initiation. This complex is thought to be involved in the regulation of replication under oxidative stress conditions. In E. coli, this complex is composed of DnaA and Dps.
A protein complex involved in inactivating the function of DnaA and thereby preventing multiple events of replication initiation. In E. coli, this complex is composed of the beta clamp (DnaN) and Hda.
A protein complex involved in inactivating the function of DnaA and thereby preventing multiple events of replication initiation. In E. coli, this complex is composed of the beta clamp (DnaN) and Hda.
Any apoptotic process in a lens fiber cell. Lens fiber cells are elongated, tightly packed cells that make up the bulk of the mature lens in a camera-type eye.
Catalysis of the reaction: a [methyl-Co(III) methanol-specific corrinoid protein] + coenzyme M = methyl-CoM + a [Co(I) methanol-specific corrinoid protein].
A process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus.
A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus.
The sodium-dependent hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their own peptide bonds.
The calcium-dependent hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their own peptide bonds.
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a superoxide stimulus. Superoxide is the anion, oxygen-, formed by addition of one electron to dioxygen (O2) or any compound containing the superoxide anion.
A protein-DNA complex that contains an oligomer of SeqA bound to GATC sites in methylated or newly-synthesized, hemi-methylated double-stranded DNA, with preference for the latter. Binding of SeqA to hemimethylated DNA sequesters oriC, prevents re-methylation of DNA by Dam and in turn stops premature re-initiation of replication during one replication cycle.
A protein-DNA complex that contains an oligomer of SeqA bound to GATC sites in methylated or newly-synthesized, hemi-methylated double-stranded DNA, with preference for the latter. Binding of SeqA to hemimethylated DNA sequesters oriC, prevents re-methylation of DNA by Dam and in turn stops premature re-initiation of replication during one replication cycle.
A protein-DNA complex that contains an oligomer of SeqA bound to GATC sites in methylated or newly-synthesized, hemi-methylated double-stranded DNA, with preference for the latter. Binding of SeqA to hemimethylated DNA sequesters oriC, prevents re-methylation of DNA by Dam and in turn stops premature re-initiation of replication during one replication cycle.
A protein-DNA complex containing at least one DNA helicase and one primase. Can also contain associated proteins. The helicase component continues to unwind the double-stranded DNA (dsDNA) and the primase component synthesizes a RNA primer during initiation or restart of replication.
Any of the protein-DNA complexes that contain a DNA helicase and associated protein(s) at the origin of replication, and build up to assembling the core primosome. The associated protein(s) chaperone the helicase to the DNA, and assembly of the pre-primosome is essential for the initiation or restart of replication. Pre-primosome complexes lack a primase component.
Any of the protein-DNA complexes that contain a DNA helicase and associated protein(s) at the origin of replication, and build up to assembling the core primosome. The associated protein(s) chaperone the helicase to the DNA, and assembly of the pre-primosome is essential for the initiation or restart of replication. Pre-primosome complexes lack a primase component.
Any of the protein-DNA complexes that contain a DNA helicase and associated protein(s) at the origin of replication, and build up to assembling the core primosome. The associated protein(s) chaperone the helicase to the DNA, and assembly of the pre-primosome is essential for the initiation or restart of replication. Pre-primosome complexes lack a primase component.
Any of the protein-DNA complexes that contain a DNA helicase and associated protein(s) at the origin of replication, and build up to assembling the core primosome. The associated protein(s) chaperone the helicase to the DNA, and assembly of the pre-primosome is essential for the initiation or restart of replication. Pre-primosome complexes lack a primase component.
Any of the protein-DNA complexes that contain a DNA helicase and associated protein(s) at the origin of replication, and build up to assembling the core primosome. The associated protein(s) chaperone the helicase to the DNA, and assembly of the pre-primosome is essential for the initiation or restart of replication. Pre-primosome complexes lack a primase component.
Any of the protein-DNA complexes that contain a DNA helicase and associated protein(s) at the origin of replication, and build up to assembling the core primosome. The associated protein(s) chaperone the helicase to the DNA, and assembly of the pre-primosome is essential for the initiation or restart of replication. Pre-primosome complexes lack a primase component.
A protein complex containing homohexameric DNA helicase DnaB, and the DNA helicase loader DnaC. The helicase loader DnaC delivers DnaB to the chromosomal origin (oriC).
A protein complex containing homohexameric DNA helicase DnaB, and the DNA helicase loader DnaC. The helicase loader DnaC delivers DnaB to the chromosomal origin (oriC).
A protein complex containing homohexameric DNA helicase DnaB, and the DNA helicase loader DnaC. The helicase loader DnaC delivers DnaB to the chromosomal origin (oriC).
A protein-DNA complex containing the initiator protein DnaA bound to high-affinity recognition sites in the unique origin of replication, oriC. DnaA-oriC binding is the first step in assembly of a bacterial pre-replicative complex (pre-RC) and is responsible for the timely initiation of replication once per cell cycle.
A protein-DNA complex containing a tetramer of DiaA attached to multiple  DnaA molecule bound to oriC DNA. Regulates timely initiation of chromosomal replication during the cell cycle by stimulating assembly of DnaA-oriC complexes, conformational changes in ATP-DnaA initiation complexes, and unwinding of oriC duplex DNA.
A protein-DNA complex containing DNA-bound DnaA attached to HU. HU is a dimer encoded by two closely related genes. Essential for the initiation of replication in bacteria; stimulates the DnaA-dependent unwinding of oriC.
A protein-DNA complex that contains DNA in combination with a protein which binds to and bends DNA. Often plays a role in DNA compaction.
Catalysis of the reaction: 1-deoxy-D-xylulose 5-phosphate + 2-iminoacetate + thiocarboxy-adenylate-[sulfur-carrier protein ThiS] = 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate + [sulfur-carrier protein ThiS] + 2 H2O.
A protein deubiquitination process in which a linear polymer of ubiquitin, formed by the amino-terminal methionine (M1) of one ubiquitin molecule and by the carboxy-terminal glycine (G76) of the next, is removed from a protein.
The process involved in the rejection of pollen of one species by cells in the stigma of another species.
The process by which a callus is formed at a wound site. A plant callus is a portion of plant tissue that consists of mass of undifferentiated plant cells. It consists primarily of parenchyma cells but possibly contains other cell types as the callus begins to differentiate.
A proteasome specifically found in mammalian testis. Contains the proteasome activator PA200 in the regulatory particle, and beta1i, beta2i, beta5i and/or alpha4s in the core (20S) subunit. Beta1i, beta2i and beta5i are inducible catalytic subunits, closely related to beta1, beta2 and beta5. Alpha4s is a sperm-specific 20S subunit, but unlike other alternative 20S subunits alpha4s lies in the outer alpha-ring and lacks catalytic activity.
A multiprotein complex that forms a stable complex with 60S ribosomal subunits containing stalled polypeptides and triggers their degradation (ribosomal quality control). In budding yeast, this complex includes Cdc48p, Rkr1p, Tae2p, Rqc1p, Npl4p and Ufd1p proteins.
A multiprotein complex that forms a stable complex with 60S ribosomal subunits containing stalled polypeptides and triggers their degradation (ribosomal quality control). In budding yeast, this complex includes Cdc48p, Rkr1p, Tae2p, Rqc1p, Npl4p and Ufd1p proteins.
The aggregation, arrangement and bonding together of a set of components to form the eukaryotic RNA polymerase I complex.
The aggregation, arrangement and bonding together of a set of components to form the eukaryotic RNA polymerase I complex.
The aggregation, arrangement and bonding together of a set of components to form the eukaryotic RNA polymerase II core complex.
The aggregation, arrangement and bonding together of a set of components to form the eukaryotic RNA polymerase II core complex.
The aggregation, arrangement and bonding together of a set of components to form the eukaryotic RNA polymerase III complex.
The aggregation, arrangement and bonding together of a set of components to form the eukaryotic RNA polymerase III complex.
The chemical reactions and pathways resulting in the breakdown of a protein or peptide encoded by an aberrant message and associated with a stalled ribosome. Degradation is initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the ribosome-associated protein.
The chemical reactions and pathways resulting in the breakdown of a protein or peptide encoded by an aberrant message and associated with a stalled ribosome. Degradation is initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the ribosome-associated protein.
The chemical reactions and pathways resulting in the breakdown of a protein or peptide encoded by an aberrant message and associated with a stalled ribosome. Degradation is initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the ribosome-associated protein.
The chemical reactions and pathways resulting in the breakdown of a protein or peptide encoded by an aberrant message and associated with a stalled ribosome. Degradation is initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the ribosome-associated protein.
The chemical reactions and pathways resulting in the breakdown of a protein or peptide encoded by an aberrant message and associated with a stalled ribosome. Degradation is initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the ribosome-associated protein.
An extrinsic apoptotic signaling pathway initiated by the cross-linking of an antigen receptor on a B cell.
An extrinsic apoptotic signaling pathway initiated by the cross-linking of an antigen receptor on a B cell.
An extrinsic apoptotic signaling pathway initiated by the cross-linking of an antigen receptor on a B cell.
Stops, prevents or reduces the activity of ATP-dependent RNA helicase.
The aggregation, arrangement and bonding together of proteins and messenger RNA (mRNA) molecules to form a messenger ribonucleoprotein (mRNP) complex.
The aggregation, arrangement and bonding together of proteins and messenger RNA (mRNA) molecules to form a messenger ribonucleoprotein (mRNP) complex.
The aggregation, arrangement and bonding together of proteins and messenger RNA (mRNA) molecules to form a messenger ribonucleoprotein (mRNP) complex.
The aggregation, arrangement and bonding together of proteins and messenger RNA (mRNA) molecules to form a messenger ribonucleoprotein (mRNP) complex.
A multimer of H-NS proteins that is involved in bacterial nucleoid condensation and negative regulation of global gene expression by directly binding to promoter regions. Recognizes both structural and sequence-specific motifs in double-stranded DNA and has binding preference for bent DNA.
A multimer of H-NS proteins that is involved in bacterial nucleoid condensation and negative regulation of global gene expression by directly binding to promoter regions. Recognizes both structural and sequence-specific motifs in double-stranded DNA and has binding preference for bent DNA.
A ribonucleoprotein complex containing both protein and messenger RNA (mRNA) molecules.
A ribonucleoprotein complex containing both protein and messenger RNA (mRNA) molecules.
A ribonucleoprotein complex containing both protein and messenger RNA (mRNA) molecules.
A ribonucleoprotein complex containing both protein and messenger RNA (mRNA) molecules.
A homotetrameric protein complex consisting of a symmetrical pair of DiaA homodimers. Facilitates DnaA binding to the origin of replication during replication initiation.
The directed movement of membrane-bounded vesicles from endosomes back to the plasma membrane, a trafficking pathway that promotes the recycling of internalized transmembrane proteins.
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of osmotic stress, and ends when the execution phase of apoptosis is triggered.
A protein complex involved in regulation of non-nitrogen-starvation (NNS) autophagic process. In S. cerevisiae this complex contains Iml1p, Npr2p and Npr3p proteins. In humans the GATOR1 complex consists of DEPDC5, Nprl2, Nprl3.
A protein complex involved in regulation of non-nitrogen-starvation (NNS) autophagic process. In S. cerevisiae this complex contains Iml1p, Npr2p and Npr3p proteins. In humans the GATOR1 complex consists of DEPDC5, Nprl2, Nprl3.
A heterodimer GTPase complex. In S. cerevisiae, this complex contains Gtr1p and Gtr2p proteins.
A heterodimeric protein complex which adenylates two molecules of the sulfur carrier subunit of the molybdopterin (MPT) cofactor synthase using ATP as part of molybdopterin cofactor (Moco) biosynthesis. In E. coli the subunits are MoeB and MoaD; Moco biosynthesis and its constituent molecules are evolutionarily conserved.
An apoptotic process in a palatal shelf epithelial cell that contributes to the shaping of the palatal shelf.
Catalysis of the reaction: a flavonoid + 3'-phosphoadenosine-5'-phosphosulfate = sulfated flavonoid + adenosine-3',5'-diphosphate. This reaction is the transfer of a sulfate group to the hydroxyl group of a flavonoid acceptor, producing the sulfated flavonoid derivative.
Catalysis of the reaction: linoleate + O2 = (9S,10E,12Z)-9-hydroperoxy-10,12-octadecadienoate.
Catalysis of the reaction: linoleate + O2 = (9S,10E,12Z)-9-hydroperoxy-10,12-octadecadienoate.
Catalysis of the reaction: linoleate + O2 = (9S,10E,12Z)-9-hydroperoxy-10,12-octadecadienoate.
Catalysis of the reaction: linoleate + O2 = (9S,10E,12Z)-9-hydroperoxy-10,12-octadecadienoate.
Catalysis of the reaction: R1H + R2OOH = R1OH + R2OH.
Long distance growth of a single neuron projection involved in cellular development. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
Long distance growth of a single neuron projection involved in cellular development. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
Long distance growth of a single neuron projection involved in cellular development. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
Long distance growth of a single neuron projection involved in cellular development. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
A process in which a protein is transported to, or maintained in, a location within the nuclear periphery.
A heterodimeric protein complex which catalyses sulfur transfer from the sulfur carrier subunit of MPT synthase to precursor Z to synthesize MPT as part of molybdopterin cofactor (Moco) biosynthesis. In E. coli the subunits are MoaE and MoaD; in human, MOCS2B and MOCS2A. Moco biosynthesis and its constituent molecules are evolutionarily conserved.
Repression of transcription of DNA at the outer repeat region of a regional centromere by altering the structure of chromatin.
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with hemolysis in the bitten organism.
A multisubunit complex likely involved in the synthesis of coenzyme A (CoA). In S. cerevisiae, the complex consists of at least Cab2, Cab3, Cab4 and Cab5 but may also include Sis2 and Vhs3. The latter subunits are shared by the GO:0071513 phosphopantothenoylcysteine decarboxylase complex that catalyses the third step of the coenzyme A (CoA) biosynthetic pathway.
A multisubunit complex likely involved in the synthesis of coenzyme A (CoA). In S. cerevisiae, the complex consists of at least Cab2, Cab3, Cab4 and Cab5 but may also include Sis2 and Vhs3. The latter subunits are shared by the GO:0071513 phosphopantothenoylcysteine decarboxylase complex that catalyses the third step of the coenzyme A (CoA) biosynthetic pathway.
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to hypoxia (lowered oxygen tension). Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. The pathway ends when the execution phase of apoptosis is triggered.
Suppression of the occurrence of translational errors, such as codon-anticodon mis-paring, during the process of translation of a protein using an mRNA template.
A process in which a protein is transported to, or maintained in, a location within a rhabdomere.
Interacting selectively and non-covalently with a talin, a family of related cytoskeletal proteins that play a role in assembly of actin filaments and migration of various cell types.
A homomeric protein complex that possesses glutamate dehydrogenase activity. This complex is evolutionarily conserved except that the number of homoprotomers per complex varies.
A homomeric protein complex that possesses glutamate dehydrogenase activity. This complex is evolutionarily conserved except that the number of homoprotomers per complex varies.
A homomeric protein complex that possesses glutamate dehydrogenase activity. This complex is evolutionarily conserved except that the number of homoprotomers per complex varies.
A homomeric protein complex that possesses glutamate dehydrogenase activity. This complex is evolutionarily conserved except that the number of homoprotomers per complex varies.
A homomeric protein complex that possesses glutamate dehydrogenase activity. This complex is evolutionarily conserved except that the number of homoprotomers per complex varies.
A homomeric protein complex that possesses glutamate dehydrogenase activity. This complex is evolutionarily conserved except that the number of homoprotomers per complex varies.
A homomeric protein complex that possesses glutamate dehydrogenase activity. This complex is evolutionarily conserved except that the number of homoprotomers per complex varies.
A homomeric protein complex that possesses glutamate dehydrogenase activity. This complex is evolutionarily conserved except that the number of homoprotomers per complex varies.
A homomeric protein complex that possesses glutamate dehydrogenase activity. This complex is evolutionarily conserved except that the number of homoprotomers per complex varies.
A homodimeric, extracellular protein complex containing two VEGF-A monomers. Binds to and activates a receptor tyrosine kinase.
A process in which a protein is transported to, or maintained in, a location at the cell tip.
A process in which a protein is transported to, or maintained in, a location in telomeric heterochromatin.
A process in which a protein is maintained in a location in telomeric heterochromatin.
A process in which a protein is maintained in a location in telomeric heterochromatin.
A protein complex consisting of the pentameric maltose transporter complex bound to two enzyme IIA (EIIA) molecules. EIIA is a component of the glucose-specific phosphotransferase system that inhibits maltose transport from the periplasm to the cytoplasm. When EIIA-bound, the maltose transporter remains in the open, inward-facing conformation, which prevents binding of maltose-loaded maltose binding protein (MBP) to the transporter.
A protein complex consisting of the pentameric maltose transporter complex bound to two enzyme IIA (EIIA) molecules. EIIA is a component of the glucose-specific phosphotransferase system that inhibits maltose transport from the periplasm to the cytoplasm. When EIIA-bound, the maltose transporter remains in the open, inward-facing conformation, which prevents binding of maltose-loaded maltose binding protein (MBP) to the transporter.
A protein complex consisting of the pentameric maltose transporter complex bound to two enzyme IIA (EIIA) molecules. EIIA is a component of the glucose-specific phosphotransferase system that inhibits maltose transport from the periplasm to the cytoplasm. When EIIA-bound, the maltose transporter remains in the open, inward-facing conformation, which prevents binding of maltose-loaded maltose binding protein (MBP) to the transporter.
The aggregation, arrangement and bonding together of a set of components to form a Dsc E3 ubiquitin ligase complex, an E3 ubiquitin ligase complex localized to the ER and Golgi membrane.
A protein complex containing homohexameric DnaB helicase, and DnaG (a primase). Facilitates the unwinding of double-stranded DNA and the synthesis of RNA primer sequences during DNA replication and repair in Prokaryotes.
A protein-DNA complex consisting of the helicase loading complex DnaB-DnaC bound to the DNA-bound DNA replication initiation protein DnaA. Essential for DNA replication initiation.
A protein-DNA complex consisting of the helicase loading complex DnaB-DnaC, replication restart proteins DnaT, PriA and PriB, and associated DNA. Involved in the restart of DNA replication after a stalled replication fork has been repaired.
A protein-DNA complex consisting of the helicase loading complex DnaB-DnaC, replication restart proteins DnaT, PriA and PriB, and associated DNA. Involved in the restart of DNA replication after a stalled replication fork has been repaired.
A protein-DNA complex consisting of the helicase loading complex DnaB-DnaC, replication restart proteins DnaT, PriA and PriC, and associated DNA. Involved in the restart of DNA replication after a stalled replication fork has been repaired.
A protein-DNA complex consisting of the helicase loading complex DnaB-DnaC, replication restart proteins DnaT, PriA and PriC, and associated DNA. Involved in the restart of DNA replication after a stalled replication fork has been repaired.
A protein-DNA complex consisting of the helicase loading complex DnaB-DnaC, replication restart proteins Rep and PriC, and associated DNA. Involved in the restart of DNA replication after a stalled replication fork has been repaired.
A protein-DNA complex consisting of the helicase loading complex DnaB-DnaC, replication restart proteins Rep and PriC, and associated DNA. Involved in the restart of DNA replication after a stalled replication fork has been repaired.
A homohexameric protein complex that possesses DNA helicase activity; functions during DNA replication and repair.
Catalysis of the reaction: histone H3 N6-acetyl-L-lysine (position 4) + H2O = histone H3 L-lysine (position 4) + acetate. This reaction represents the removal of an acetyl group from lysine at position 4 of the histone H3 protein.
Catalysis of the reaction: ATP + H2O = ADP + phosphate, where this reaction drives the unwinding of the DNA helix of DNA containing four-way junctions, including Holliday junctions.
Catalysis of the reaction: ATP + H2O = ADP + phosphate, where this reaction drives the unwinding of the DNA helix of DNA containing four-way junctions, including Holliday junctions.
The modification of histone H2A by the addition of a phosphate group.
Interacting selectively and non-covalently with damaged DNA containing single-strand breaks (SSBs).
Interacting selectively and non-covalently with damaged DNA containing single-strand breaks (SSBs).
Any process in which a protein is transported to, or maintained at, a region of a chromosome at which a DNA double-strand break has occurred.
Any process in which a protein is transported to, or maintained at, a region of a chromosome at which a DNA double-strand break has occurred.
Any process in which a protein is transported to, or maintained at, a region of a chromosome at which a DNA double-strand break has occurred.
A protein deubiquitination process in which a K27-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 27 of the ubiquitin monomers, is removed from a protein.
A protein deubiquitination process in which a K33-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 33 of the ubiquitin monomers, is removed from a protein.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a copper ion stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a copper ion stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a copper ion stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a cadmium ion stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a cadmium ion stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a cadmium ion stimulus.
The disaggregation of the SCF ubiquitin ligase complex in response to cadmium stress.
The chemical reactions and pathways resulting in the breakdown of a G protein-coupled receptor.
A process in which a protein is transported to, or maintained in, a location within the nucleoplasm.
A process in which a protein is transported to, or maintained in, a location within the nucleoplasm.
A process in which a protein is transported to, or maintained in, a location within the nucleoplasm.
Catalysis of the removal of the cap from an unmethylated 5'-end capped RNA resulting in the release of the entire cap structure (GpppN) and a 5' monophosphorylated RNA.
Interacting selectively and non-covalently with an EH domain of a protein. The EH stand for Eps15 homology. This was originally identified as a motif present in three copies at the NH2-termini of Eps15 and of the related molecule Eps15R.
Protein complex involved in maltose transport through the plasma membrane. In E. coli, the complex is a tetramer and consists of a cytoplasmic ATPase MalK homodimer together with a heterodimeric transmembrane subunit MalF-MalG.
Protein complex involved in maltose transport through the plasma membrane. In E. coli, the complex is a tetramer and consists of a cytoplasmic ATPase MalK homodimer together with a heterodimeric transmembrane subunit MalF-MalG.
Protein complex involved in maltose transport through the plasma membrane. In E. coli, the complex is a tetramer and consists of a cytoplasmic ATPase MalK homodimer together with a heterodimeric transmembrane subunit MalF-MalG.
Protein complex involved in maltose transport through the plasma membrane. In E. coli, the complex is a tetramer and consists of a cytoplasmic ATPase MalK homodimer together with a heterodimeric transmembrane subunit MalF-MalG.
Protein complex involved in maltose transport through the plasma membrane. In E. coli, the complex is a tetramer and consists of a cytoplasmic ATPase MalK homodimer together with a heterodimeric transmembrane subunit MalF-MalG.
A protein-DNA complex containing IHF heterodimers (an alpha and a beta chain) bound to DNA. IHF binds to double-stranded DNA in a structure- and sequence-specific manner and bends the DNA into a nucleosome-like structure, the bacterial nucleoid.
A protein-DNA complex containing IHF heterodimers (an alpha and a beta chain) bound to DNA. IHF binds to double-stranded DNA in a structure- and sequence-specific manner and bends the DNA into a nucleosome-like structure, the bacterial nucleoid.
A protein-DNA complex that consists of HU heterodimers (an alpha and a beta chain) assembled into octamers along DNA. HU binds to double-stranded DNA in a structure- and sequence-specific manner and bends the DNA into a nucleosome-like structure.
A process in which a protein is transported to, or maintained at, the actomyosin contractile ring.
The process in which the 3' end of a pre-tRNA molecule is converted to that of a mature tRNA in the mitochondrion.
The process in which the 3' end of a pre-tRNA molecule is converted to that of a mature tRNA in the mitochondrion.
The process in which the 3' end of a pre-tRNA molecule is converted to that of a mature tRNA in the mitochondrion.
The chemical reactions and pathways resulting in the formation of acetyl-CoA from pantothenate via phosphopantothenate and CoA.
The chemical reactions and pathways resulting in the formation of acetyl-CoA from pantothenate via phosphopantothenate and CoA.
The chemical reactions and pathways resulting in the formation of acetyl-CoA from pantothenate via phosphopantothenate and CoA.
The process whereby a membrane-bounded vesicle is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane.
The process whereby a membrane-bounded vesicle is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane.
The process whereby a membrane-bounded vesicle is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane.
The process whereby a membrane-bounded vesicle is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane.
The process whereby a membrane-bounded vesicle is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane.
A circulatory process that occurs at the level of the lymphatic vasculature.
A heteromeric protein complex consisting of a multi-transmembrane spanning subunit (the light chain) and a type II glycoprotein subunit (the heavy chain) that functions to transport amino acids across a plasma membrane.
Any process that modulates the extent to which lymphatic vessels can be pervaded by fluid.
Any process that modulates the size of lymphatic vessels.
Interacting selectively and non-covalently with euchromatin, a dispersed and relatively uncompacted form of chromatin.
Catalysis of the reaction: acetyl-CoA + N-terminal L-serine in peptide = CoA + N-acetyl-L-serine-peptide.
Catalysis of the reaction: acetyl-CoA + N-terminal L-glutamate in peptide = CoA + N-acetyl-L-glutamate-peptide.
Protein complex facilitating ATP-dependent cobalamin (vitamin B12) transport through inner cell membrane (periplasm to cytoplasm) in Gram-negative bacteria. In E. coli the system is composed of a periplasmic cobalamin-binding protein (BtuF), an integral membrane homodimer, BtuC, and a cytoplasmic ATP-binding homodimer BtuD.
Protein complex facilitating ATP-dependent cobalamin (vitamin B12) transport through inner cell membrane (periplasm to cytoplasm) in Gram-negative bacteria. In E. coli the system is composed of a periplasmic cobalamin-binding protein (BtuF), an integral membrane homodimer, BtuC, and a cytoplasmic ATP-binding homodimer BtuD.
Protein complex facilitating ATP-dependent cobalamin (vitamin B12) transport through inner cell membrane (periplasm to cytoplasm) in Gram-negative bacteria. In E. coli the system is composed of a periplasmic cobalamin-binding protein (BtuF), an integral membrane homodimer, BtuC, and a cytoplasmic ATP-binding homodimer BtuD.
Protein complex facilitating ATP-dependent cobalamin (vitamin B12) transport through inner cell membrane (periplasm to cytoplasm) in Gram-negative bacteria. In E. coli the system is composed of a periplasmic cobalamin-binding protein (BtuF), an integral membrane homodimer, BtuC, and a cytoplasmic ATP-binding homodimer BtuD.
A decrease in the diameter of collecting lymphatic vessels.
Protein complex involved in cobalamin (vitamin B12) transport through the plasma membrane. In E. coli, the complex is a tetramer and consists of the cytoplasmic ATPase BtuD homodimer together with the transmembrane BtuC homodimer.
Protein complex involved in cobalamin (vitamin B12) transport through the plasma membrane. In E. coli, the complex is a tetramer and consists of the cytoplasmic ATPase BtuD homodimer together with the transmembrane BtuC homodimer.
Protein complex involved in cobalamin (vitamin B12) transport through the plasma membrane. In E. coli, the complex is a tetramer and consists of the cytoplasmic ATPase BtuD homodimer together with the transmembrane BtuC homodimer.
The aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic U snRNP body.
A bacterial transmembrane transporter complex that spans the entire cell membrane system and possesses ATP-dependent xenobiotic transport activity pumping drugs (typically antibiotics) and other toxins directly from the cytosol out of the bacterial cell. Typically, it is trimeric consisting of a inner membrane ATPase (IMP), a periplasmic membrane fusion protein (MFP) and an outer membrane factor (OMF). In E. coli, macrolide transporter complexes may consists of MacB (IMP), MacA (MFP) and TolC (OMF) or AcrB (IMP), AcrA (MFP) and TolC (OMF). Trimeric TolC is a common OMF found in many macrolide transporter complexes.
A bacterial transmembrane transporter complex that spans the entire cell membrane system and possesses ATP-dependent xenobiotic transport activity pumping drugs (typically antibiotics) and other toxins directly from the cytosol out of the bacterial cell. Typically, it is trimeric consisting of a inner membrane ATPase (IMP), a periplasmic membrane fusion protein (MFP) and an outer membrane factor (OMF). In E. coli, macrolide transporter complexes may consists of MacB (IMP), MacA (MFP) and TolC (OMF) or AcrB (IMP), AcrA (MFP) and TolC (OMF). Trimeric TolC is a common OMF found in many macrolide transporter complexes.
A bacterial transmembrane transporter complex that spans the entire cell membrane system and possesses ATP-dependent xenobiotic transport activity pumping drugs (typically antibiotics) and other toxins directly from the cytosol out of the bacterial cell. Typically, it is trimeric consisting of a inner membrane ATPase (IMP), a periplasmic membrane fusion protein (MFP) and an outer membrane factor (OMF). In E. coli, macrolide transporter complexes may consists of MacB (IMP), MacA (MFP) and TolC (OMF) or AcrB (IMP), AcrA (MFP) and TolC (OMF). Trimeric TolC is a common OMF found in many macrolide transporter complexes.
A bacterial transmembrane transporter complex that spans the entire cell membrane system and possesses ATP-dependent xenobiotic transport activity pumping drugs (typically antibiotics) and other toxins directly from the cytosol out of the bacterial cell. Typically, it is trimeric consisting of a inner membrane ATPase (IMP), a periplasmic membrane fusion protein (MFP) and an outer membrane factor (OMF). In E. coli, macrolide transporter complexes may consists of MacB (IMP), MacA (MFP) and TolC (OMF) or AcrB (IMP), AcrA (MFP) and TolC (OMF). Trimeric TolC is a common OMF found in many macrolide transporter complexes.
The MacAB-TolC complex is a macrolide transporter complex found in E.coli and related gram-negative bacteria. Its transport activity is specific to macrolide compounds containing 14- and 15-membered lactones. It consists of the dimeric inner membrane ATPase MacB, the hexameric, periplasmic membrane fusion protein MacA and the trimeric outer membrane factor TolC.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
An ATP-binding cassette (ABC) transporter complex that is capable of methionine-importing activity. An example is the bacterial MetNIQ methionine transporter, that consists of the dimeric ATPase subunit MetN located at the cytoplasmic side of the plasma membrane and the dimeric transmembrane subunit MetI. MetQ is regarded as the periplasmic methionine-binding chaperon subunit, and is capable of transporting methionine from the periplasm into the cytoplasm in an ATP-dependent manner.
A dimeric protein complex containing two ModE subunits. Binds directly to DNA to regulate transcription, and is involved in (positively and negatively) regulating various aspects of molybdenum metabolism.
An ATP-binding cassette (ABC) transporter complex made up of a dimer of MsbA. Facilitates the export across the plasma membrane of, amongst others, lipid A and lipopolysaccharide. In contrast to most ABC transporter complexes, each chain of the homodimer contains both the transmembrane domain (TMD) and the cytoplasmic ATP-binding domain (NBD).
An ATP-binding cassette (ABC) transporter complex made up of a dimer of MsbA. Facilitates the export across the plasma membrane of, amongst others, lipid A and lipopolysaccharide. In contrast to most ABC transporter complexes, each chain of the homodimer contains both the transmembrane domain (TMD) and the cytoplasmic ATP-binding domain (NBD).
A protein complex containing an alkanesulfonate monooxygenase subunit (SsuD tetramer in E.coli) and a flavin oxidoreductase subunit (SsuE dimer in E.coli). Involved in the utilization of alkanesulfonates as sulfur sources under conditions of sulfate or cysteine starvation.
A protein complex capable of alkanesulfonate monooxygenase activity. Involved in the utilization of alkanesulfonates as sulfur sources under conditions of sulfate or cysteine starvation, catalyzing the conversion of alkanesulfonates into aldehydes and sulfite. In E.coli the complex consists of a SsuD tetramer.
A protein complex capable of FMN reductase activity. Reduces FMN to FMNH2 in a NAD(P)H-dependent manner. In E.coli, consists of a SsuE dimer.
A protein complex capable of FMN reductase activity. Reduces FMN to FMNH2 in a NAD(P)H-dependent manner. In E.coli, consists of a SsuE dimer.
A protein complex capable of FMN reductase activity. Reduces FMN to FMNH2 in a NAD(P)H-dependent manner. In E.coli, consists of a SsuE dimer.
A protein complex capable of FMN reductase activity. Reduces FMN to FMNH2 in a NAD(P)H-dependent manner. In E.coli, consists of a SsuE dimer.
A protein complex containing two transmembrane subunits; a MdtB dimer and one unit of MdtC. Capable of exporting substrates across the cell membrane. Involved in conferring antibiotic resistance of Gram-negative bacteria by transporting drugs across the membrane.
Any protein complex that possesses oxidoreductase activity.
Any protein complex that possesses oxidoreductase activity.
A protein complex capable of catalyzing the conversion of taurine and alpha-ketoglutarate to sulfite, aminoacetaldehyde and succinate under sulfur or cysteine starvation conditions. Its expression is repressed by the presence of sulfate or cysteine. In E. coli it is a homodimer or homotetramer of the protein TauD.
A protein complex capable of catalyzing the conversion of taurine and alpha-ketoglutarate to sulfite, aminoacetaldehyde and succinate under sulfur or cysteine starvation conditions. Its expression is repressed by the presence of sulfate or cysteine. In E. coli it is a homodimer or homotetramer of the protein TauD.
A protein complex capable of catalyzing the conversion of taurine and alpha-ketoglutarate to sulfite, aminoacetaldehyde and succinate under sulfur or cysteine starvation conditions. Its expression is repressed by the presence of sulfate or cysteine. In E. coli it is a homodimer or homotetramer of the protein TauD.
Catalysis of the reaction: jasmonyl-Ile + H2O = jasmonic acid + L-isoleucine.
A transmembrane protein complex capable of transporting positively charged hydrophobic drugs across the plasma membrane thereby involved in conferring resistance to a wide range of toxic compounds (e.g. methyl viologen, ethidium bromide and acriflavine). It is commonly found in bacteria. In E. coli it forms a homodimer.
Any process in which an organism activates, maintains or increases the frequency, rate or extent of the RNA levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of the RNA levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism activates, maintains or increases the frequency, rate or extent of the indole acetic acid levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism activates, maintains or increases the frequency, rate or extent of the indole acetic acid levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism activates, maintains or increases the frequency, rate or extent of the jasmonic acid levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism activates, maintains or increases the frequency, rate or extent of the ethylene levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of salicylic acid levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of protein levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of intracellular transport in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism activates, maintains or increases the frequency, rate or extent of transcription in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of phytoalexin production in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism activates, maintains or increases the frequency, rate or extent of the abscisic acid levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Any process in which an organism activates, maintains or increases the frequency, rate or extent of protein levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Bacterial chaperonin complex consisting of a heptameric 10kDa chaperonin subunit GroES and a tetradecameric (2x7) 60kDa chaperonin subunit GroEL. The 60kDa subunit possesses ATPase activity while the holo-enzyme is responsible for the correct folding of proteins.
Bacterial chaperonin complex consisting of a heptameric 10kDa chaperonin subunit GroES and a tetradecameric (2x7) 60kDa chaperonin subunit GroEL. The 60kDa subunit possesses ATPase activity while the holo-enzyme is responsible for the correct folding of proteins.
A protein complex capable of cysteine desulfurase activity decomposing L-cysteine to L-alanine and sulfur. It belongs to a ubiquitous family of pyridoxal 5-phosphate (PLP)-dependent enzymes. In E. coli it consists of a SufS dimer.
A protein complex capable of cysteine desulfurase activity decomposing L-cysteine to L-alanine and sulfur. It belongs to a ubiquitous family of pyridoxal 5-phosphate (PLP)-dependent enzymes. In E. coli it consists of a SufS dimer.
A protein complex capable of cysteine desulfurase activity decomposing L-cysteine to L-alanine and sulfur. It belongs to a ubiquitous family of pyridoxal 5-phosphate (PLP)-dependent enzymes. In E. coli it consists of a SufS dimer.
The ProVWX complex belongs to the family of ATP-binding cassette (ABC) transporter proteins complexes. It consists of a cytoplasmic ATPase subunit ProV, a transmembrane subunit ProW and a periplasmic binding protein ProX. It is capable of translocating a wide variety of solute (e.g. glycine betaine) across the plasma membrane and is activated under osmotic stress conditions.
Any process in which an organism activates, maintains or increases the frequency, rate or extent of the cytokinin levels in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.
Catalysis of the reaction: beta-nicotinamide D-ribonucleotide (NMN-) + H2O = beta-nicotinamide D-riboside (nicotinamide ribose, NmR) + phosphate.
Catalysis of the reaction: beta-nicotinamide D-ribonucleotide (NMN-) + H2O = beta-nicotinamide D-riboside (nicotinamide ribose, NmR) + phosphate.
Narrow, electron-dense part of the rhoptry that extends through the conoid at the apical tip of an apicomplexan parasite. The rhoptry neck serves as a duct through which the contents of the rhoptry are secreted after attachment to the host has been completed and at the commencement of invasion.
Interacting selectively and non-covalently with a histone methyltransferase enzyme.
The maintenance of a paranodal junction, a highly specialized cell-cell junction found in vertebrates, which forms between a neuron and a glial cell, and has structural similarity to Drosophila septate junctions. A paranodal junction flanks the node of Ranvier in myelinated nerve, electrically isolates the myelinated from unmyelinated nerve segments, and physically separates the voltage-gated sodium channels at the node from the cluster of potassium channels underneath the myelin sheath.
The maintenance of a paranodal junction, a highly specialized cell-cell junction found in vertebrates, which forms between a neuron and a glial cell, and has structural similarity to Drosophila septate junctions. A paranodal junction flanks the node of Ranvier in myelinated nerve, electrically isolates the myelinated from unmyelinated nerve segments, and physically separates the voltage-gated sodium channels at the node from the cluster of potassium channels underneath the myelin sheath.
The maintenance of a paranodal junction, a highly specialized cell-cell junction found in vertebrates, which forms between a neuron and a glial cell, and has structural similarity to Drosophila septate junctions. A paranodal junction flanks the node of Ranvier in myelinated nerve, electrically isolates the myelinated from unmyelinated nerve segments, and physically separates the voltage-gated sodium channels at the node from the cluster of potassium channels underneath the myelin sheath.
A protein complex capable of catalyzing the transfer of sulfur atoms from one compound (donor) to another (acceptor).
A protein complex capable of catalyzing the transfer of sulfur atoms from one compound (donor) to another (acceptor).
A protein complex capable of catalyzing the transfer of sulfur atoms from one compound (donor) to another (acceptor).
A protein complex capable of catalyzing the transfer of sulfur atoms from one compound (donor) to another (acceptor).
A protein complex capable of assembling an iron-sulfur (Fe-S) cluster.
A protein complex capable of assembling an iron-sulfur (Fe-S) cluster.
A protein complex capable of catalyzing the transfer of an iron-sulfur (Fe-S) cluster from one compound (donor) to another (acceptor).
A protein complex capable of catalyzing the transfer of an iron-sulfur (Fe-S) cluster from one compound (donor) to another (acceptor).
A protein complex capable of catalyzing the transfer of an iron-sulfur (Fe-S) cluster from one compound (donor) to another (acceptor).
A protein complex capable of catalyzing the transfer of an iron-sulfur (Fe-S) cluster from one compound (donor) to another (acceptor).
A protein dimer containing two STING monomers. It binds cyclic purine di-nucleotides.  Activation of the sting complex by 2',5'-3'-5'-cyclic GMP-AMP activates nuclear transcription factor kB (NF-kB) and interferon regulatory factor 3 (IRF3) which then induce transcription of the genes encoding type I IFN and cytokines active in the  innate immune response.
A protein complex capable of phosphomannomutase activity.
A protein complex capable of phosphomannomutase activity.
A protein complex capable of phosphomannomutase activity.
A protein complex capable of phosphomannomutase activity.
A protein complex capable of catalyzing the transfer of a phosphate group from one position to another within a single molecule.
A protein complex capable of catalyzing the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor).
A protein complex which is capable of diamine N-acetyltransferase activity.
A protein complex which is capable of diamine N-acetyltransferase activity.
A protein complex which is capable of diamine N-acetyltransferase activity.
The directed movement of the proteasome core complex (AKA core particle (CP)) from the cytoplasm into the nucleus.
Any process where the proteasome core particle (CP) is sequestered in the protein storage granule in the cytoplasm.
Catalysis of the hydrolysis of ester linkages within a double-stranded deoxyribonucleic acid molecule by creating internal breaks.
Interacting selectively and non-covalently with a steroid hormone.
A heterodimeric transcription factor complex composed of the bZIP proteins atf1 and pcr1. The heterodimer binds m26 sites (homologous to CRE).
Catalysis of the transfer of a phosphate group to the threonine-120 residue of histone H2A.
The modification of histone H2A by the addition of a phosphate group to a threonine residue at position 120 of the histone.
The modification of histone H2A by the addition of a phosphate group to a threonine residue at position 120 of the histone.
A calcium channel complex in the mitochondrial inner membrane capable of highly-selective calcium channel activity. Its components include the EF-hand-containing proteins mitochondrial calcium uptake 1 (MICU1) and MICU2, the pore-forming subunit mitochondrial calcium uniporter (MCU) and its paralog MCUb, and the MCU regulator EMRE.
A calcium channel complex in the mitochondrial inner membrane capable of highly-selective calcium channel activity. Its components include the EF-hand-containing proteins mitochondrial calcium uptake 1 (MICU1) and MICU2, the pore-forming subunit mitochondrial calcium uniporter (MCU) and its paralog MCUb, and the MCU regulator EMRE.
Interacting selectively and non-covalently with an RNA molecule modified by N6-methyladenosine (m6A), a modification present at internal sites of mRNAs and some non-coding RNAs.
Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of DNA damage.
A protein complex that is capable of identifying lesions in DNA, such as pyrimidine-dimers, intrastrand cross-links, and bulky adducts. The wide range of substrate specificity suggests that the repair complex recognizes distortions in the DNA helix. It subsequently recruits a nucleotide-excision repair, preincision complex.
A protein complex that is capable of identifying lesions in DNA on the actively transcribed strand of the DNA duplex as well as a small subset of lesions not recognized by the general nucleotide-excision repair pathway. The wide range of substrate specificity suggests that the repair complex recognizes distortions in the DNA helix. It subsequently recruits a nucleotide-excision repair, preincision complex.
A protein complex that forms during vegetative growth and is involved in the selective degradation of meiosis-specific transcripts. Contains at least Mmi1, or an ortholog of it.
A protein complex that forms during vegetative growth and is involved in the selective degradation of meiosis-specific transcripts. Contains at least Mmi1, or an ortholog of it.
A protein complex that contributes to the endocytic process and bud growth in yeast. It is involved in the precise timing of actin assembly during endocytosis.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of leucine.
Interacting selectively and non-covalently with a keratin filament, an intermediate filament composed of acidic and basic keratins (types I and II), typically expressed in epithelial cells.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a subsynaptic reticulum. A subsynaptic reticulum is an elaborate tubulolamellar membrane system that underlies the postsynaptic cell membrane.
Grouping of multiple copies of a signal at a cellular location. May promote receptor clustering and alter the signal transduction response.
A cytoplasmic dense-core vesicle that transports a range of proteins including piccolo, bassoon, N-cadherin and syntaxin. The transported proteins may be associated with the external side of the vesicle, rather than being contained within the vesicle, therefore forming an aggregate of vesicle and proteins. Piccolo-bassoon transport vesicles (or PTVs) range in size from approximately 80 nm in diameter for dense core vesicles to 130 nm by 220 nm in area for aggregates. They are packaged via the trans-Golgi network before being transported through the axon.
The modification of a histone by addition of a methyl group to an glutamine residue.
Catalysis of the reaction: S-adenosyl-L-methionine + (histone)-glutamine = S-adenosyl-L-homocysteine + (histone)-N5-methyl-glutamine.
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter using a mechanism that involves the localization of a transcription factor and initiated in response to the DNA damage checkpoint signaling.
The chemical reactions and pathways resulting in the breakdown of the unspliced pre-mRNA (pre-messenger RNA).
The chemical reactions and pathways resulting in the breakdown of the unspliced pre-mRNA (pre-messenger RNA).
A series of molecular signals initiated by the binding of anti-Mullerian hormone to its receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
A MAPK cascade that occurs as a result of deprivation of nourishment.
A MAPK cascade that occurs as a result of deprivation of nourishment.
Any peptidyl-tyrosine dephosphorylation that is involved in inactivation of protein kinase activity.
A protein complex consisting of two chains of platelet-derived growth factor (PDGF) subunits. PDGF dimers bind to PDGF receptors in the plasma membrane and induce receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes. PDGFs are found in all vertebrates where at least 2 different chains (A and B) exist. In human (and other mammals), four types of PDGF chains (A, B, C, and D) are known which form five different dimers (AA, AB, BB, CC and DD).
A protein complex consisting of two chains of platelet-derived growth factor (PDGF) subunits. PDGF dimers bind to PDGF receptors in the plasma membrane and induce receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes. PDGFs are found in all vertebrates where at least 2 different chains (A and B) exist. In human (and other mammals), four types of PDGF chains (A, B, C, and D) are known which form five different dimers (AA, AB, BB, CC and DD).
A protein complex consisting of two chains of platelet-derived growth factor (PDGF) subunits. PDGF dimers bind to PDGF receptors in the plasma membrane and induce receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes. PDGFs are found in all vertebrates where at least 2 different chains (A and B) exist. In human (and other mammals), four types of PDGF chains (A, B, C, and D) are known which form five different dimers (AA, AB, BB, CC and DD).
A protein complex consisting of two chains of platelet-derived growth factor (PDGF) subunits. PDGF dimers bind to PDGF receptors in the plasma membrane and induce receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes. PDGFs are found in all vertebrates where at least 2 different chains (A and B) exist. In human (and other mammals), four types of PDGF chains (A, B, C, and D) are known which form five different dimers (AA, AB, BB, CC and DD).
A protein complex consisting of two chains of platelet-derived growth factor (PDGF) subunits. PDGF dimers bind to PDGF receptors in the plasma membrane and induce receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes. PDGFs are found in all vertebrates where at least 2 different chains (A and B) exist. In human (and other mammals), four types of PDGF chains (A, B, C, and D) are known which form five different dimers (AA, AB, BB, CC and DD).
A protein complex consisting of two chains of platelet-derived growth factor (PDGF) subunits. PDGF dimers bind to PDGF receptors in the plasma membrane and induce receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes. PDGFs are found in all vertebrates where at least 2 different chains (A and B) exist. In human (and other mammals), four types of PDGF chains (A, B, C, and D) are known which form five different dimers (AA, AB, BB, CC and DD).
The movement of a neutrophil within or between different tissues and organs of the body.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transition metal nanoparticle.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transition metal nanoparticle.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gold nanoparticle stimulus.
Interacting selectively and non-covalently with phosphorylated serine residues in the C-terminal domain of RNA polymerase II.
Interacting selectively and non-covalently with phosphorylated serine residues in the C-terminal domain of RNA polymerase II.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
A tetrameric protein complex consisting of two platelet-derived growth factor (PDGF) receptor subunits and two PDGF ligand subunits. Binding of the PDGF ligand dimer to the PDGF receptor in the plasma membrane induces receptor dimerisation and activation. PDGFs are involved in a wide variety of signalling processes and are found in all vertebrates. At least two different receptor chains (A and B) and four types of ligand chains (A, B, C, and D) are known forming a wide variety of combinations of receptor-ligand complexes.
Combining with anti-Mullerian hormone to initiate a change in cell activity.
Any process involved in forming the mature 5' end of an snRNA molecule.
Any disaggregation of an actomyosin contractile ring into its constituent components that is involved in a mitotic cell cycle.
Any disaggregation of an actomyosin contractile ring into its constituent components that is involved in a mitotic cell cycle.
Any disaggregation of an actomyosin contractile ring into its constituent components that is involved in a mitotic cell cycle.
Any disaggregation of an actomyosin contractile ring into its constituent components that is involved in a mitotic cell cycle.
Any disaggregation of an actomyosin contractile ring into its constituent components that is involved in a mitotic cell cycle.
Interacting selectively and non-covalently with any part of a preribosome.
Catalysis of the transfer of a methyl group from S-adenosyl-L-methionine to the 5'-gamma-phosphate in an RNA molecule.
A conjugation process that results in the union of cellular and genetic information from compatible mating types, without the formation of zygotes. An example of this process is found in Candida albicans.
A process in which RNA is transported to and maintained in a part of a chromosome that is organized into chromatin.
A protein complex that is capable of efflux transmembrane transporter activity.
A protein complex that is capable of efflux transmembrane transporter activity.
The phosphorylation of a peptidyl-threonine to form peptidyl-O-phospho-L-threonine on an identical protein. For example, phosphorylation by the other kinase within a homodimer.
A cytoskeletal part that consists of an array of microtubules and associated molecules that forms at the end of anaphase, and in which microtubules are nucleated from an equatorial microtubule organizing center.
A cytoskeletal part that consists of an array of microtubules and associated molecules that forms at the end of anaphase, and in which microtubules are nucleated from an equatorial microtubule organizing center.
A renal system process in which amino acids are taken up from the collecting ducts, glomerulus and proximal and distal loops of the nephron. In non-mammalian species, absorption may occur in related structures.
Protein complex that associates with the kinetochores.
A cellular protein complex localization that acts on a Bub1-Bub3 complex; as a result, the complex is transported to, or maintained in, a specific location at the kinetochore.
Interacting selectively and non-covalently with the cellulosome, an extracellular multi-enzyme complex containing several enzymes aligned on a non-catalytic scaffolding that functions to hydrolyze plant cell wall polysaccharides.
Interacting selectively and non-covalently with the cellulosome, an extracellular multi-enzyme complex containing several enzymes aligned on a non-catalytic scaffolding that functions to hydrolyze plant cell wall polysaccharides.
A ubiquitin ligase complex consisting of Bre1 and Rad6 that mediates monoubiquitination of histone H2B to form H2BK123ub1. H2BK123ub1 gives a specific tag for epigenetic transcriptional activation, elongation by RNA polymerase II, telomeric silencing, and is also a prerequisite for H3K4me and H3K79me formation. It thereby plays a central role in histone code and gene regulation. It also modulates the formation of double-strand breaks during meiosis.
A ubiquitin ligase complex consisting of UBR1 and RAD6 components. It polyubiquitinates proteins containing non-acetylated N-terminal residues causing their subsequent degradation by the proteasome as part of the Ac/N-End Rule pathway. It recognizes non-acetylated N-terminal methionine if it is followed by a hydrophobic residue. Additionally, it acts in an N-end rule independent manner as a component of a novel quality control pathway for proteins synthesized on cytosolic ribosomes.
A ubiquitin ligase complex consisting of MUB1, RAD6 and UBR2 components. It ubiquitinates, and targets for destruction, the RPN4 transcription factor, which upregulates the proteasome genes. The binding of MUB1 may position the RPN4 ubiquitylation site proximal to the Ubiquitin-RAD6 thioester and allow the transfer of Ubiquitin from RAD6 to RPN4. One of its components, MUB1, is a short-lived protein ubiquitinated by the UBR2-RAD6 ubiquitin conjugating enzyme.
A ubiquitin ligase complex consisting of RAD6 and UBR2 components. It may act in a quality control pathway for proteins synthesized on cytosolic ribosomes. The UBR2 component lacks sequence motifs required for N-end rule degradation.
A ubiquitin ligase complex consisting of RSP5 and BUL components. It polyubiquinates plasma membrane transporters and permeases, required for their endocytosis and subsequent degradation in the vacuole. BUL1 or BUL2, respectively, bind to the target protein, enabling ubiquitylation by Rsp5. Phosphorylation of BUL proteins results in binding to 14-3-3 proteins, protecting the permeases from down-regulation.
A ubiquitin ligase complex consisting of RSP5 and BUL components. It polyubiquinates plasma membrane transporters and permeases, required for their endocytosis and subsequent degradation in the vacuole. BUL1 or BUL2, respectively, bind to the target protein, enabling ubiquitylation by Rsp5. Phosphorylation of BUL proteins results in binding to 14-3-3 proteins, protecting the permeases from down-regulation.
Interacting selectively and non-covalently with a type-I dockerin domain of a protein. Type-I dockerin domain is the binding partner of type-1 cohesin domain.
Interacting selectively and non-covalently with a type-II dockerin domain of a protein. Type-II dockerin domain is the binding partner of type-II cohesin domain.
Interacting selectively and non-covalently with a type-III dockerin domain of a protein. Type-III dockerin domain is the binding partner of type-III cohesin domain.
Interacting selectively and non-covalently with a type-I cohesin domain of a protein. Type-I cohesin domain is the binding partner of type-I dockerin domain.
Interacting selectively and non-covalently with a type-II cohesin domain of a protein. Type-II cohesin domain is the binding partner of type-II dockerin domain.
Interacting selectively and non-covalently with a type-III cohesin domain of a protein. Type-III cohesin domain is the binding partner of type-III dockerin domain.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
A protein complex that consists of a phospho relay component and a MAPK cascade component.  The complex is involved in signaling oxidative stress and osmostress.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex consisting of Atg1 (or Atg1 homologs e.g. ULK1, ULK2 in mammals) and Atg13 along with other proteins that regulate its function (e.g. Atg17 in yeast or RB1CC1(FIP200) in mammals). This complex has serine/threonine protein kinase activity and is involved in autophagosome formation.
A protein complex involved in septin ring formation during mitosis. In Saccharomyces cerevisiae it consists of BNI5, CDC3, CDC10, CDC11, CDC12, GIN4, NAP1 and SHS1. At least 2 GIN4 molecules are involved.
A collagen homotrimer of alpha1(XIX) chains; type XIX collagen triple helices localize to basement membrane zones in differentiating muscle cells.
A collagen homotrimer of alpha1(XX) chains.
A collagen homotrimer of alpha1(XXI) chains; type XXI collagen triple helices found in the extracellular matrix component of blood vessel walls and in the cytoplasm of cultured human aortic smooth muscle.
A collagen homotrimer of alpha1(XXII) chains; type XXII collagen triple helices acts as a cell adhesion ligand for skin epithelial cells and fibroblasts.
A collagen homotrimer of alpha1(XXIII) chains; type XXIII collagen triple helices span the plasma membrane.
A collagen homotrimer of alpha1(XXIV) chains; type XXIV collagen triple helices may participate in regulating type I collagen fibrillogenesis at specific anatomical locations during fetal development.
A collagen homotrimer of alpha1(XXVI) chains.
A collagen homotrimer of alpha1(XXVII) chains. These trimers form thin, non-striated fibrils. Type XXVII collagen triple helices play a role during the calcification of cartilage and the transition of cartilage to bone.
A collagen homotrimer of alpha1(XXVIII) chains.
A collagen homotrimer of alpha1(XXV) chains; type XXV collagen triple helices span the plasma membrane.
A protein complex that cycles between the nucleus where it is part of the RNA polymerase II and the cytoplasmic mRNA processing body where it mediates the two major cytoplasmic mRNA decay pathways.
A heterotetrameric protein complex involved in the sulfur-relay system required for 2-thiolation of 5-methylaminomethyl-2-thiouridine (mnm5s2U) at tRNA wobble positions. In E. coli it consists of a central IscS dimer with the two TusA protomers bound to one of the IscS units each via persulfide (-SSH) groups.
A heterotetrameric protein complex involved in the sulfur transfer during iron-sulfur cluster assembly and in the modification of tRNA wobble positions. In E. coli it consisting of a central IscS dimer with the IscU protomers attached to one of the IscS units each via a disulfide (-SSH) group.
A tetrameric protein complex capable of acetyltransferase activity. It can catalyze the transfer of an acetyl group from acetyl-CoA to an acceptor residue on histone H-3, histone H-4, or on polyamines. The complex is also capable of acetylating certain small basic proteins. The two Hpa2 dimers that make up the tetramer are held together by interactions between the bound acetyl-CoA molecules.
A type-I transmembrane protein complex located in the endoplasmic reticulum (ER) consisting of an IRE1-IRE1 dimer, which forms in response to the accumulation of unfolded protein in the ER. The dimeric complex has endoribonuclease (RNase) activity and evokes the unfolded protein response (UPR) by cleaving an intron of a mRNA coding for the transcription factor HAC1 in yeast or XBP1 in mammals; the complex cleaves a single phosphodiester bond in each of two RNA hairpins (with non-specific base paired stems and loops of consensus sequence CNCNNGN, where N is any base) to remove an intervening intron from the target transcript.
A type-I transmembrane protein complex located in the endoplasmic reticulum (ER) consisting of an IRE1-IRE1 dimer, which forms in response to the accumulation of unfolded protein in the ER. The dimeric complex has endoribonuclease (RNase) activity and evokes the unfolded protein response (UPR) by cleaving an intron of a mRNA coding for the transcription factor HAC1 in yeast or XBP1 in mammals; the complex cleaves a single phosphodiester bond in each of two RNA hairpins (with non-specific base paired stems and loops of consensus sequence CNCNNGN, where N is any base) to remove an intervening intron from the target transcript.
A protein complex involved in the spindle checkpoint, preventing the activation of the anaphase-promoting complex until all chromosomes are correctly attached in a bipolar fashion to the mitotic spindle. In budding yeast this complex consists of Mad2p and Cdc20p, and in mammalian cells it consists of MAD2 and CDC20.
A protein complex that acts as a two-component GTPase-activating protein for Tem1 GTPase, thus regulating a signal transduction cascade, called the mitotic exit network (MEN), which is required for mitotic exit and cytokinesis. Bub2/Bfa1 keeps Tem1 inactive until the spindle is properly oriented, thus inhibiting MEN activation.
A response to alcohol that results in a state of tolerance to alcohol.
A response to butan-1-ol that results in a state of tolerance to butan-1-ol.
A response to isobutanol that results in a state of tolerance to isobutanol.
A laminin complex composed of alpha4, beta2 and gamma3 polypeptide chains.
A laminin complex composed of alpha5, beta2 and gamma2 polypeptide chains.
A laminin complex composed of alpha5, beta2 and gamma3 polypeptide chains.
A homotrimeric or homopentameric glycoprotein that functions at the interface of the cell membrane and the extracellular matrix through its interactions with proteins and proteoglycans, such as collagens, integrins and fibronectin, to regulate matrix structure and cellular behaviour.
A region of heterochromatin that is formed dynamically in response to environmental signals by a process that does not require RNAi, and is enriched in histone H3 methylated on lysine 9 (H3K9me).
A region of heterochromatin that is formed dynamically under specific growth conditions by a process that requires RNAi, and is enriched in histone H3 methylated on lysine 9 (H3K9me).
A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a secondary cell septum following nuclear division.
A protein complex that consists of a heterodimer formed by Red1 and Mtl1 or homologs thereof, and that promotes degradation of mRNAs and noncoding RNAs and associates with different proteins to assemble heterochromatin via distinct mechanisms.
A heterodimeric protein complex consisting of BID and BCL-xl, members of the Bcl-2 family of anti- and proapoptotic regulators.
The movement of substances between cells via gap junctions. A gap junction is a fine cytoplasmic channel, found in animal cells, that connects the cytoplasm of one cell to that of an adjacent cell, allowing ions and other molecules to pass freely between the two cells.
A protein complex facilitating glucose transport into, out of or within a cell, or between cells.
A protein complex facilitating transport of molecules (proteins, small molecules, nucleic acids) into, out of or within a cell, or between cells.
A homodimeric protein complex composed of the E3 ubiquitin-protein ligase BRE1. Plays a role in regulating association of RNA polymerase II with active genes.
A homodimeric protein complex composed of the E3 ubiquitin-protein ligase BRE1. Plays a role in regulating association of RNA polymerase II with active genes.
A ubiquitin ligase complex. In D. melanogaster, it regulates ubiquitination and proteolysis of the BMP receptor Thickveins in cystoblasts, potentially by controlling Tkv ubiquitination and degradation.
A protein complex consisting of a SUMO protein bound to a SUMO activating enzyme complex. Activation by the E1 complex and linkage to the E2 enzyme UBE2I is required for the formation of covalent bonds between SUMO and its ultimate target proteins.
The generation of L-methionine from methionine sulphoxide.
A protein complex consisting of a SUMO (small ubiquitin-related modifier) protein bound to a SUMO-conjugating E2 ligase. Sumoylation of the E2 ligase is an intermediate step required for the formation of covalent bonds between a SUMO protein and its ultimate protein target. SUMO is transferred to the E2 ligase by a SUMO-activating E1 enzyme. Sumoylation of the target protein is either facilitated directly by the sumoylated E2 ligase or aided by an optional E3 ligase.
An actin-rich cytoskeletal network located beneath the microvilli of the apical plasma membrane of polarized epithelial cells. In addition to actin filaments, the terminal web may contain actin-binding proteins, myosin motor proteins, and intermediate filaments. The terminal web can function as a contractile structure that influences the spatial distribution of microvilli as well as the development and morphogenesis of tissues containing polarized epithelial cells.
A multifunctional supermolecular complex, containing several proteins with hemicellulase activity. Functions to hydrolyze hemicellulose.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a zinc ion stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a zinc ion stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a zinc ion stimulus.
A protein complex capable of phosphorylating a large number of protein targets. Contributes to cell proliferation under glycose starvation conditions. In human, the complex is present as a dimer.
A protein complex capable of phosphorylating a large number of protein targets. Contributes to cell proliferation under glycose starvation conditions. In human, the complex is present as a dimer.
A protein complex capable of pyruvate kinase activity. PKM2 only exists as homotetramer when bound to beta-d-fructofuranose 1,6-bisphosphate (CHEBI:28013).
Catalysis of the reaction: butanal + NADH + H+ => n-butanol + NAD+.
A response that results in a state of tolerance to an organic substance.
A response that results in a state of tolerance to ketone.
A response that results in a state of tolerance to aldehyde.
A response that results in a state of tolerance to phenol.
A response that results in a state of tolerance to organic acid.
A response that results in a state of tolerance to alkane.
A inward rectifier potassium channel complex. Homo- or heterotetramer composed of subunits of the eukaryotic Kir2 protein family. Plays a key role in maintaining the correct resting potential in eukaryotic cells.
The reproductive developmental process whose specific outcome is the progression of the baculum over time, from its formation to the mature structure.
The reproductive developmental process whose specific outcome is the progression of the baculum over time, from its formation to the mature structure.
The reproductive developmental process whose specific outcome is the progression of the baculum over time, from its formation to the mature structure.
An extracellular matrix consisting of a densely packed organomineral assembly in which the mineral phase represents the majority of the material by weight.
A protein complex capable of sequence-specific DNA binding RNA polymerase II transcription factor activity through binding to a symmetrical DNA sequence (E-boxes) (5'-CACGTG-3'). Found in a variety of viral and cellular promoters.
A protein complex capable of sequence-specific DNA binding RNA polymerase II transcription factor activity through binding to a symmetrical DNA sequence (E-boxes) (5'-CACGTG-3'). Found in a variety of viral and cellular promoters.
A protein complex capable of sequence-specific DNA binding RNA polymerase II transcription factor activity through binding to a symmetrical DNA sequence (E-boxes) (5'-CACGTG-3'). Found in a variety of viral and cellular promoters.
A protein complex capable of sequence-specific DNA binding RNA polymerase II transcription factor activity through binding to a symmetrical DNA sequence (E-boxes) (5'-CACGTG-3'). Found in a variety of viral and cellular promoters.
The directed movement of lipid molecules passing through the blood-brain barrier.
Hydrolysis of Lys48-linked ubiquitin unit(s) from a ubiquitinated protein.
Hydrolysis of Lys48-linked ubiquitin unit(s) from a ubiquitinated protein.
Interacting selectively and non-covalently with a ubiquitin-specific protease.
Interacting selectively and non-covalently with a ubiquitin-specific protease.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of biotin.
The developmental process in which the hyaloid vascular plexus is destroyed as a part of its normal progression.
The area in the center of the meiotic spindle where the spindle microtubules from opposite poles overlap.
Advancement of the mitotic cleavage furrow from the outside of the cell inward towards the center of the cell. The cleavage furrow acts as a 'purse string' which draws tight to separate daughter cells during mitotic cytokinesis and partition the cytoplasm between the two daughter cells. The furrow ingresses until a cytoplasmic bridge is formed.
The chemical reactions and pathways resulting in the formation of a lactosyl-ceramide derivative in which a galactose is linked to the galactose via an alpha 1,3 linkage (vs alpha 1,4 for globosides).
The directed movement of iron ions into the phloem from the xylem.
A protein complex capable of ubiquitin-conjugating enzyme activity during ER-associated protein degradation (ERAD). In S. cerevisiae, UBC7 is the ubiquitin-conjugating enzyme (E2) and requires binding to the ER surface by CUE1.
A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 33 of the ubiquitin monomers, is added to a protein.
A protein complex involved in DNA repair processes including direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
A protein complex involved in DNA repair processes including direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
A trimeric cell-cell fusion complex that serves as a scaffold for zippering up the extracellular domains, bringing the transmembrane segments into close proximity such that they can continue zippering within the two membranes into one. Two prefusion monomers cluster at the surface of adjacent cells. Parallel EFF-1 interactions occur across cells and a third monomer, which can come from either cell, adds on to make an intermediate, extended trimer.
A protein complex, at least composed of CUL7, CCDC8 and OBSL1, that is required for maintaining microtubule and genome integrity.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of cell wall damage. The process begins with detection of the damage and ends with a change in state or activity of the cell.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the meiotic spindle pole body.
The error-free repair of a single-strand break in DNA in which the broken DNA molecule is repaired using homologous sequences. A strand in the broken DNA searches for a homologous region in an intact chromosome to serve as the template for DNA synthesis. The restoration of two intact DNA molecules results in the exchange, reciprocal or nonreciprocal, of genetic material between the intact DNA molecule and the broken DNA molecule.
Any process which produces queuosine from derivatives of it, without de novo synthesis.
Transmembrane complex that mediates resistance to copper and silver by cation efflux directly from the cell using the proton-motive force. Spans the inner membrane, periplasm, and outer membrane. Primarily activated under anaerobic conditions by CusR and CusS but also expressed under extreme copper stress, in aerobic growth.
Transmembrane complex that mediates resistance to copper and silver by cation efflux directly from the cell using the proton-motive force. Spans the inner membrane, periplasm, and outer membrane. Primarily activated under anaerobic conditions by CusR and CusS but also expressed under extreme copper stress, in aerobic growth.
Transmembrane complex that mediates resistance to copper and silver by cation efflux directly from the cell using the proton-motive force. Spans the inner membrane, periplasm, and outer membrane. Primarily activated under anaerobic conditions by CusR and CusS but also expressed under extreme copper stress, in aerobic growth.
Transmembrane complex that mediates resistance to copper and silver by cation efflux directly from the cell using the proton-motive force. Spans the inner membrane, periplasm, and outer membrane. Primarily activated under anaerobic conditions by CusR and CusS but also expressed under extreme copper stress, in aerobic growth.
Transmembrane complex that mediates resistance to copper and silver by cation efflux directly from the cell using the proton-motive force. Spans the inner membrane, periplasm, and outer membrane. Primarily activated under anaerobic conditions by CusR and CusS but also expressed under extreme copper stress, in aerobic growth.
The regrowth of lost or destroyed epithelium.
Interacting selectively and non-covalently with the mitochondrial large ribosomal subunit RNA (LSU rRNA), a constituent of the mitochondrial large ribosomal subunit.
Interacting selectively and non-covalently with the mitochondrial large ribosomal subunit RNA (LSU rRNA), a constituent of the mitochondrial large ribosomal subunit.
The process occurring during the embryonic phase whose specific outcome is the progression of the lung over time, from its formation to the mature structure.
The process occurring during the embryonic phase whose specific outcome is the progression of the liver over time, from its formation to the mature structure.
The process occurring during the embryonic phase whose specific outcome is the progression of the brain over time, from its formation to the mature structure.
The transfer, from NAD, of ADP-ribose to a protein amino acid residue.
Interacting selectively and non-covalently with a protein antigen.
A transmembrane, G protein-coupled signalling receptor complex recognized by calcitonin gene-related peptides (CGRP).
A transmembrane, G protein-coupled signalling receptor complex recognized by calcitonin gene-related peptides (CGRP).
A transmembrane, G protein-coupled signalling receptor complex recognized by calcitonin gene-related peptides (CGRP).
Interacting selectively and non-covalently with calcitonin gene-related peptide (CGRP).
Interacting selectively and non-covalently with calcitonin gene-related peptide (CGRP).
Interacting selectively and non-covalently with calcitonin gene-related peptide (CGRP).
A series of molecular signals initiated by an extracellular calcitonin gene-related peptide (CGRP) combining with a calcitonin gene-related peptide receptor on the surface of the target cell. Calcitonin gene-related peptide receptors may form dimers, trimers or tetramers.
A series of molecular signals initiated by an extracellular calcitonin gene-related peptide (CGRP) combining with a calcitonin gene-related peptide receptor on the surface of the target cell. Calcitonin gene-related peptide receptors may form dimers, trimers or tetramers.
A series of molecular signals initiated by an extracellular calcitonin gene-related peptide (CGRP) combining with a calcitonin gene-related peptide receptor on the surface of the target cell. Calcitonin gene-related peptide receptors may form dimers, trimers or tetramers.
Interacting selectively and non-covalently with adrenomedullin (AM).
A series of molecular signals initiated by an extracellular adrenomedullin combining with a dimeric adrenomedullin receptor on the surface of the target cell.
Catalysis of the reaction: hercynylcysteine sulfoxide + 2H+ = ergothioneine + pyruvate + ammonium.
Catalysis of the reaction: hercynylselenocysteine + 2H+ = selenoneine + pyruvate + ammonium.
A small pigmented organelle used in single-celled organisms to detect light.
A small pigmented organelle used in single-celled organisms to detect light.
The repair of a replication-born double-strand DNA break in which the DNA molecule is repaired using the homologous sequence of the sister chromatid which serves as a template to repair the breaks.
A protein complex involved in the peroxisomal import machinery. In S. cerevisiae, this complex contains the proteins Pex17p, Pex14p, Pex19, and Pex13p.
A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a brain-derived neurotrophic factor stimulus.
The release of snoRNA from pre-rRNA.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
The septation initiation signaling process by which the activity of the septation initiation network (SIN) is activated asymmetrically on the spindle pole bodies.
Heterochromatic regions of the chromosome found at the subtelomeric regions.
Catalysis of the reaction: glyoxal + H2O = glycolic acid. Catalysis occurs in the absence of a cofactor.
A kinetochore component required for both meiotic and mitotic spindle assembly checkpoints.
Catalysis of the reaction: ATP + a protein arginine = ADP + protein arginine phosphate.
A voltage-gated calcium-release channel complex of the sarcoplasmic or endoplasmic reticulum. It plays an important role in the excitation-contraction (E-C) coupling of muscle cells. RyR comprises a family of ryanodine receptors, widely expressed throughout the animal kingdom.
Replication fork processing that includes recombination between DNA near the arrested fork and homologous sequences. Proteins involved in homologous recombination are required for replication restart.
Replication fork processing that includes recombination between DNA near the arrested fork and homologous sequences. Proteins involved in homologous recombination are required for replication restart.
An electron-dense plaque at either end of a stereocilia tip link that provides the anchor in the stereocilia membrane.
The directed movement of microRNA (miRNA) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.
A protein complex responsible for transporting proteins into the peroxisomal matrix. An example of this complex is Pex14 found in S. cerevisae which has 9 core components and 12 transient interaction partners.
A protein complex responsible for transporting proteins into the peroxisomal matrix. An example of this complex is Pex14 found in S. cerevisae which has 9 core components and 12 transient interaction partners.
A protein complex responsible for transporting proteins into the peroxisomal matrix. An example of this complex is Pex14 found in S. cerevisae which has 9 core components and 12 transient interaction partners.
Interacting selectively and non-covalently with a protein that is part of an extracellular matrix.
The process of forming the mature 3' end of a priRNA molecule.
The process of forming the mature 3' end of a priRNA molecule.
The process of forming the mature 3' end of a siRNA molecule.
The process of forming the mature 3' end of a siRNA molecule.
A DNA-binding transcription factor complex consisting of CSL and mastermind proteins in complex with the cleaved, intracellular domain of Notch. It is required for both repression and activation of Notch target genes.
An electron-dense plaque at the lower end of a stereocilia tip link that provides the anchor in the stereocilia membrane at the tip of the stereocilium from which the tip link rises.
An electron-dense plaque at the upper end of a stereocilia tip link that provides the anchor in the stereocilia membrane on the side of the stereocilium where the tip link ends.
The posttranscriptional addition of a methyl group to the 2' oxygen atom of a nucleotide residue in an snRNA molecule.
The posttranscriptional addition a methyl group to the 2'-oxygen atom of a nucleotide residue in an U6 snRNA molecule.
Catalysis of the reaction: MAP kinase threonine phosphate + H2O = MAP kinase threonine + phosphate and MAP kinase serine phosphate + H2O = MAP kinase serine + phosphate.
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to nitrosative stress; a state often resulting from exposure to high levels of nitric oxide (NO) or the highly reactive oxidant peroxynitrite, which is produced following interaction of NO with superoxide anions.
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to nitrosative stress; a state often resulting from exposure to high levels of nitric oxide (NO) or the highly reactive oxidant peroxynitrite, which is produced following interaction of NO with superoxide anions.
The phosphorylation by a protein of one or more of its own threonine amino acid residues, or a threonine residue on an identical protein.
Interacting selectively and non-covalently with an F-box domain of a protein.
Interacting selectively and non-covalently with any part of a U1 small nuclear ribonucleoprotein particle.
Interacting selectively and non-covalently with any part of a U2 small nuclear ribonucleoprotein particle.
Interacting selectively and non-covalently with an exon-exon junction complex, a protein complex deposited by the spliceosome upstream of messenger RNA exon-exon junctions. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay.
Interacting selectively and non-covalently with a linear polymer of ubiquitin. Linear ubiquitin polymers are formed by linking the amino-terminal methionine (M1) of one ubiquitin molecule to the carboxy-terminal glycine (G76) of the next.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in the homeostasis of organismal or cellular pH (with pH < 7). pH is a measure of the acidity or basicity of an aqueous solution.
A ubiquitin ligase complex containing Parkin (PARK2), the F-box protein FBXW7 (also called SEL-10) and a cullin from the Cul1 subfamily; substrate specificity is conferred by the F-box protein.
A ubiquitin ligase complex containing Parkin (PARK2), the F-box protein FBXW7 (also called SEL-10) and a cullin from the Cul1 subfamily; substrate specificity is conferred by the F-box protein.
A ubiquitin ligase complex containing Parkin (PARK2), the F-box protein FBXW7 (also called SEL-10) and a cullin from the Cul1 subfamily; substrate specificity is conferred by the F-box protein.
A ubiquitin ligase complex containing Parkin (PARK2), the F-box protein FBXW7 (also called SEL-10) and a cullin from the Cul1 subfamily; substrate specificity is conferred by the F-box protein.
A ubiquitin ligase complex containing Parkin (PARK2), the F-box protein FBXW7 (also called SEL-10) and a cullin from the Cul1 subfamily; substrate specificity is conferred by the F-box protein.
A protein complex involved in the disassembly and subsequent reassembly of nucleosomes. It associates with the coding region of transcriptionally active genes where it interacts with the RNA polymerase II and affects its processivity during co-transcriptional RNA processing and maturation. It exists as a functionally independent part of the NuA4 complex.
A type of voltage-dependent calcium channel responsible for excitation-contraction coupling of skeletal, smooth, and cardiac muscle. 'L' stands for 'long-lasting' referring to the length of activation.
A type of voltage-dependent calcium channel responsible for excitation-contraction coupling of skeletal, smooth, and cardiac muscle. 'L' stands for 'long-lasting' referring to the length of activation.
A phospholipid phosphatase complex that catalyses the hydrolysis of the second messenger PtdIns (3,4,5)P3. Will also dephosphorylate PtdIns(3,4)P2, PtdIns3P, and Ins(1,3,4,5)P4. Dimerization is critical for its lipid phosphatase function.
A phospholipid phosphatase complex that catalyses the hydrolysis of the second messenger PtdIns (3,4,5)P3. Will also dephosphorylate PtdIns(3,4)P2, PtdIns3P, and Ins(1,3,4,5)P4. Dimerization is critical for its lipid phosphatase function.
A phospholipid phosphatase complex that catalyses the hydrolysis of the second messenger PtdIns (3,4,5)P3. Will also dephosphorylate PtdIns(3,4)P2, PtdIns3P, and Ins(1,3,4,5)P4. Dimerization is critical for its lipid phosphatase function.
The attachment of a mitochondrione and an endoplasmic reticulum  via molecular tethers that physically bridge their respective membranes and attach them to each other. The tethering may facilitate exchange of metabolites between the organelles.
The attachment of a mitochondrione and an endoplasmic reticulum  via molecular tethers that physically bridge their respective membranes and attach them to each other. The tethering may facilitate exchange of metabolites between the organelles.
The attachment of a mitochondrione and an endoplasmic reticulum  via molecular tethers that physically bridge their respective membranes and attach them to each other. The tethering may facilitate exchange of metabolites between the organelles.
The attachment of a mitochondrione and an endoplasmic reticulum  via molecular tethers that physically bridge their respective membranes and attach them to each other. The tethering may facilitate exchange of metabolites between the organelles.
The attachment of a mitochondrione and an endoplasmic reticulum  via molecular tethers that physically bridge their respective membranes and attach them to each other. The tethering may facilitate exchange of metabolites between the organelles.
A membrane-bounded intracellular vesicle involved in the degradation of peroxisome by macropexophagy.
Interacting selectively and non-covalently with lipooligosaccharide. Lipooligosaccharides (LOSs) are the major glycolipids expressed on mucosal Gram-negative bacteria.
Interacting selectively and non-covalently with lipooligosaccharide. Lipooligosaccharides (LOSs) are the major glycolipids expressed on mucosal Gram-negative bacteria.
Interacting selectively and non-covalently with the transferrin receptor.
Interacting selectively and non-covalently with the leptin receptor.
Any process that reduces or removes the toxicity of iron ion. These include transport of iron away from sensitive areas and to compartments or complexes whose purpose is sequestration of iron ion.
Omega-shaped (as in the Greek capital letter) intracellular membrane-bounded organelle enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. Omegasomes are the first step of the formation of autophagosomes via the phagophore assembly sites.
A protein complex that is anchored at the cortical face of the plasma membrane, and contains proteins involved in regulating cell cycle progression. In Schizosaccharomyces pombe, lateral cortical nodes are several megadaltons in size, and contain Slf1, which anchors the complex at the membrane, and the methyltransferase Skb1 in stoichiometric quantities, and may contain other proteins.
Catalysis of the reaction: (R)-2-hydroxyacid + a quinone = 2-oxoacid + a quinol.
Catalysis of the reaction: (R)-2-hydroxyacid + a quinone = 2-oxoacid + a quinol.
Catalysis of the reaction: (R)-2-hydroxyacid + a quinone = 2-oxoacid + a quinol.
Catalysis of the reaction: (R)-2-hydroxyacid + a quinone = 2-oxoacid + a quinol.
Catalysis of the reaction: (R)-2-hydroxyacid + a quinone = 2-oxoacid + a quinol.
Catalysis of the reaction: (R)-2-hydroxyacid + a quinone = 2-oxoacid + a quinol.
Catalysis of the reaction a long-chain aldehyde + O(2) + 2 NADPH = an alkane + formate + H(2)O + 2 NADP(+).
The sumoylation by a protein of one or more of its own amino acid residues, or residues on an identical protein.
The sumoylation by a protein of one or more of its own amino acid residues, or residues on an identical protein.
A NuA3 complex that catalyzes the acetylation of Histone H3. In S. cerevisiae, this complex consists of Eaf6p, Nto1p, Sas3p, Taf14p, Yng1p and associates with H3K4me3 using Yng1p.
A NuA3 complex that catalyzes the acetylation of Histone H3. In S. cerevisiae, this complex consists of Eaf6p, Nto1p, Sas3p, Taf14p, Pdp3 and associates with H3K4me3 via Pdp3p.
Protein complex found in Drosophila consisting of the gene products of cuff, del and rhi. It regulates the licensing of transcription of dual-strand PIWI interacting RNA (piRNA) source loci by binding to dual-strand-cluster chromatin, probably via the H3K9me3-binding activity of Rhi. Rhi binding brings the putative termination cofactor Cuff in close proximity to the nascent piRNA precursor transcript which it appears to protect from degradation.
Protein complex found in Drosophila consisting of the gene products of cuff, del and rhi. It regulates the licensing of transcription of dual-strand PIWI interacting RNA (piRNA) source loci by binding to dual-strand-cluster chromatin, probably via the H3K9me3-binding activity of Rhi. Rhi binding brings the putative termination cofactor Cuff in close proximity to the nascent piRNA precursor transcript which it appears to protect from degradation.
Interacting selectively and non-covalently with piRNA clusters, double-stranded DNA regions that give rise to PIWI-interacting RNAs (piRNAs).
Interacting selectively and non-covalently with uni-strand piRNA clusters, double-stranded DNA regions that give rise to PIWI-interacting RNAs (piRNAs) that map predominantly to only one strand and exhibit hallmarks of canonical Pol II transcription. Uni-strand piRNA clusters are found in many taxa.
Interacting selectively and non-covalently with dual-strand piRNA clusters, double-stranded DNA regions that give rise to PIWI-interacting RNAs (piRNAs) where piRNAs originate from both DNA strands via noncanonical transcription.
Interacting selectively and non-covalently with a ciliary targeting sequence, a specific peptide sequence that acts as a signal to localize a membrane protein to the ciliary membrane.
A synaptic vesicle belonging to the pool of vesicles that are the first to be released as a result of chemical or electrical stimulation e.g. by an action potential, have the highest presynaptic membrane fusion probability and correspond to about 1% of the total number of synaptic vesicles at a resting terminal bouton.
A synaptic vesicle belonging to the pool of vesicles that are the first to be released as a result of chemical or electrical stimulation e.g. by an action potential, have the highest presynaptic membrane fusion probability and correspond to about 1% of the total number of synaptic vesicles at a resting terminal bouton.
A synaptic vesicle belonging to the pool that repopulate vacancies within the readily releasable pool (RRP) of synaptic vesicles, and require more significant stimuli than the RRP in order to release neurotransmitter; about 10-15% of the total number of synaptic vesicles at a resting terminal bouton are in this state.
A synaptic vesicle belonging to the pool that remain unreleased even after prolonged stimulation  causes a saturating degree of vesicular turnover.  50-80% of the total number of synaptic vesicles at a resting terminal bouton are in this pool.
A synaptic vesicle belonging to the pool that remain unreleased even after prolonged stimulation  causes a saturating degree of vesicular turnover.  50-80% of the total number of synaptic vesicles at a resting terminal bouton are in this pool.
The nuclear RNA silencing (NURS) complex is a protein complex formed by Red1, Mtl1, Red5, Rmn1, Iss10/Pir1, and Ars2/Pir2 that regulates RNA degradation and histone H3 lysine 9 methylation. It is likely related to the human CBCN complex.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultrasonic stimulus.
The intramolecular conversion of uridine to pseudouridine in an mRNA molecule.
Catalysis of the reaction: UDP-glucuronate + inositol phosphorylceramide (IPC) = UDP + GlcA-IPC.
A histone deacetylase complex involved in chromatin organization. In Schizosaccharomyces pombe this complex consists of Clr6, Nts1, Mug165, and Png3.
The chemical reactions and pathways resulting in the breakdown of lactate (2-hydroxypropanoic acid) in the presence of oxygen.
The chemical reactions and pathways resulting in the breakdown of lactate (2-hydroxypropanoic acid) in the absence of oxygen.
The chemical reactions and pathways resulting in the breakdown of a fatty acid in the absence of oxygen. A fatty acid is any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.
The chemical reactions and pathways resulting in the breakdown of lignin in the absence of oxygen. Lignin is a class of polymers of phenylpropanoid units.
The chemical reactions and pathways resulting in the breakdown of cellulose, a linear beta1-4 glucan of molecular mass 50-400 kDa with the pyranose units in the -4C1 conformation, in absence of oxygen.
The chemical reactions and pathways resulting in the breakdown of pectin, a polymer containing a backbone of alpha-1,4-linked D-galacturonic acid residues, in the absence of oxygen.
A large proton-transporting two-sector ATPase protein complex that catalyzes the synthesis or hydrolysis of ATP by a rotational mechanism, coupled to the transport of protons across a membrane and is found in Archaea.
A large proton-transporting two-sector ATPase protein complex that catalyzes the synthesis or hydrolysis of ATP by a rotational mechanism, coupled to the transport of protons across a membrane and is found in Archaea.
The chemical reactions and pathways resulting in the formation of methane from methanol and hydrogen.
The chemical reactions and pathways resulting in the formation of methane from methanol and hydrogen.
A Mad2-dependent mitotic cell cycle checkpoint which delays cytokinetic actinomycin ring assembly if there is a delay in early M-phase.
A Mad2-dependent mitotic cell cycle checkpoint which delays cytokinetic actinomycin ring assembly if there is a delay in early M-phase.
Modulation of the frequency, rate or extent of cytoplasmic translation as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
Any microtubule that is part of a mitotic spindle; anchored at one spindle pole.
Protein complex required for the asymmetric division of neuroblasts in Drosophila. Coordinates asymmetric localization of cell fate determinants with orientation of the mitotic spindle resulting in different daughter cells upon division. Localizes at the apical cortex of the neuroblast: Raps maintains, but does not initiate, Insc apically, while Insc segregates Raps asymmetrically. Complex appears to be conserved in mammals (composed of INSC and GPSM1 or GPSM2).
Protein complex required for the asymmetric division of neuroblasts in Drosophila. Coordinates asymmetric localization of cell fate determinants with orientation of the mitotic spindle resulting in different daughter cells upon division. Localizes at the apical cortex of the neuroblast: Raps maintains, but does not initiate, Insc apically, while Insc segregates Raps asymmetrically. Complex appears to be conserved in mammals (composed of INSC and GPSM1 or GPSM2).
A protein complex that causes translational repression in Drosophila. Prevents assembly of ribosomes at the mRNA by interfacing with a sequence-specific RNA-binding protein leading to recruitment of the CCR4 complex and consequently, reduction of the mRNA's poly(A) tail length. The complex is also required for dorso-ventral pattern formation in the embryo.
Component of the core exon-exon-junction complex (EJC). Fairly conserved in eukaryotes; in Drosophila, consists of the Mago and Y14 (tsunagi) gene products. Important for coupling nuclear and cytoplasmic events in gene expression. Inhibits the ATPase activity of eIF4AIII (Q9VHS8) to ensure a stable association of the EJC core with the mRNA.
Component of the core exon-exon-junction complex (EJC). Fairly conserved in eukaryotes; in Drosophila, consists of the Mago and Y14 (tsunagi) gene products. Important for coupling nuclear and cytoplasmic events in gene expression. Inhibits the ATPase activity of eIF4AIII (Q9VHS8) to ensure a stable association of the EJC core with the mRNA.
Component of the core exon-exon-junction complex (EJC). Fairly conserved in eukaryotes; in Drosophila, consists of the Mago and Y14 (tsunagi) gene products. Important for coupling nuclear and cytoplasmic events in gene expression. Inhibits the ATPase activity of eIF4AIII (Q9VHS8) to ensure a stable association of the EJC core with the mRNA.
Steps required to transform a dense core granule generated at the trans-Golgi network into a fully formed and transmissible dense core granule. Dense core granule maturation proceeds through clathrin-mediated membrane remodeling events and is essential for efficient processing of cargo within dense core granules as well as for removing factors that might otherwise interfere with dense core granule trafficking and exocytosis.
A specialized secretory organelle found in neurons and associated with the formation of dendrodendritic gap junctions.
The secretion of molecules (e.g. neuropeptides, insulin-related peptides or neuromodulators such as serotonin and dopamine) contained within a membrane-bounced dense core granule by fusion of the granule with the plasma membrane of a cell in response to increased cytosolic calcium levels.
Any maintenance of fidelity that is involved in mitotic cell cycle DNA replication.
Any maintenance of fidelity that is involved in mitotic cell cycle DNA replication.
Any maintenance of fidelity that is involved in mitotic cell cycle DNA replication.
Any maintenance of fidelity that is involved in mitotic cell cycle DNA replication.
A DNA replication process that uses parental DNA as a template for the DNA-dependent DNA polymerases that synthesize the new strands during the mitotic cell cycle.
The process of inhibiting aggregation and assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that is dependent on interaction with a chaperone, and independent of ATP hydrolysis.
Cyclin-dependent kinase complex which reversibly associates with the Mediator complex. In Saccharomyces cerevisiae it consists of SSN2, SSN3, SSN8 and SRB8.
Cyclin-dependent kinase complex which reversibly associates with the Mediator complex. In Saccharomyces cerevisiae it consists of SSN2, SSN3, SSN8 and SRB8.
Cyclin-dependent kinase complex which reversibly associates with the Mediator complex. In Saccharomyces cerevisiae it consists of SSN2, SSN3, SSN8 and SRB8.
Protein complex involved in the disassembly of Mago-Y14 from the spliced mRNA during first round of translation, independently of the translational machinery. Conserved from fission yeast to humans.
Protein complex involved in the disassembly of Mago-Y14 from the spliced mRNA during first round of translation, independently of the translational machinery. Conserved from fission yeast to humans.
The chemical reactions and pathways resulting in the formation of piRNAs, Piwi-associated RNAs, a class of 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism.
Nuclear transcriptional repressor complex that is capable of negatively regulating CLOCK-BMAL-dependent transactivation of genes in a delayed negative feedback manner which generates circadian rhythms.
Transcription factor complex which interacts with E-box regulatory elements in target genes, including Period (Per1, Per2, Per3) and Cryptochrome (Cry1, Cry2), to activate their transcription during the daytime. The CRY-PER complexes inhibit CLOCK-BMAL1-driven transcription in a negative feedback loop to generate circadian rhythms.
An RNA interference where the silencing signal spreads 5' along the target mRNA, outside of the initial target sequence. Typically involves the formation of secondary siRNAs formed when the initial mRNA target sequence functions as a template for 5' to 3' synthesis of new dsRNA.
An RNA interference where the silencing signal spreads 3' along the target mRNA, outside of the initial target sequence. Typically involves the formation of secondary siRNAs formed when the initial mRNA target sequence functions as a template for 5' to 3' synthesis of new dsRNA.
The pathway by which a ribonucleotide is removed from DNA and replaced by a deoxyribonucleotide. The ribonucleotide is incised by RNase H2, and further excised by an endonuclease. The resulting 1 nt gap is then repaired by DNA polymerase and DNA ligase.
Catalysis of the reaction: ATP + H2O = ADP + phosphate, in the presence of single-stranded DNA; drives the unwinding of the DNA helix in the direction 3' to 5'.
The process in which a pyrimidine nucleotide is transported across the mitochondrial inner membrane, into the mitochondrial matrix.
A protein complex that includes separase (a protease which cleaves cohesin as part of mitotic sister chromatid separation) and securin, a protease inhibitor. Mitotic sister chromatid separation is inhibited until securin is degraded by the Anaphase Promoting Complex.
Binds to and increases the activity of m7G(5')pppN diphosphatase.
The process in which the nematode tail spike is generated and organized. An example of this process is seen in C. elegans, where the tapered tail spike is formed during embryogenesis by a filamentous process that passes posteriorly through hyp10, the tail ventral hypodermis; the filamentous process is formed by a binucleate cell, the tail-spike cell, that subsequently undergoes programmed cell death.
The regrowth of bone following its loss or destruction.
A protein complex located in the inner membrane of mitochondria that is involved in the assembly of the peripheral (or stator) stalk of the mitochondrial proton-transporting ATP synthase (also known as the F1F0 ATP synthase). In budding yeast, this complex includes Ina22p and Ina17p.
Interacting selectively and non-covalently with a Baculovirus Inhibitor of apoptosis protein Repeat (BIR) domain.
A multiprotein complex that is involved in the transcription regulation of mating genes in the yeast S. cerevisiae.
A multiprotein complex that is involved in the transcriptional regulation of primarily filamentation genes, but also mating genes, in the yeast S. cerevisiae.
A protein complex that is involved in endocytosis in the yeast S. cerevisiae.
A protein complex that is involved in the transfer of the four mannoses in the GPI-anchor precursor. In yeast S. cerevisiae this complex consists of Pbn1p and Gpi14p and in rat this complex consists of PIG-X and PIG-M.
A protein complex that functions as a phospholipid-translocating P-Type ATPase. In budding yeast, this complex consists of Cdc50p and Drs2p proteins, and is involved in the trafficking of transport vesicles between the late Golgi and the early endosome.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
A protein complex that functions as a phospholipid-translocating P-Type ATPase.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a nickel ion stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a nickel ion stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a nickel ion stimulus.
A protein complex consisting of one subunit known as Dom34 or Pelota that has similarity to translation termination factor eRF1, and another subunit, Hbs1, that is a GTPase with similarity to translation termination factor eRF3. The Dom34-Hbs1 complex has a role in cotranslational mRNA quality control by promoting ribosomal subunit dissociation and peptidyl-tRNA release when translation is stalled, facilitating no-go decay and nonstop decay.
Catalysis of the reaction: S-methyl-5'-thioadenosine + thermospermine + H+ = S-adenosyl 3-(methylthio)propylamine + spermidine.
The organization process that preserves a neuron projection in a stable functional or structural state. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
The organization process that preserves a neuron projection in a stable functional or structural state. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
The organization process that preserves a neuron projection in a stable functional or structural state. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
The organization process that preserves a neuron projection in a stable functional or structural state. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
The organization process that preserves a neuron projection in a stable functional or structural state. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
The organization process that preserves a neuron projection in a stable functional or structural state. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
The directed movement of phosphoenolpyruvate into the Golgi lumen across the Golgi membrane.
Any of the mitotic spindle microtubules that come from each pole and overlap at the spindle midzone.
Catalysis of the reaction: acetyl-CoA + a xylan= CoA + an acetylated xylan.
The directed movement of fructose substance from outside of a cell, across the plasma membrane and into the cytosol.
The process in which a manganese ion is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which a solute is transported from one side of a membrane to the other into, out of or within a mitochondrion.
The process in which S-adenosyl-L-methionine is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which ATP is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which thiamine pyrophosphate is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which a tricarboxylic acid is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which a phosphate ion is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which FAD is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which NAD is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which alpha-ketoglutarate is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which alpha-ketoglutarate is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which 2-oxoadipate is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which 5'-adenylyl sulfate is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which 3'-phospho-5'-adenylyl sulfate is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which oxaloacetate is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which 2-isopropylmalate(2-) is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which sulfate is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which malonate(1-) is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which coenzyme A is transported across a mitochondrial membrane, into or out of the mitochondrion.
Modulation of the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is deprived of copper ions.
An exosome complex that is assembled in the multivesicular body (MVB) membrane and chaperoned to the exosome by the ESCRT-III machinery.
A protein complex that is wholly or partially contained within the lumen or membrane of the extracellular vesicular exosome.
A protein complex that is wholly or partially contained within the lumen or membrane of the extracellular vesicular exosome.
Covalent attachment of the ubiquitin-like protein UFM1 to a protein, forming an UFM1 chain.
A protein kinase chaperone complex required for the proper folding, maturation and stabilization of target proteins (mostly signalling protein kinases, some steroid hormone receptors), usually during or immediately after completion of translation. The highly conserved, phosphorylated CDC37-Ser13 (vertebrates) or cdc37-Ser14 (yeast) is essential for complex assembly and target protein binding. CDC37-Ser13 (Ser14) is phosphorylated by Casein kinase II (CK2), which in turn is a target of CDC37 creating a positive feedback loop. Complex binding also prevents rapid ubiquitin-dependent proteosomal degradation of target proteins.
An inward rectifier potassium channel complex expressed in cardiac muscle, specifically the sinoatrial node and atria, where it controls the heart rate, via regulation by G protein-coupled receptor signalling. In mammals it is composed of GIRK1 (or Kir3.1) and GIRK4 (or Kir3.4) subunits.
An inward rectifier potassium channel complex expressed in cardiac muscle, specifically the sinoatrial node and atria, where it controls the heart rate, via regulation by G protein-coupled receptor signalling. In mammals it is composed of GIRK1 (or Kir3.1) and GIRK4 (or Kir3.4) subunits.
An inward rectifier potassium channel complex expressed in cardiac muscle, specifically the sinoatrial node and atria, where it controls the heart rate, via regulation by G protein-coupled receptor signalling. In mammals it is composed of GIRK1 (or Kir3.1) and GIRK4 (or Kir3.4) subunits.
A protein serine/threonine phosphatase complex that in S. pombe consists of the proteins Dis2, Ppn1, and Swd22.
The process in which UDP-N-acetylglucosamine is transported across a membrane.
The process in which UDP-N-acetylglucosamine is transported across a membrane.
The process in which GDP-mannose is transported across a membrane.
The process in which GDP-mannose is transported across a membrane.
The process by which centromeres/kinetochores become localized to clusters during a meiotic nuclear division. For example, in Schizosaccharomyces pombe, centromeres are located in one or two clusters away from the spindle pole body during meiosis.
A ribonucleoprotein complex that has RNA-directed RNA polymerase (RdRP) activity, and is composed of telomerase reverse transcriptase (TERT) and the non-coding RNA component of mitochondrial RNA processing endoribonuclease (RMRP).
The directed movement of potassium ions from outside of a cell, across the plasma membrane and into the cytosol.
Any of the meiotic spindle microtubules that radiate in all directions from the spindle poles and are thought to contribute to the forces that separate the poles and position them in relation to the rest of the cell.
The process in which L-ornithine is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which L-ornithine is transported across a mitochondrial membrane, into or out of the mitochondrion.
The process in which L-ornithine is transported across a mitochondrial membrane, into or out of the mitochondrion.
Combining with an extracellular glucose molecule and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
The removal of a methyl group from the C-terminal amino acid of a protein.
The membrane of the perinuclear endoplasmic reticulum, which is the portion of endoplasmic reticulum, the intracellular network of tubules and cisternae, that occurs near the nucleus.
The phosphorylation of a peptidyl-serine to form peptidyl-O-phospho-L-serine on an identical protein. For example, phosphorylation by the other kinase within a homodimer.
The phosphorylation of a peptidyl-serine to form peptidyl-O-phospho-L-serine on an identical protein. For example, phosphorylation by the other kinase within a homodimer.
Any process that modulates the frequency, rate or extent of cytoplasmic translational termination.
Increases the activity of the enzyme phospholipase D.
A complex of accessory proteins (cardiac troponin T, cardiac troponin I and cardiac troponin C) found associated with actin in cardiac muscle thin filaments; involved in calcium regulation important for muscle contraction.
Catalysis of the reaction: UDP-beta-L-arabinofuranose + a [protein]-trans-4-hydroxy-L-proline <=> a protein-O-(beta-L-arabinofuranose)-trans-4-hydroxy-L-proline + UDP + H+.
A protein complex required for prokaryotic cell division (FtsZ-dependent cytokinesis). These complexes are assembled and recruited to the cell septum in a strictly controlled sequence and co-ordinate invagination of the cell membrane, inward growth of the peptidoglycan layer, constriction of the outer membrane and separation of daughter cells.
A protein complex required for prokaryotic cell division (FtsZ-dependent cytokinesis). Part of the divisome. Assembled independently of the other divisome components in the cytoplasm prior to transport to the cell septum. In E. coli consists of FtsB, FtsL and FtsQ.
A protein complex required for prokaryotic cell division (FtsZ-dependent cytokinesis). Part of the divisome. Assembled independently of the other divisome components in the cytoplasm prior to transport to the cell septum. In E. coli consists of FtsB and FtsL.
Transcription factor complex consisting of ATF4 and CREB1 subunits that is capable of binding to cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3') as part of the positive regulation of transcription. Regulatory targets include the GRP78 (HSPA5) promoter in humans, whose activation by this complex is part of the ER stress response pathway.
Transcription factor complex consisting of ATF1 and ATF4 subunits that is capable of binding to cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3') of the GRP78 (HSPA5) promoter. Involved in the ER stress response pathway.
The directed movement of asparagine into the vacuole across the vacuolar membrane.
A protein ufmylation process in which a polymer of the ubiquitin-like protein UFM1 is formed by linkages between lysine residues at position 69 of the UFM1 monomers, is added to a protein.
Interacting selectively and non-covalently with the nascent polypeptide-associated complex, which is a heterodimeric protein complex that can reversibly bind to ribosomes and is located in direct proximity to newly synthesized polypeptide chains as they emerge from the ribosome.
Interacting selectively and non-covalently with the nascent polypeptide-associated complex, which is a heterodimeric protein complex that can reversibly bind to ribosomes and is located in direct proximity to newly synthesized polypeptide chains as they emerge from the ribosome.
Catalysis of the reaction: L-altrarate = 5-dehydro-4-deoxy-D-glucarate + H(2)O.
Combining with basic secretagogues to initiate pseudo-allergic reactions in mast cells.
The modification of histone H3 by the removal of an acetyl group from lysine at position 4 of the histone.
A protein complex consisting of IRE1 (inositol-requiring enzyme-1) bound to AIP1 (ASK1-interacting protein 1/DAB2-interacting protein).
A protein complex consisting of IRE1 (inositol-requiring enzyme-1) bound to AIP1 (ASK1-interacting protein 1/DAB2-interacting protein).
A protein complex consisting of IRE1 (inositol-requiring enzyme-1) bound to AIP1 (ASK1-interacting protein 1/DAB2-interacting protein).
The mitotic cell cycle process where mono-orientation defects are corrected in order to ensure sister chromatids establish stable attachments to microtubules emanating from opposite spindle poles.
The mitotic cell cycle process where mono-orientation defects are corrected in order to ensure sister chromatids establish stable attachments to microtubules emanating from opposite spindle poles.
Catalysis of the hydrolysis of ester linkages within 3' overhang single-stranded deoxyribonucleic acid by creating internal breaks.
Increases the activity of a single-stranded DNA endodeoxyribonuclease activator activity.
Catalysis of the hydrolysis of ester linkages within 5' overhang single-stranded deoxyribonucleic acid by creating internal breaks.
The process by which the rods of the retina gradually become fully responsive to dim light when no longer exposed to bright light.
A protein complex of the endoplasmic reticulum membrane that consists of IRE1 (Inositol-requiring enzyme-1), TRAF2 (TNF receptor-associated factor 2) and ASK1 (Apoptosis signal-regulating kinase 1, a MAP3K).
Interacting selectively and non-covalently with an RNA molecule containing GU repeats.
Catalysis of the generation of a 'twisting' activity resulting in the scission of a membrane, coupled to the hydrolysis of a nucleoside triphosphate.
A process in which a mitotic spindle pole body is transported to, or maintained in, a specific location in the nuclear envelope.
Binds to and modulates the activity of glutamate-cysteine ligase.
Binds to and modulates the activity of acetolactate synthase.
Modulation of the frequency, rate or extent of cytoplasmic translational initiation as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
A LINC complex implicated in the connection of DNA double strand breaks to the cytoskeleton during DNA double-strand break repair.
The joining of two lipid bilayers that surround the mitochondria.
A protein complex that regulates actin cable formation, polarized cell growth, and cytokinesis in a formin-dependent manner. In S. cerevisiae the complex is composed of Bud14p and two Kelch family proteins, Kel1p and Kel2p.
A protein complex that regulates actin cable formation, polarized cell growth, and cytokinesis in a formin-dependent manner. In S. cerevisiae the complex is composed of Bud14p and two Kelch family proteins, Kel1p and Kel2p.
The directed movement of magnesium ions out of mitochondrial matrix into the cytosol by means of some agent such as a transporter or pore.
A heterodimeric transcription factor complex that is composed of CHOP (C/EBP homology protein, GADD153) and ATF4 (activating transcription factor 4, also known as cAMP response element binding protein-2/CREB-2) subunits.
A heterodimeric transcription factor complex that is composed of CHOP (C/EBP homology protein, GADD153) and ATF4 (activating transcription factor 4, also known as cAMP response element binding protein-2/CREB-2) subunits.
A heterodimeric transcription factor complex that is composed of CHOP (C/EBP homology protein, GADD153) and ATF4 (activating transcription factor 4, also known as cAMP response element binding protein-2/CREB-2) subunits.
A heterodimeric transcription factor complex that is composed of CHOP (C/EBP homology protein, GADD153) and ATF4 (activating transcription factor 4, also known as cAMP response element binding protein-2/CREB-2) subunits.
A heterodimeric transcription factor complex that is composed of CHOP (C/EBP homology protein, GADD153) and ATF4 (activating transcription factor 4, also known as cAMP response element binding protein-2/CREB-2) subunits.
The modification of histone H3 by the removal of an acetyl group from lysine at position 9 of the histone.
A receptor complex composed of two ANPR-A molecules and expressed in the heart atrium in mammals; it plays a major role in the regulation of blood pressure and salt-fluid volume homeostasis. Binding of the ligand AMP in response to atrial distension (high blood volume) leads to guanylate cyclase activity of the ANPR-A receptor complex, thereby elevating intracellular cGMP levels. The end result is a reduction in blood volume and, therefore, a reduction in cardiac output and systemic blood pressure.
An ESCRT complex that has AAA-ATPase activity and is involved in ESCRT-mediated intralumenal vesicle formation and the final stages of cytokinesis. The complex catalyzes disassembly of the ESCRT III filament around the neck of the budding vesicle in an ATP-driven reaction, resulting in membrane scission and recycling of the ESCRT III components back to the cytosol. In yeast, it is formed by the AAA ATPase Vps4 and its cofactor Vta1.
An ESCRT complex that has AAA-ATPase activity and is involved in ESCRT-mediated intralumenal vesicle formation and the final stages of cytokinesis. The complex catalyzes disassembly of the ESCRT III filament around the neck of the budding vesicle in an ATP-driven reaction, resulting in membrane scission and recycling of the ESCRT III components back to the cytosol. In yeast, it is formed by the AAA ATPase Vps4 and its cofactor Vta1.
An ESCRT complex that has AAA-ATPase activity and is involved in ESCRT-mediated intralumenal vesicle formation and the final stages of cytokinesis. The complex catalyzes disassembly of the ESCRT III filament around the neck of the budding vesicle in an ATP-driven reaction, resulting in membrane scission and recycling of the ESCRT III components back to the cytosol. In yeast, it is formed by the AAA ATPase Vps4 and its cofactor Vta1.
An ESCRT complex that has AAA-ATPase activity and is involved in ESCRT-mediated intralumenal vesicle formation and the final stages of cytokinesis. The complex catalyzes disassembly of the ESCRT III filament around the neck of the budding vesicle in an ATP-driven reaction, resulting in membrane scission and recycling of the ESCRT III components back to the cytosol. In yeast, it is formed by the AAA ATPase Vps4 and its cofactor Vta1.
An ESCRT complex that has AAA-ATPase activity and is involved in ESCRT-mediated intralumenal vesicle formation and the final stages of cytokinesis. The complex catalyzes disassembly of the ESCRT III filament around the neck of the budding vesicle in an ATP-driven reaction, resulting in membrane scission and recycling of the ESCRT III components back to the cytosol. In yeast, it is formed by the AAA ATPase Vps4 and its cofactor Vta1.
An ESCRT complex that has AAA-ATPase activity and is involved in ESCRT-mediated intralumenal vesicle formation and the final stages of cytokinesis. The complex catalyzes disassembly of the ESCRT III filament around the neck of the budding vesicle in an ATP-driven reaction, resulting in membrane scission and recycling of the ESCRT III components back to the cytosol. In yeast, it is formed by the AAA ATPase Vps4 and its cofactor Vta1.
An ESCRT complex that has AAA-ATPase activity and is involved in ESCRT-mediated intralumenal vesicle formation and the final stages of cytokinesis. The complex catalyzes disassembly of the ESCRT III filament around the neck of the budding vesicle in an ATP-driven reaction, resulting in membrane scission and recycling of the ESCRT III components back to the cytosol. In yeast, it is formed by the AAA ATPase Vps4 and its cofactor Vta1.
A heterodimeric protein complex that is composed of CHOP (C/EBP homology protein, GADD153) and ATF3 (activating transcription factor 3) subunits.
A heterodimeric protein complex that is composed of CHOP (C/EBP homology protein, GADD153) and ATF3 (activating transcription factor 3) subunits.
A heterodimeric protein complex that is composed of CHOP (C/EBP homology protein, GADD153) and ATF3 (activating transcription factor 3) subunits.
A heterodimeric protein complex that is composed of CHOP (C/EBP homology protein, GADD153) and ATF3 (activating transcription factor 3) subunits.
The dilated terminal portions of neurosecretory axons constituting the hypothalamohypophyseal tract, found in close proximity to sinusoidal capillaries in the posterior pituitary. Herring bodies consist of aggregates of membrane-bound neurosecretory vesicles where oxytocin or antidiuretic hormone (ADH) are stored prior to release. Each Herring body also contains ATP and either neurophysin I or neurophysin II which bind to oxytocin and ADH, respectively.
Stops, prevents or reduces the activity of a guanyl nucleotide exchange factor.
Any process that stops, prevents or reduces the rate of cytoplasmic translation initiation as a result of a stimulus indicating the organism is under stress.
The membrane organization process that joins two mitochondrial outer membranes to form a single membrane.
The membrane organization process that joins two mitochondrial inner membranes to form a single membrane.
A protein complex found as a homopentamer of the phospholamban (PLN) protein in the sarcoplasmic reticulum (SR) membrane of cardiomyocytes. Cardiac PLN is a main determinant of muscle contraction and relaxation, by regulating intracellular calcium levels.
A protein complex found as a homopentamer of the phospholamban (PLN) protein in the sarcoplasmic reticulum (SR) membrane of cardiomyocytes. Cardiac PLN is a main determinant of muscle contraction and relaxation, by regulating intracellular calcium levels.
A protein complex found as a homopentamer of the phospholamban (PLN) protein in the sarcoplasmic reticulum (SR) membrane of cardiomyocytes. Cardiac PLN is a main determinant of muscle contraction and relaxation, by regulating intracellular calcium levels.
A protein complex consisting of IRE1 (Inositol-requiring enzyme-1), RACK1 (Receptor of activated protein kinase C 1, GNB2L1) and PP2A (protein phosphatase 2A). RACK1 acts as an adaptor to bridge an interaction between IRE1 and PP2A.
A protein complex consisting of IRE1 (Inositol-requiring enzyme-1), RACK1 (Receptor of activated protein kinase C 1, GNB2L1) and PP2A (protein phosphatase 2A). RACK1 acts as an adaptor to bridge an interaction between IRE1 and PP2A.
Interacting selectively and non-covalently with the protein-tyrosine kinase receptor ErbB-4/HER4.
The process in which the branching structure of the submandibular gland is generated and organized.
The process in which the branching structure of the submandibular gland is generated and organized.
A type of punctate focus localized to the perinuclear region of germline cytoplasm in C. elegans. Mutator foci are required for RNA interference (RNAi) and serve as sites of small inhibitory RNA (siRNA) amplification. As such, proteins that localize to mutator foci include RNA-directed RNA polymerases (RdRPs) and beta-nucleotidyltransferases. Mutator foci are distinct from, but adjacent to or partially overlap, P granules.
Interacting selectively and non-covalently with the enzyme protein phosphatase 5.
That part of the dendrite closest to the cell body of the neuron.
A natural reduction in reproductive capacity with aging, often taking the form of a switch from regular reproductive cycles to irregular and infrequent ones.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prolactin stimulus. The anterior pituitary hormone prolactin has a number of roles including being essential for lactation.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a granulocyte colony-stimulating factor stimulus.
Catalysis of the reaction: 1D-myo-inositol 2,4,5-trisphosphate + H2O = 1D-myo-inositol 2,4-bisphosphate + phosphate.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of iron ion.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a granulocyte colony-stimulating factor stimulus.
The binding activity of a molecule that attaches the spindle microtubules to the kinetochore.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prolactin stimulus.
A dimeric, sequence specific DNA-binding transcription factor complex regulating the expression of genes involved in immune and inflammatory responses. Exists at least as alpha and beta homodimeric forms. Binds to regulatory regions of several acute-phase and cytokines genes and probably plays a role in the regulation of acute-phase reaction, inflammation and hemopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Transcription factor activity is inhibited by binding of CHOP forming heterodimers with alternative transcription factor activities.
A dimeric, sequence specific DNA-binding transcription factor complex regulating the expression of genes involved in immune and inflammatory responses. Exists at least as alpha and beta homodimeric forms. Binds to regulatory regions of several acute-phase and cytokines genes and probably plays a role in the regulation of acute-phase reaction, inflammation and hemopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Transcription factor activity is inhibited by binding of CHOP forming heterodimers with alternative transcription factor activities.
A dimeric, sequence specific DNA-binding transcription factor complex regulating the expression of genes involved in immune and inflammatory responses. Exists at least as alpha and beta homodimeric forms. Binds to regulatory regions of several acute-phase and cytokines genes and probably plays a role in the regulation of acute-phase reaction, inflammation and hemopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Transcription factor activity is inhibited by binding of CHOP forming heterodimers with alternative transcription factor activities.
A dimeric, sequence specific DNA-binding transcription factor complex regulating the expression of genes involved in immune and inflammatory responses. Exists at least as alpha and beta homodimeric forms. Binds to regulatory regions of several acute-phase and cytokines genes and probably plays a role in the regulation of acute-phase reaction, inflammation and hemopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Transcription factor activity is inhibited by binding of CHOP forming heterodimers with alternative transcription factor activities.
A dimeric, sequence specific DNA-binding transcription factor complex regulating the expression of genes involved in immune and inflammatory responses. Exists at least as alpha and beta homodimeric forms. Binds to regulatory regions of several acute-phase and cytokines genes and probably plays a role in the regulation of acute-phase reaction, inflammation and hemopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Transcription factor activity is inhibited by binding of CHOP forming heterodimers with alternative transcription factor activities.
A dimeric, sequence specific DNA-binding transcription factor complex regulating the expression of genes involved in immune and inflammatory responses. Exists at least as alpha and beta homodimeric forms. Binds to regulatory regions of several acute-phase and cytokines genes and probably plays a role in the regulation of acute-phase reaction, inflammation and hemopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Transcription factor activity is inhibited by binding of CHOP forming heterodimers with alternative transcription factor activities.
Catalysis of the reaction: 1D-myo-inositol 4,5,6-trisphosphate + H2O = 1D-myo-inositol 4,6-bisphosphate + phosphate.
Catalysis of the reaction: 1D-myo-inositol 1,2,4,5-tetrakisphosphate + H2O = 1D-myo-inositol 1,2,4-trisphosphate + phosphate.
Catalysis of the reaction: 1D-myo-inositol 2,4,5,6-tetrakisphosphate + H2O = 1D-myo-inositol 2,4,6-trisphosphate + phosphate.
Catalysis of the reaction: 1D-myo-inositol 1,2,4,5,6-pentakisphosphate + H2O = 1D-myo-inositol 1,2,4,6-tetrakisphosphate + phosphate.
The multiplication or reproduction of sebocytes by cell division, resulting in the expansion of their population. A sebocyte is an epithelial cell that makes up the sebaceous glands, and secrete sebum.
Interacting selectively and non-covalently with a 4 iron, 3 sulfur (4Fe-3S) cluster, an uncommon iron-sulfur cluster with unique properties found in oxygen-tolerant Ni-Fe hydrogenases of various bacteria.
The clustering process in which t-SNARES are localized to distinct domains in the cell membrane. t-SNAREs are cell surface proteins which are part of secretory microdomain assemblies.
A protein complex capable of stimulus-inducible nitric-oxide synthase activity. S-nitrosylates cysteine residues in target proteins, a principal mechanism of nitric oxide (NO)-mediated signal transduction. In mammals consists of NOS2, S100A8 and S100A9. S100A9 acts both as an adaptor linking NOS2 to its target and as a transnitrosylase that transfers the nitric oxide moiety from NOS2 to its target, via its own S-nitrosylated cysteine.
A transferase complex which is capable of transferring nitrogenous groups from one component to another.
The process of binding or confining manganese ions such that they are separated from other components of a biological system.
The process of binding or confining manganese ions such that they are separated from other components of a biological system.
The process of binding or confining manganese ions such that they are separated from other components of a biological system.
The process of binding or confining manganese ions such that they are separated from other components of a biological system.
The process of binding or confining manganese ions such that they are separated from other components of a biological system.
The process of binding or confining manganese ions such that they are separated from other components of a biological system.
The process of binding or confining manganese ions such that they are separated from other components of a biological system.
A protein complex composed of S100A8 and S100A9 and capable of limiting Mn(2+) and Zn(2+) availability at sites of infection. Also binds Ca(2+). Expressed and released by neutrophils and epithelial cells, it exhibits broad-spectrum antimicrobial activity attributed to its metal-binding properties. Endogenous ligand of toll-like receptor 4 (TLR4) and of the receptor for advanced glycation end products (RAGE) initiating signal transduction through NF-kappa-B pathways.
A protein complex composed of a S100A8 dimer and capable of binding to toll-like receptor 4 (TLR4).
A protein complex composed of a S100A9 dimer and capable of binding to toll-like receptor 4 (TLR4) and the receptor for advanced glycation end products (RAGE) initiating signal transduction through NF-kappa-B pathways. Transports arachidonic acid between the cytosol and the NADPH oxidase complex at the plasma membrane in neutrophils as part of an inflammatory signal cascade leading to an oxidative burst. Complexes with microtubules to increase cell motility.
Catalysis of the reaction: (S)-dihydroorotate + fumarate = orotate + succinate.
A transcription factor complex formed by two or more subunits of Nkx-2.5. Nkx-2.5 is an evolutionary conserved transcription factor important for the specification and differentiation of cardiomyocytes during heart development. It is also required for spleen development. It binds DNA either as a monomer, or a homodimer, or a heterodimer complex to activate or inhibit expression of genes.
A transcription factor complex formed by two or more subunits of Nkx-2.5. Nkx-2.5 is an evolutionary conserved transcription factor important for the specification and differentiation of cardiomyocytes during heart development. It is also required for spleen development. It binds DNA either as a monomer, or a homodimer, or a heterodimer complex to activate or inhibit expression of genes.
A transcription factor complex formed by two or more subunits of Nkx-2.5. Nkx-2.5 is an evolutionary conserved transcription factor important for the specification and differentiation of cardiomyocytes during heart development. It is also required for spleen development. It binds DNA either as a monomer, or a homodimer, or a heterodimer complex to activate or inhibit expression of genes.
A transcription factor complex formed by two or more subunits of Nkx-2.5. Nkx-2.5 is an evolutionary conserved transcription factor important for the specification and differentiation of cardiomyocytes during heart development. It is also required for spleen development. It binds DNA either as a monomer, or a homodimer, or a heterodimer complex to activate or inhibit expression of genes.
A heterotetrameric protein complex comprising two Annexin A2 (AnxA2) monomers and two copies of its binding partner, S100 protein p11 (S100A10).
A heterotetrameric protein complex comprising two Annexin A2 (AnxA2) monomers and two copies of its binding partner, S100 protein p11 (S100A10).
A heterotetrameric protein complex comprising two Annexin A2 (AnxA2) monomers and two copies of its binding partner, S100 protein p11 (S100A10).
A heterotetrameric protein complex comprising two Annexin A2 (AnxA2) monomers and two copies of its binding partner, S100 protein p11 (S100A10).
A heterotetrameric protein complex comprising two Annexin A2 (AnxA2) monomers and two copies of its binding partner, S100 protein p11 (S100A10).
A heterotetrameric protein complex comprising two Annexin A2 (AnxA2) monomers and two copies of its binding partner, S100 protein p11 (S100A10).
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and a low-density lipoprotein receptor (LDLR). Interaction typically occurs through the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR, and complex formation promotes degradation of the LDLR through the endosome/lysosome pathway.
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and a low-density lipoprotein receptor (LDLR). Interaction typically occurs through the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR, and complex formation promotes degradation of the LDLR through the endosome/lysosome pathway.
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and a low-density lipoprotein receptor (LDLR). Interaction typically occurs through the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR, and complex formation promotes degradation of the LDLR through the endosome/lysosome pathway.
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and a low-density lipoprotein receptor (LDLR). Interaction typically occurs through the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR, and complex formation promotes degradation of the LDLR through the endosome/lysosome pathway.
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and Annexin A2 (AnxA2).
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and Annexin A2 (AnxA2).
A protein complex consisting of the serine protease PCSK9 (Proprotein convertase subtilisin/kexin-9) and Annexin A2 (AnxA2).
The joining of the lipid bilayer membrane around a vesicle to the lipid bilayer membrane of the ERGIC. This can involve anterograde or retrograde transport vesicles.
The joining of the lipid bilayer membrane around a vesicle to the lipid bilayer membrane of the ERGIC. This can involve anterograde or retrograde transport vesicles.
The joining of the lipid bilayer membrane around a vesicle to the lipid bilayer membrane of the ERGIC. This can involve anterograde or retrograde transport vesicles.
The joining of the lipid bilayer membrane around a vesicle to the lipid bilayer membrane of the ERGIC. This can involve anterograde or retrograde transport vesicles.
The joining of the lipid bilayer membrane around an ERGIC-derived vesicle to the lipid bilayer membrane of the ER. Such vesicles include COPI-coated transport vesicles involved in retrograde transport.
The joining of the lipid bilayer membrane around an ERGIC-derived vesicle to the lipid bilayer membrane of the ER. Such vesicles include COPI-coated transport vesicles involved in retrograde transport.
The joining of the lipid bilayer membrane around a vesicle to the lipid bilayer membrane around the Golgi cis cisterna. This can involve anterograde or retrograde transport vesicles.
The joining of the lipid bilayer membrane around a vesicle to the lipid bilayer membrane around the Golgi medial cisterna. This can involve anterograde or retrograde transport vesicles.
The joining of the lipid bilayer membrane around a medial-Golgi-derived vesicle to the lipid bilayer membrane around the Golgi trans cisterna. Vesicles are involved in anterograde transport.
The component of the ERGIC membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
The lipid bilayer surrounding any of the thin, flattened compartments that form the cis portion of the Golgi complex.
The lipid bilayer surrounding any of the thin, flattened compartments that form the medial portion of the Golgi complex.
The lipid bilayer surrounding any of the thin, flattened compartments that form the trans portion of the Golgi complex.
A protein complex that promotes the biogenesis of mitochondrial F1Fo-ATP synthase by facilitating assembly of the peripheral stalk. Loss of INAC function causes dissociation of the F1-domain from the membrane-integral Fo-portion.
A protein complex that promotes the biogenesis of mitochondrial F1Fo-ATP synthase by facilitating assembly of the peripheral stalk. Loss of INAC function causes dissociation of the F1-domain from the membrane-integral Fo-portion.
The modification of histone H4 by the removal of an acetyl group from lysine at position 16 of the histone.
The modification of histone H4 by the removal of an acetyl group from lysine at position 12 of the histone.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a melanocyte-stimulating hormone stimulus. The binding of any one of three melanocyte-stimulating hormones causes dispersal of melanosomes in melanophores of poikilothermic vertebrates.
A protein complex consisting of a macrophage colony-stimulating factor (CSF1, also called M-CSF) dimer bound to a dimerized receptor (CSF1R, also called FMS). Receptor dimerization requires the presence of the ligand.
A protein complex consisting of a macrophage colony-stimulating factor (CSF1, also called M-CSF) dimer bound to a dimerized receptor (CSF1R, also called FMS). Receptor dimerization requires the presence of the ligand.
A protein complex consisting of a macrophage colony-stimulating factor (CSF1, also called M-CSF) dimer bound to a dimerized receptor (CSF1R, also called FMS). Receptor dimerization requires the presence of the ligand.
A protein complex consisting of a macrophage colony-stimulating factor (CSF1, also called M-CSF) dimer bound to a dimerized receptor (CSF1R, also called FMS). Receptor dimerization requires the presence of the ligand.
A protein complex consisting of a macrophage colony-stimulating factor (CSF1, also called M-CSF) dimer bound to a dimerized receptor (CSF1R, also called FMS). Receptor dimerization requires the presence of the ligand.
A process in which the DNA double-strand breaks are attached to the inner surface of the nuclear envelope proximal to the spindle pole body, or iMTOCs.
A macromolecular complex containing separate protein, lipid and RNA molecules. Separate in this context means not covalently bound to each other.
A protein-lipid-RNA complex containing separate high-density lipoprotein (HDL), lipid and RNA molecules. Separate in this context means not covalently bound to each other.
A protein-lipid-RNA complex containing separate low-density lipoprotein (LDL), lipid and RNA molecules. Separate in this context means not covalently bound to each other.
The joining of the lipid bilayer membrane around an endoplasmic reticulum-derived vesicle to the lipid bilayer membrane of the ERGIC. Such vesicles include COPII-coated transport vesicles involved in anterograde transport.
The joining of the lipid bilayer membrane around an endoplasmic reticulum-derived vesicle to the lipid bilayer membrane of the ERGIC. Such vesicles include COPII-coated transport vesicles involved in anterograde transport.
The joining of the lipid bilayer membrane around a Golgi vesicle to the lipid bilayer membrane of the ERGIC. Such vesicles include COPI-coated transport vesicles involved in retrograde transport.
The joining of the lipid bilayer membrane around a Golgi vesicle to the lipid bilayer membrane of the ERGIC. Such vesicles include COPI-coated transport vesicles involved in retrograde transport.
The joining of the lipid bilayer membrane around an ERGIC-derived vesicle to the lipid bilayer membrane around the Golgi cis cisterna. Such vesicles include COPII-coated transport vesicles involved in anterograde transport.
The joining of the lipid bilayer membrane around an ERGIC-derived vesicle to the lipid bilayer membrane around the Golgi cis cisterna. Such vesicles include COPII-coated transport vesicles involved in anterograde transport.
The joining of the lipid bilayer membrane around an ERGIC-derived vesicle to the lipid bilayer membrane around the Golgi cis cisterna. Such vesicles include COPII-coated transport vesicles involved in anterograde transport.
The joining of the lipid bilayer membrane around an ERGIC-derived vesicle to the lipid bilayer membrane around the Golgi cis cisterna. Such vesicles include COPII-coated transport vesicles involved in anterograde transport.
The joining of the lipid bilayer membrane around an ERGIC-derived vesicle to the lipid bilayer membrane around the Golgi cis cisterna. Such vesicles include COPII-coated transport vesicles involved in anterograde transport.
The joining of the lipid bilayer membrane around a Golgi medial cisterna-derived vesicle to the lipid bilayer membrane around the Golgi cis cisterna. Such vesicles include COPI-coated transport vesicles involved in retrograde transport.
The joining of the lipid bilayer membrane around a cis-Golgi-derived vesicle to the lipid bilayer membrane around the medial-Golgi cisterna. Vesicles are involved in anterograde transport.
The joining of the lipid bilayer membrane around a trans-Golgi-derived vesicle to the lipid bilayer membrane around the medial-Golgi cisterna. Such vesicles include COPI-coated transport vesicles involved in retrograde transport.
The component of the Golgi cis cisterna membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
The component of the Golgi medial cisterna membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
The component of the Golgi trans cisterna membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
A protein complex composed of four proteins, loss of which results in Usher Syndrome type 2 (USH2 syndrome), a leading genetic cause of combined hearing and vision loss. This complex is conserved in many species; in mice, it is composed of USH2A, GPR98 (aka ADGRV1), WHRN, and PDZD7.
The removal of palmitoleyl group, a 16-carbon monounsaturated fatty acid (C16:1), from a lipoprotein.
Catalysis of the transfer of a palmitoleyl group, a 16-carbon monounsaturated fatty acid (C16:1), to an acceptor molecule.
Catalysis of a hydrolase reaction that removes a palmitoleyl moiety, a 16-carbon monounsaturated fatty acid (C16:1), from some substrate.
Any process that results in the specification, formation or maintenance of the physical structure of nucleolar chromatin.
Any process that results in the specification, formation or maintenance of the physical structure of nucleolar chromatin.
The component of the ERGIC membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
The component of the ERGIC membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
The component of the ERGIC membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
The component of the Golgi cis membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
The component of the Golgi medial membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
The component of the Golgi trans membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
The multiplication or reproduction of cholangiocytes, resulting in the expansion of the cholangiocyte population. A cholangiocyte is an epithelial cell that is part of the bile duct. Cholangiocytes contribute to bile secretion via net release of bicarbonate and water.
A protein complex involved in the assembly of the mitotic checkpoint complex that in turn inhibits the anaphase promoting complex/cyclosome (APC/C).
Heterochromatic regions of the chromosome found at the subtelomeric regions of a chromosome in the nucleus.
The associative learning process by which an animal learns and remembers an association between a neutral, unchanging environment and a putatively rewarding, internal state produced by a xenobiotic or drug.
A process that results in the assembly, arrangement of constituent parts, or disassembly of a presynaptic active zone.
A homodimeric mismatch repair complex involved in binding to and correcting insertion/deletion mutations.
Transcription factor complex that inhibits binding of Tcf to beta-catenin while preserving interaction of catenin with cadherin thus inhibiting transcription mediated by beta-catenin-Tcf complex.
A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription.
A protein complex that negatively regulates apoptotic processes. In human, this anti-apoptotic complex is a homodimer of BIRC5 (survivin) and provides one survivin molecule to the chromosomal passenger complex (CPC).
A protein complex that negatively regulates apoptotic processes. In human, this anti-apoptotic complex is a homodimer of BIRC5 (survivin) and provides one survivin molecule to the chromosomal passenger complex (CPC).
Catalysis of the transfer of galactose from UDP-galactose to hydroxyproline residues present in the peptide backbone.
Interacting selectively and non-covalently with the coding sequence (CDS) of an mRNA molecule.
Interacting selectively and non-covalently with the coding sequence (CDS) of an mRNA molecule.
Part of the 9+2 axoneme, that occurs in most motile cilia, consisting of the pair of two single central microtubules and their associated structures which include the central pair projections, the central pair bridges linking the two tubules, and the central pair caps which are attached to the distal or plus ends of the microtubules.
Part of the 9+2 axoneme, that occurs in most motile cilia, consisting of the two bridges which connect the central pair of single microtubules.
Part of the 9+2 axoneme, that occurs in most motile cilia, consisting of the projections off of the central pair of single microtubules.
One of two microtubules present in the axonemal central pair. It is distinguishable from the C2 axonemal microtubule (also called C2 tubule) by the presence of differing protein components of the projections.
One of two microtubules present in the axonemal central pair. It is distinguishable from the C1 axonemal microtubule (also called C1 tubule) by the presence of differing protein components of the projections.
A serine/threonine protein kinase complex involved in cell survival, apoptosis and autophagic cell death pathways. DAPK1 is activated by the dephosphorylation of a n-terminal serine and calcium-calmodulin binding.
Cytoplasm situated in close proximity to a nuclear pore complex.
A homodimeric protein complex that is capable of binding a range of carbohydrates and is involved in anti-inflammatory and pro-apoptotic processes.
A homodimeric protein complex that is capable of binding a range of carbohydrates and is involved in anti-inflammatory and pro-apoptotic processes.
Combining with a cord factor, an M. tuberculosis cell wall glycolipid, and transmitting a signal from one side of the membrane to the other to initiate a change in cell activity.
Combining with a cord factor, an M. tuberculosis cell wall glycolipid, and transmitting a signal from one side of the membrane to the other to initiate a change in cell activity.
A conserved, heteroheptameric, cytoplasmic protein complex composed of Lsm1, Lsm2, Lsm3, Lsm4, Lsm5, Lsm6, Lsm7, and Pat1, or orthologs thereof, that shows a strong binding preference for oligoadenylated RNAs over polyadenylated RNAs. May bind further associated proteins. Facilitates the deadenylation-dependent decapping of mRNA in the P-body thereby regulating mRNA decay and subsequent degradation by the 5' to 3' pathway.
A multimeric protein complex involved in tubulin alpha-beta-subunit folding assembly consisting of beta-tubulin-TFC-D, alpha-tubulin-TFC-E and TFC-C, through which tubulin subunit association and dimer release occur.
A protein complex involved in the assembly of the mitotic checkpoint complex that in turn inhibits the anaphase promoting complex/cyclosome (APC/C). The MAD1 dimer recruits the open form of MAD2 (O-MAD2) turning it into the closed form (C-MAD2) upon binding. C-MAD2 inhibits CDC20, a member of the APC/C, upon release from the MAD1-MAD2 complex.
The covalent alteration of one or more nucleotides within a primary miRNA molecule to produce a primary miRNA molecule with a sequence that differs from that coded genetically.
A protein complex between the ATPase VCP (p97) and its cofactor p47 (NSFL1C). In human, the protein complex consists of one homotrimer of NSFL1C/p47 per homohexamer of VCP/p97.
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A process that results in the endonucleolytic cleavage of the damaged strand of DNA immediately 5' of a UV-induced damage site, and is the first part of a DNA repair process that acts on both cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone 6-4 photoproducts (6-4PPs).
A non-membrane-bounded organelle found within the chloroplasts of algae and hornworts; responsible for carbon dioxide fixation.
A protein complex formed between the N-terminus of the giant sarcomeric filament protein titin and the Z-disk ligand, telethonin. The complex is part of the Z-disk of the skeletal and cardiac sarcomere. Telethonin binding to titin might be essential for the initial assembly, stabilization and functional integrity of the titin filament, and hence important for muscle contraction relaxation in mature myofibrils.
Any process in which an astral microtubule is maintained in a specific location in a cell by attachment to a mitotic spindle pole body. Microtubules attach to spindle pole bodies at the minus end.
Any process in which a gamma-tubulin complex is transported to, or maintained in, a specific location at a mitotic spindle pole body.
Any process in which a gamma-tubulin complex is transported to, or maintained in, a specific location at a mitotic spindle pole body.
Any process in which a gamma-tubulin complex is transported to, or maintained in, a specific location at a mitotic spindle pole body.
Any process that modulates the establishment or extent of a membrane potential in the depolarizing direction away from the resting potential in a vascular smooth muscle cell.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of endoplasmic reticulum stress caused by a manganese stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of endoplasmic reticulum stress caused by a manganese stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of endoplasmic reticulum stress caused by a manganese stimulus.
Catalysis of the reaction: pseudouridine 5'-phosphate + H2O = pseudouridine + phosphate.
The multiplication or reproduction of granulosa cells, resulting in the expansion of the granulosa cells population. A granulosa cell is a supporting cell for the developing female gamete in the ovary of mammals. They develop from the coelomic epithelial cells of the gonadal ridge.
An extracellular vesicle released from the plasma membrane and ranging in size from about 100 nm to 1000 nm.
An extracellular vesicle released from the plasma membrane and ranging in size from about 100 nm to 1000 nm.
An extracellular vesicle released from the plasma membrane and ranging in size from about 100 nm to 1000 nm.
A protein modification process that results in the addition of a sialic acid unit to the end of an oligosaccharide chain in a glycoprotein.
The posttranscriptional addition of methyl groups to specific residues in an primary miRNA molecule.
A quatrefoil tethering complex required for endocytic recycling.
The regulated release of trypsinogen from the cells of the exocrine pancreas.
Any process carried out at the cellular level that reduces or removes the toxicity of a toxic substance. These may include transport of the toxic substance away from sensitive areas and to compartments or complexes whose purpose is sequestration of the toxic substance.
Increases the activity of the enzyme polynucleotide adenylyltransferase.
The directed movement of a Schwann cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
Any end of a microtubule. Microtubule ends differ in that the so-called microtubule plus-end is the one that preferentially grows by polymerization, with respect to the minus-end.
The region of the cell cortex in a mitotically dividing cell that flanks the central spindle and corresponds to the site of actomyosin ring formation that results in cleavage furrow formation and ingression.
The removal of tubulin heterodimers from one or both ends of a microtubule that is part of the mitotic spindle.
The binding activity of a molecule that brings together a ubiquitin ligase and its substrate. Usually mediated by F-box BTB/POZ domain proteins.
Binds to and increases the activity of a ubiquitin ligase.
Binds to and increases the activity of a ubiquitin ligase.
The mitotic cell cycle process in which sister chromatids establish stable, end-on attachments to the plus ends of microtubules emanating from opposite spindle poles, oriented such that separation can proceed. This is the final step in metaphase plate congression.
Enables the transmembrane transfer of a cation by a channel that opens when a change in the osmolarity occurs in the extracellular space of the cell in which the cation channel resides.
A thin sheetlike process extended by the leading edge of an axonal or dendritic growth cone; contains a dense meshwork of actin filaments.
The process of coupling alanine to alanyl-tRNA, catalyzed by alanyl-tRNA synthetase involved in cytoplasmic translation.
Interacting selectively and non-covalently with any member of the arrestin family, proteins involved in agonist-mediated desensitization of G protein-coupled receptors.
The actin filament-based process in which cytoplasmic actin filaments slide past one another resulting in contraction of a myofibroblast.
The actin filament-based process in which cytoplasmic actin filaments slide past one another resulting in contraction of a myofibroblast.
A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry of the large intestine, exclusive of the rectum. The colon is that part of the large intestine that connects the small intestine to the rectum.
The process that results in the uptake of a prostaglandin receptor into an endocytic vesicle.
The flow of blood through the gastric mucosa of an animal, enabling the transport of nutrients and the removal of waste products.
The portion of an axon or dendrite that is close to the neuronal cell body.
A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry in the intestine between the stomach and the large intestine.
The clathrin-mediated endocytosis of an extracellular exosome.
The clathrin-mediated endocytosis of an extracellular exosome.
The regulated release of substance P, a peptide hormone that is involved in neurotransmission, inflammation, and antimicrobial activity.
The regulated release of matrix metallopeptidases, a family of zinc-dependent endopeptidases that can degrade extracellular matrix proteins and process other types of proteins.
The regulated release of matrix metallopeptidases, a family of zinc-dependent endopeptidases that can degrade extracellular matrix proteins and process other types of proteins.
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
The regulated release of endothelin from a cell. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions.
The regulated release of endothelin from a cell. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions.
The regulated release of endothelin from a cell. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions.
The regulated release of endothelin from a cell. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions.
The regulated release of endothelin from a cell. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions.
The regulated release of endothelin from a cell. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an angiotensin stimulus. Angiotensin is any of three physiologically active peptides (angiotensin II, III, or IV) processed from angiotensinogen.
A spherical particle containing non-covalently associated proteins and lipids. Examples are plasma lipoprotein particles which transport lipids in the blood or lymph.
A process in which a protein is transported to, or maintained in, the cell periphery.
A transmembrane signalling receptor complex found exclusively on platelets. Involved in haemostasis and thrombosis where it aids blood coagulation.
A transmembrane signalling receptor complex found exclusively on platelets. Involved in haemostasis and thrombosis where it aids blood coagulation.
A transmembrane signalling receptor complex found exclusively on platelets. Involved in haemostasis and thrombosis where it aids blood coagulation.
The leaflet of the plasma membrane that faces the cytoplasm and any proteins embedded or anchored in it or attached to its surface surrounding a dendritic spine.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus given while being held immobile.
Interacting selectively and non-covalently with protein tyrosine kinase.
Cytoplasm situated near, or occurring around, a phagosome.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a double-stranded DNA stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of water immersion while being held immobile.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a double-stranded DNA stimulus.
Any process that decreases the activity of a transcription factor that activates transcription of Hedgehog-target genes in response to Smoothened signaling. In Drosophila, Cubitus interruptus (Ci) is the only identified transcription factor so far in the Hedgehog signaling pathway. In vertebrates members of the Gli protein family are activated by Hedgehog signaling.
A protein repressing GLI's transcription factor activity when SMO signalling is inactive. Upon ligand binding to the upstream receptor PTC (Patched) GLI dissociates from SUFU and activates transcription of hedgehog-target genes. In mammals it consists of SUFU and one of the GLI family proteins.
The multiplication or reproduction of thyroid gland epithelial cells, resulting in the expansion of the thyroid gland epithelial cell population.
The multiplication or reproduction of thyroid gland epithelial cells, resulting in the expansion of the thyroid gland epithelial cell population.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glial cell derived neurotrophic factor stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glial cell derived neurotrophic factor stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glial cell derived neurotrophic factor stimulus.
The process whose specific outcome is the progression of a dorsal root ganglion over time, from its formation to the mature structure.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glial cell derived neurotrophic factor stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glial cell derived neurotrophic factor stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glial cell derived neurotrophic factor stimulus.
The controlled release of substance P by a cell, in which the substance P acts as a neurotransmitter.
The region of a cell situated by the cell sides which interface adjacent cells and near the base. Often used in reference to animal polarized epithelial cells.
A specialized region of the axon terminus portion of a rod bipolar axon. A rod bipolar cell is a neuron found in the retina and having connections with rod photoreceptor cells and neurons in the inner plexiform layer.
A specialized region of the axon terminus portion of a photoreceptor cell axon. A photoreceptor cell is a neuron specialized to detect and transduce light.
The regrowth of a destroyed pancreas.
The process in which a uridine residue at position 34 in the anticodon of a mitochondrial tRNA is post-transcriptionally thiolated at the C2 position. This process involves transfer of a sulfur from cysteine to position C2 by several steps.
A scaffolding structure present within the inner region of the ciliary transition zone. The central cylinder lies between the outer doublet and inner singlet microtubules.
A series of molecular signals initiated by activation of a ligand-gated ion channel on the surface of a cell. The pathway begins with binding of an extracellular ligand to a ligand-gated ion channel and ends with a molecular function that directly regulates a downstream cellular process, e.g. transcription.
Interacting selectively and non-covalently with an F-BAR domain of a protein, a domain of about 60 residues that occurs in a wide range of cytoskeletal proteins.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the endoplasmic reticulum (ER) tubular network membrane.
Any process in which a microtubule is maintained in a specific location in a cell by attachment to a mitotic spindle pole body. Microtubules attach to spindle pole bodies at the minus end.
A protein ternary complex that anchors microtubule minus ends to mitotic spindle pole bodies. The founding complex contains a microtubule anchoring protein (Msd1 in fission yeast), A WD-repeat Wdr8 family protein and and a minus end-directed kinesin.
A thin, stiff protrusion extended by the leading edge of an axonal or dendritic growth cone.
The process in which the association between sister chromatids of a replicated chromosome centromeric region is maintained during homologous chromosome segregation after cohesin is cleaved by separase along the arm regions.
A nucleic acid binding activity that brings together complementary sequences of ssDNA so that they pair by hydrogen bonds to form a double-stranded DNA.
A zone of apposition between the vacuolar membrane and the mitochondrial outer membrane, important for transfer of lipids between the two organelles.
A zone of apposition between the vacuolar membrane and the mitochondrial outer membrane, important for transfer of lipids between the two organelles.
Catalysis of the template-independent extension of the 3'- end of an RNA strand by addition of one adenosine molecule at a time. Cannot initiate a chain 'de novo'. The primer, depending on the source of the enzyme, may be an RNA, or oligo(A) bearing a 3'-OH terminal group.
The directed movement of L-arginine out of the vacuole, across the vacuolar membrane.
A focus at the mating projection tip where the cell wall is degraded during conjugation with cellular fusion. Actin filaments form an aster-like structure from this location.
A process that occurs in response to signals generated as a result of mitotic DNA integrity checkpoint signaling.
The directed movement of basic amino acids from one side of a membrane to the other.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
Interacting selectively and non-covalently with messenger RNA (mRNA) of a specific nucleotide composition or a specific sequence motif.
Nucleoplasm situated in close proximity and peripheral to a nuclear pore complex.
Interacting selectively and non-covalently with an enzyme that catalyzes the removal of an amino group from a substrate, producing ammonia (NH3).
The process in which a hepatocyte (specialized epithelial cell of the liver) loses the structural or functional features that characterize it in the mature organism, or some other relatively stable phase of the organism's life history. Under certain conditions, these cells can revert back to the features of the stem cells that were their ancestors.
Interacting selectively and non-covalently with C-rich, single-stranded DNA.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carcinoembryonic antigen stimulus. The carcinoembryonic antigens represent a family of glycoproteins
The directed slow movement of non-membranous molecules in nerve cell axons. It is comprised of a "slow component a" (SCa) and a "slow component b" (SCb) which differ in transport rates and protein composition.
Catalysis of the reaction: ATP + H2O = ADP + phosphate. Catalysis of the removal of clathrin from vesicle membranes, coupled to the hydrolysis of ATP.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an odorant stimulus. An odorant is any substance capable of stimulating the sense of smell.
A matrix composed of supramolecular assemblies of lysosomal enzymes and lipids which forms at a pH of 5.0 within the lysosome.
Interacting selectively and non-covalently with double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding.
Catalysis of 3' exonucleolytic cleavage of poly(U), to form poly(U)-N containing a 3' uridine cyclic phosphate (U>P).
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an endothelin stimulus. Endothelin is any of three secretory vasoconstrictive peptides (endothelin-1, -2, -3).
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lectin stimulus. A lectin is a carbohydrate-binding protein, highly specific for binding sugar moieties.
Interacting selectively and non-covalently with a section of chromatin that is associated with gene promoter sequences of DNA.
A mitochondrion that occurs adjacent to the sarcolemma in striated muscle cells and responds in distinct ways to physiological triggers.
A mitochondrion that occurs adjacent to the sarcolemma in striated muscle cells and responds in distinct ways to physiological triggers.
A mitochondrion that occurs in between fibrils of striated muscle cells and responds in distinct ways to physiological triggers.
A mitochondrion that occurs in between fibrils of striated muscle cells and responds in distinct ways to physiological triggers.
A mitochondrion that occurs in between fibrils of striated muscle cells and responds in distinct ways to physiological triggers.
The regulated production of heat in response to short term environmental changes, such as stress, diet or reduced temperature.
Binds to and stops, prevents or reduces the activity of ribonucleoside-diphosphate reductase.
The directed movement of a peptide pheromone across a membrane and out of a cell by a secretion or export pathway used solely for the export of peptide pheromones that contributes to a conjugation process that results in the union of cellular and genetic information from compatible mating types.
Any process in which the vacuole is maintained in a specific location within a cell and prevented from moving elsewhere.
Any process in which the vacuole is maintained in a specific location within a cell and prevented from moving elsewhere.
Any process in which the vacuole is maintained in a specific location within a cell and prevented from moving elsewhere.
A membrane glycoprotein complex with aspartyl proteinase and metalloproteinase activity which is expressed in the gut. An example of this is found in the nematode Haemonchus contortus.
A membrane glycoprotein complex with aspartyl proteinase and metalloproteinase activity which is expressed in the gut. An example of this is found in the nematode Haemonchus contortus.
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
A protein complex containing a secreted Wnt protein associated with its receptor, Frizzled (Fz), and co-receptor low density lipoprotein receptor-related protein 5 (LRP5) or LRP6.
The directed movement of a protein along a microtubule to the spindle pole body, mediated by motor proteins.
The modification of histone H2A by the addition of an phosphate group to the serine residue in the SQE motif of the histone.
The attachment of a lytic vacuole to the endoplasmic reticulum, which may facilitate exchange of metabolites between the organelles.
The attachment of a lytic vacuole to the endoplasmic reticulum, which may facilitate exchange of metabolites between the organelles.
The attachment of a lytic vacuole to the endoplasmic reticulum, which may facilitate exchange of metabolites between the organelles.
Interacting selectively and non-covalently with methionine-initator methionine tRNA.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lectin stimulus. A lectin is a carbohydrate-binding protein, highly specific for binding sugar moieties.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an endothelin stimulus. Endothelin is any of three secretory vasoconstrictive peptides (endothelin-1, -2, -3).
A cyclin dependent kinase (CDK) complex that contains a kinase subunit and a regulatory cyclin subunit. An example of this complex in budding yeast S. cerevisiae consists of the Pho85 kinase and the Pho80 cyclin.
A protein complex that cleaves ubiquitin from specific substrates. In the budding yeast Saccharomyces cerevisiae, this complex consists of Ubp3p and Bre5p.
A protein complex that resides in the inner nuclear membrane and anchors telomeres to the nuclear envelope. In fission yeast, it is composed of Bqt3 and Bqt4.
The multiplication or reproduction of acinar cells, resulting in the expansion of a cell population. An acinar cell is a secretory cell that is grouped together with other cells of the same type to form grape-shaped clusters known as acini (singular acinus).
The multiplication or reproduction of acinar cells, resulting in the expansion of a cell population. An acinar cell is a secretory cell that is grouped together with other cells of the same type to form grape-shaped clusters known as acini (singular acinus).
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone-releasing hormone stimulus. Growth hormone-releasing hormone regulates the release of growth hormone, as well as some pancreatic proteins, and possibly other proteins.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone-releasing hormone stimulus. Growth hormone-releasing hormone regulates the release of growth hormone, as well as some pancreatic proteins, and possibly other proteins.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone-releasing hormone stimulus. Growth hormone-releasing hormone regulates the release of growth hormone, as well as some pancreatic proteins, and possibly other proteins.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone-releasing hormone stimulus. Growth hormone-releasing hormone regulates the release of growth hormone, as well as some pancreatic proteins, and possibly other proteins.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone-releasing hormone stimulus. Growth hormone-releasing hormone regulates the release of growth hormone, as well as some pancreatic proteins, and possibly other proteins.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone-releasing hormone stimulus. Growth hormone-releasing hormone regulates the release of growth hormone, as well as some pancreatic proteins, and possibly other proteins.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone-releasing hormone stimulus. Growth hormone-releasing hormone regulates the release of growth hormone, as well as some pancreatic proteins, and possibly other proteins.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gastrin stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemokine stimulus.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemokine stimulus.
A protein complex that is involved in the assembly of the V-ATPase complex. In the budding yeast Saccharomyces cerevisiae, this complex consists of Vma12p and Vma22p.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
Any process that decreases the frequency, rate or extent of sterol import, by down regulation of transcription from an RNA polymerase II promoter.
The component of the plasma membrane surrounding the cell tip consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the plasma membrane surrounding the cell tip or some other covalently attached group such as a GPI anchor that is similarly embedded in the plasma membrane surrounding the cell tip.
The multiplication or reproduction of vascular smooth muscle cells, resulting in the expansion of a cell population. A vascular smooth muscle cell is a non-striated, elongated, spindle-shaped cell found lining the blood vessels.
The side of the nuclear pore complex (NPC) that faces the nucleoplasm.
The side of the nuclear pore complex (NPC) that faces the nucleoplasm.
The side of the nuclear pore complex (NPC) that faces the nucleoplasm.
The side of the nuclear pore complex (NPC) that faces the cytoplasm.
The side of the nuclear pore complex (NPC) that faces the cytoplasm.
The side of the nuclear pore complex (NPC) that faces the cytoplasm.
A heterodimeric complex that functions as a GTPase-Activating Protein (GAP) Complex for members of the Rag family of GTPases. In the budding yeast, this complex contains Lst4 and Lst7, while the orthologous mammalian complex contains Follicular (FLCN) and either follicular interaction protein 1 (FNIP1) or FNIP2.
A heterodimeric complex that functions as a GTPase-Activating Protein (GAP) Complex for members of the Rag family of GTPases. In the budding yeast, this complex contains Lst4 and Lst7, while the orthologous mammalian complex contains Follicular (FLCN) and either follicular interaction protein 1 (FNIP1) or FNIP2.
A heterodimeric complex that functions as a GTPase-Activating Protein (GAP) Complex for members of the Rag family of GTPases. In the budding yeast, this complex contains Lst4 and Lst7, while the orthologous mammalian complex contains Follicular (FLCN) and either follicular interaction protein 1 (FNIP1) or FNIP2.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gastrin stimulus.
Any process that reduces or removes the toxicity of copper ions in a cell. These include transport of copper cations away from sensitive areas and to compartments or complexes whose purpose is sequestration.
The modification of rRNA structure by addition of an acetyl group to rRNA. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid.
Catalysis of the reaction: acetyl-CoA + cytidine = CoA + N4-acetylcytidine. The cytidine is within the polynucleotide chain of an rRNA.
The posttranscriptional addition of one or more acetyl groups to specific residues in an RNA molecule.
Catalysis of the reaction: 3,4-dihydroxy-5-polyprenylbenzoic acid + S-adenosyl-L-methionine = 3-methoxy-4-hydroxy-5-polyprenylbenzoic acid + S-adenosyl-L-homocysteine + H+.
Catalysis of the reaction: 2-polyprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinol + S-adenosyl-L-methionine = ubiquinol-n + S-adenosyl-L-homocysteine + H+.
Catalysis of the reaction: 2-polyprenyl-6-hydroxyphenol + S-adenosyl-L-methionine = 2-polyprenyl-6-methoxyphenol + S-adenosyl-L-homocysteine + H+.
Interacting selectively and non-covalently with a histone H4 in which the lysine residue at position 20 has been modified by trimethylation.
Interacting selectively and non-covalently with a netrin receptor.
The cell cycle process in which sister chromatid arms are physically detached from each other during mitosis.
The cell cycle process in which chromosome arm chromatin structure is compacted prior to and during mitosis in eukaryotic cells.
The cell cycle process in which centromere chromatin structure is compacted prior to and during mitosis.
Any process that modulates the frequency, rate or extent of protein localization to cell cortex of cell tip.
A process in which a protein is transported to, or maintained in, the cell cortex of the cell tip.
The process by which SPO11/Rec12-oligonucleotide complexes are removed from 5' DNA double-strand breaks induced during meiosis. Proteins involved in this process include the MRX/MRN complex and Sae2/Ctp1/RBBP8(CtIP).
The process following clipping in double-strand break processing of SPO11 induced breaks, where long-tract single-stranded 3'-end DNA is generated from naked (SPO11 has been removed) 5' ends.
A constriction site at the junction of the plasma, flagellar and flagellar pocket membranes where the flagellum emerges from the cell body. Observed in some unicellular eukaryotic species such as Chlamydomonas, Giardia and Trypanosoma.
A constriction site at the junction of the plasma, flagellar and flagellar pocket membranes where the flagellum emerges from the cell body. Observed in some unicellular eukaryotic species such as Chlamydomonas, Giardia and Trypanosoma.
A constriction site at the junction of the plasma, flagellar and flagellar pocket membranes where the flagellum emerges from the cell body. Observed in some unicellular eukaryotic species such as Chlamydomonas, Giardia and Trypanosoma.
A constriction site at the junction of the plasma, flagellar and flagellar pocket membranes where the flagellum emerges from the cell body. Observed in some unicellular eukaryotic species such as Chlamydomonas, Giardia and Trypanosoma.
A constriction site at the junction of the plasma, flagellar and flagellar pocket membranes where the flagellum emerges from the cell body. Observed in some unicellular eukaryotic species such as Chlamydomonas, Giardia and Trypanosoma.
A constriction site at the junction of the plasma, flagellar and flagellar pocket membranes where the flagellum emerges from the cell body. Observed in some unicellular eukaryotic species such as Chlamydomonas, Giardia and Trypanosoma.
The cell pole distal from the most recent cell division.
The cell pole proximal to the most recent cell division.
A small, flexible, finger-like projection of cytoplasm containing an array of microtubles and located near the flagellar pores in some photosynthetic as well as nonphotosynthetic dinoflagellate species. Its functions are not fully understood, but it has been associated with feeding behavior (phagotrophy).
A cilium-like cell projection emanating from the inner segment and running alongside the outer segment of photoreceptors.
A protein complex that contains beta-catenin and a member of the T-cell factor (TCF)/lymphoid enhancer binding factor (LEF) family of transcription factors.
A protein complex that contains beta-catenin and a member of the T-cell factor (TCF)/lymphoid enhancer binding factor (LEF) family of transcription factors.
A protein complex that contains beta-catenin and a member of the T-cell factor (TCF)/lymphoid enhancer binding factor (LEF) family of transcription factors.
A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension combined with low atmospheric pressure. Hypoxia is defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95% and hypobaric is defined as atmospheric pressure below 0.74 atm (greater than 2,500 m above sea level).
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of exposure to aversive or demanding psychological and social conditions that tax or exceed the behavioral resources of the organism.
The plasma membrane that is part of the head section of a sperm cell.
The component of the plasma membrane consisting of the gene products that penetrate only the periplasmic side of the membrane.
The action of a molecule that contributes to the structural integrity of an ascospore wall.
The outermost layers of the spore wall, as described in Schizosaccharomyces pombe.
The cytoplasm of an ovum.
The repair of double-strand breaks in DNA via homologous and nonhomologous mechanisms to reform a continuous DNA helix that contributes to reciprocal meiotic recombination.
Interacting selectively and non-covalently with a proteasome complex and a nuclear inner membrane, in order to maintain the nuclear membrane localization of the proteasome.
Interacting selectively and non-covalently with a proteasome complex and a nuclear inner membrane, in order to maintain the nuclear membrane localization of the proteasome.
Any process in which the proteasome is transported to, or maintained at the nuclear periphery.
The multiplication or reproduction of hepatic stellate cells, resulting in the expansion of a hepatic stellate cell population. Hepatic stellate cells are found in the perisinusoidal space of the liver, and are capable of multiple roles including storage of retinol, presentation of antigen to T cells (including CD1d-restricted NKT cells), and upon activation, production of extracellular matrix components. This cell type comprises approximately 8-15% of total cells in the liver.
The multiplication or reproduction of hepatic stellate cells, resulting in the expansion of a hepatic stellate cell population. Hepatic stellate cells are found in the perisinusoidal space of the liver, and are capable of multiple roles including storage of retinol, presentation of antigen to T cells (including CD1d-restricted NKT cells), and upon activation, production of extracellular matrix components. This cell type comprises approximately 8-15% of total cells in the liver.
The multiplication or reproduction of hepatic stellate cells, resulting in the expansion of a hepatic stellate cell population. Hepatic stellate cells are found in the perisinusoidal space of the liver, and are capable of multiple roles including storage of retinol, presentation of antigen to T cells (including CD1d-restricted NKT cells), and upon activation, production of extracellular matrix components. This cell type comprises approximately 8-15% of total cells in the liver.
A protein complex that is composed of at least EXD1, TDRD12 and some PIWI protein. The complex is required for MILI slicing-triggered biogenesis and loading of MIWI2 piRNAs
The process by which synaptic transmission, induced by the arrival of a spike (action potential) at a synapse, acts to increase the amount of neurotransmitter released in response to the arrival of subsequent spikes.  This effect is seen when a train of closely space spikes arrives at a synapse with a low initial release probability.  It occurs in a timeframe of tens to hundreds of milliseconds.
The process of secretion by a cell that results in the release of intracellular molecules contained within a lysosome by fusion of the vesicle with the plasma membrane of a cell, induced by a rise in cytosolic calcium-ion levels.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of amino acids.
Catalyzes the hydrolysis of terminal non-reducing alpha-sulfoquinovoside residues in alpha-sulfoquinovosyl diacylglycerides and alpha-sulfoquinovosyl glycerol, generating alpha-sulfoquinovose.
Catalysis of the oxidative demethylation of N1-methyladenosine RNA, with concomitant decarboxylation of 2-oxoglutarate and releases oxidized methyl group on N1-methyladenosine as formaldehyde.
Catalysis of the oxidative demethylation of N6-methyladenosine RNA, with concomitant decarboxylation of 2-oxoglutarate and releases oxidized methyl group on N6-methyladenosine as formaldehyde.
Interacting selectively and non-covalently with 5.8S ribosomal RNA, a eukaryotic ribosomal RNA which forms a complex with 28S RNA.
A process in which the microtubule cytoskeleton is attached to the nuclear envelope.
A nuclear compartment containing significant amounts of non-nucleolar, spliceosomal components. It is commonly found in germinal vesicle (GV) stage oocytes, and is similar to both nucleoli and sphere organelles.
A nuclear compartment containing significant amounts of non-nucleolar, spliceosomal components. It is commonly found in germinal vesicle (GV) stage oocytes, and is similar to both nucleoli and sphere organelles.
A nuclear compartment containing significant amounts of non-nucleolar, spliceosomal components. It is commonly found in germinal vesicle (GV) stage oocytes, and is similar to both nucleoli and sphere organelles.
Interacting selectively and non-covalently with any protein involved in the process of removing sections of the primary RNA transcript to form the mature form of the RNA.
The process in which a vascular smooth muscle cell (a non-striated, elongated, spindle-shaped cell found lining the blood vessels) loses the structural or functional features that characterize it in the mature organism, or some other relatively stable phase of the organism's life history. Under certain conditions, these cells can revert back to the features of the stem cells that were their ancestors.
The addition of one or more acetyl groups to a xylan molecule.
The phosphorylation by a protein of one or more of its own aspartate amino acid residues, or an aspartate residue on an identical protein.
The phosphorylation by a protein of one or more of its own aspartate amino acid residues, or an aspartate residue on an identical protein.
Catalysis of movement along a microtubule, coupled to the hydrolysis of ATP.
Any of the mitotic spindle microtubules that attach to the kinetochores of chromosomes by their plus ends, and maneuver the chromosomes during mitotic chromosome segregation.
A mechanism to recapture 'lost' chromosomes (chromosomes which have become detached from the spindle) during metaphase of mitotic chromosome segregation. Chromosomes with unattached kinetochores are migrated along (non polar) spindle microtubules to the mitotic spindle pole body by a combination of microtubule depolymerisation and 'kinetochore sliding' (migration of the chromosome along the microtubule). The chromosome subsequently migrates along the polar spindle microtubule to the metaphase plate.
A mechanism to recapture 'lost' chromosomes (chromosomes which have become detached from the spindle) during metaphase of mitotic chromosome segregation. Chromosomes with unattached kinetochores are migrated along (non polar) spindle microtubules to the mitotic spindle pole body by a combination of microtubule depolymerisation and 'kinetochore sliding' (migration of the chromosome along the microtubule). The chromosome subsequently migrates along the polar spindle microtubule to the metaphase plate.
A mechanism to recapture 'lost' chromosomes (chromosomes which have become detached from the spindle) during metaphase of mitotic chromosome segregation. Chromosomes with unattached kinetochores are migrated along (non polar) spindle microtubules to the mitotic spindle pole body by a combination of microtubule depolymerisation and 'kinetochore sliding' (migration of the chromosome along the microtubule). The chromosome subsequently migrates along the polar spindle microtubule to the metaphase plate.
Interacting selectively and non-covalently with the replication fork barrier found in the mating type region of fission yeast.
Interacting selectively and non-covalently with the replication fork barrier found in the mating type region of fission yeast.
Any process in which a spindle pole body is maintained in a specific location. A spindle pole body is a type of microtubule organizing center found in fungal cells.
Any process in which a spindle pole body is maintained in a specific location. A spindle pole body is a type of microtubule organizing center found in fungal cells.
Any process in which a spindle pole body is maintained in a specific location. A spindle pole body is a type of microtubule organizing center found in fungal cells.
The cell cycle process in which a cell progresses from meiosis I to meiosis II.
Any process involved in the progression from anaphase/telophase of meiosis II to the creation of end products of meiosis, in which ploidy is reduced by half.
The cell cycle process in which a cell progresses from metaphase to anaphase as part of meiosis I.
The cell cycle process in which a cell progresses from metaphase to anaphase as part of meiosis I.
The cell cycle process in which a cell progresses from metaphase to anaphase as part of meiosis II.
The cell cycle process in which a cell progresses from metaphase to anaphase as part of meiosis II.
The movement of vesicles and protein complexes carried out by molecular motors, kinesins and dynein, along the microtubule tracks within the manchette and by myosin along actin filaments.
The directed movement of a protein to a specific location at the meiotic spindle pole body.
Interacting selectively and non-covalently with G-rich, single-stranded DNA.
The directed movement of a fibroblast guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
A protein complex that is located at the ciliary transition zone and consists of the NPHP4 and NPHP1 proteins. It acts as an organiser of the transition zone inner structure, specifically the Y-shaped links, in conjunction with the MKS complex. It is involved in ciliary protein trafficking and is required for correct functioning of the WNT and Hippo signaling pathways.
The process of regulating the proliferation and elimination of eosinophils such that the total number of eosinophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.
The process of regulating the proliferation and elimination of eosinophils such that the total number of eosinophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.
The process of regulating the proliferation and elimination of eosinophils such that the total number of eosinophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.
The process of regulating the proliferation and elimination of eosinophils such that the total number of eosinophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.
The process of regulating the proliferation and elimination of basophils such that the total number of basophils within a whole or part of an organism is stable over time in the absence of an outside stimulus.
The directed movement of drugs out of a cell or organelle across a membrane.
The directed movement of drugs passing through the blood-brain barrier.
Establishment of the barrier between the blood and the retina. The blood-retinal barrier is located at two levels, forming an outer barrier in the retinal pigment epithelium and an inner barrier in the endothelial membrane of the retinal vessels. Both these membranes have tight junctions of the "nonleaky" type.
Establishment of the barrier between the blood and the retina. The blood-retinal barrier is located at two levels, forming an outer barrier in the retinal pigment epithelium and an inner barrier in the endothelial membrane of the retinal vessels. Both these membranes have tight junctions of the "nonleaky" type.
A protein complex probably required for the internalization of endosomes during actin-coupled endocytosis. Links the site of endocytosis to the cell membrane-associated actin cytoskeleton, coordinating ARP2/3 stimulation at the later stages of endocytosis. Present in the late endocytic coat.
Catalysis of the reaction: cytosylglucuronic acid + H(+) = cytosylarabinopyranose + CO(2).
The process of generating ATP in the nucleus from poly-ADP-D-ribose. Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming.
The directed movement of a toxin into, out of or within a cell, or between cells where two or more organisms of the same or different species are involved.
A process in which a host organism modulates the frequency, rate or extent of a viral gene product binding to RNA.
A process in which a host organism modulates the frequency, rate or extent of the activity of a viral RNA-binding transcription factor.
Interacting selectively and non-covalently with a trans-activation response (TAR) element, a hairpin RNA structure located at the 5' end of all HIV-1 transcripts, and which is required for trans-activation of a viral promoter.
Glycoprotein complex of the C1q/TNF superfamily found in the extracellular matrix (ECM) where it is an important component of the elastic fiber system. A homotrimer that will combine to form supramolecular EMILIN structures.
Glycoprotein complex of the C1q/TNF superfamily found in the extracellular matrix (ECM) where it is an important component of the elastic fiber system. A homotrimer that will combine to form supramolecular EMILIN structures.
Glycoprotein complex of the C1q/TNF superfamily found in the extracellular matrix (ECM) where it is an important component of the elastic fiber system. A homotrimer that will combine to form supramolecular EMILIN structures.
Glycoprotein complex of the C1q/TNF superfamily found in the extracellular matrix (ECM) where it is an important component of the elastic fiber system. A homotrimer that will combine to form supramolecular EMILIN structures.
Glycoprotein complex of the C1q/TNF superfamily involved in cell adhesion. A homotrimer that will combine to form supramolecular Multimerin structures.
Glycoprotein complex of the C1q/TNF superfamily involved in cell adhesion. A homotrimer that will combine to form supramolecular Multimerin structures.
Glycoprotein complex of the C1q/TNF superfamily involved in cell adhesion. A homotrimer that will combine to form supramolecular Multimerin structures.
Glycoprotein complex of the C1q/TNF superfamily involved in cell adhesion. A homotrimer that will combine to form supramolecular Multimerin structures.
Glycoprotein complex of the C1q/TNF superfamily involved in cell adhesion. A homotrimer that will combine to form supramolecular Multimerin structures.
Glycoprotein complex of the C1q/TNF superfamily involved in cell adhesion. A homotrimer that will combine to form supramolecular Multimerin structures.
Glycoprotein complex of the C1q/TNF superfamily involved in cell adhesion. A homotrimer that will combine to form supramolecular Multimerin structures.
Glycoprotein complex of the C1q/TNF superfamily involved in cell adhesion. A homotrimer that will combine to form supramolecular Multimerin structures.
A linear array of nuclear envelope membrane proteins composed of nesprin-2G and SUN2, which couple the nucleus to moving actin cables, resulting in rearward nuclear transport (away from the leading edge).
The process whereby the centrosome is held at the cell center while the nucleus moves to the cell rear by actin retrograde flow resulting in the position of the centrosome between the nucleus and the leading edge of the cell.
The directed movement of a protein to a specific location at the mitotic spindle pole body.
The directed movement of a protein along a microtubule to the mitotic spindle pole body, mediated by motor proteins.
The removal of a methyl group from one or more residues within a tRNA molecule.
Catalysis of the removal of a methyl group from one or more positions within a tRNA molecule.
The disaggregation of a DNA recombinase complex into its constituent strand exchange proteins (recombinases).
Any process that modulates the frequency, rate or extent of a DNA damage checkpoint.
Any process that stops, prevents, or reduces the frequency, rate or extent of a DNA damage checkpoint.
Any process that activates or increases the frequency, rate or extent of a DNA damage checkpoint.
Any process that modulates the frequency, rate or extent of metanephric S-shaped body morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric S-shaped body morphogenesis.
Any process that modulates the frequency, rate or extent of metanephric comma-shaped body morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of metanephric comma-shaped body morphogenesis.
Any process that modulates the frequency, rate or extent of protein localization to the cell surface.
Any process that modulates the frequency, rate or extent of protein localization to the cell surface.
Any process that stops, prevents, or reduces the frequency, rate or extent of protein localization to the cell surface.
Any process that stops, prevents, or reduces the frequency, rate or extent of protein localization to the cell surface.
Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface.
Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface.
Any process that modulates the frequency, rate or extent of adaxial/abaxial pattern formation.
Any process that modulates the frequency, rate or extent of auxin polar transport.
Any process that modulates the frequency, rate or extent of arginine biosynthetic process via ornithine.
Any process that modulates the frequency, rate or extent of arginine biosynthetic process via ornithine.
Any process that modulates the frequency, rate or extent of arginine biosynthetic process via ornithine.
Any process that modulates the frequency, rate or extent of endosperm development.
Any process that modulates the frequency, rate or extent of determination of dorsal identity.
Any process that stops, prevents, or reduces the frequency, rate or extent of determination of dorsal identity.
Any process that activates or increases the frequency, rate or extent of determination of dorsal identity.
Any process that modulates the frequency, rate or extent of male gonad development.
Any process that modulates the frequency, rate or extent of male gonad development.
Any process that stops, prevents, or reduces the frequency, rate or extent of male gonad development.
Any process that stops, prevents, or reduces the frequency, rate or extent of male gonad development.
Any process that activates or increases the frequency, rate or extent of male gonad development.
Any process that activates or increases the frequency, rate or extent of male gonad development.
Any process that modulates the frequency, rate or extent of jasmonic acid mediated signaling pathway.
Any process that modulates the frequency, rate or extent of lateral root development.
Any process that modulates the frequency, rate or extent of leaf development.
Any process that modulates the frequency, rate or extent of leaf formation.
Any process that modulates the frequency, rate or extent of multicellular organismal development.
Any process that modulates the frequency, rate or extent of animal organ morphogenesis.
Any process that modulates the frequency, rate or extent of photoperiodism, flowering.
Any process that modulates the frequency, rate or extent of photoperiodism, flowering.
Any process that modulates the frequency, rate or extent of photoperiodism, flowering.
Any process that modulates the frequency, rate or extent of photoperiodism, flowering.
Any process that modulates the frequency, rate or extent of photoperiodism, flowering.
Any process that modulates the frequency, rate or extent of proanthocyanidin biosynthetic process.
Any process that modulates the frequency, rate or extent of proanthocyanidin biosynthetic process.
Any process that modulates the frequency, rate or extent of proanthocyanidin biosynthetic process.
Any process that modulates the frequency, rate or extent of proanthocyanidin biosynthetic process.
Any process that modulates the frequency, rate or extent of response to red or far red light.
Any process that modulates the frequency, rate or extent of salicylic acid mediated signaling pathway.
Any process that modulates the frequency, rate or extent of secondary shoot formation.
Any process that modulates the frequency, rate or extent of secondary shoot formation.
Any process that modulates the frequency, rate or extent of secondary shoot formation.
Any process that modulates the frequency, rate or extent of secondary shoot formation.
Any process that modulates the frequency, rate or extent of seed dormancy process.
Any process that modulates the frequency, rate or extent of seed maturation.
Any process that modulates the frequency, rate or extent of stem cell division.
Any process that modulates the frequency, rate or extent of stem cell population maintenance.
Any process that modulates the frequency, rate or extent of stomatal complex patterning.
Any process that modulates the frequency, rate or extent of stomatal complex development.
Any process that modulates the frequency, rate or extent of trichome morphogenesis.
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in axis elongation.
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in axis elongation.
Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.
Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.
Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.
Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.
Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.
Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.
Any process that modulates the frequency, rate or extent of cardiac cell fate specification.
Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac cell fate specification.
Any cell cycle regulatory process that controls the commitment of a cell from G1 to S phase of the mitotic cell cycle.
Any process that modulates the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
Any process that stops, prevents, or reduces the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
Any process that activates or increases the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
Any process that modulates the frequency, rate or extent of non-canonical Wnt signaling pathway.
Any process that modulates the frequency, rate or extent of non-canonical Wnt signaling pathway.
Any process that modulates the frequency, rate or extent of non-canonical Wnt signaling pathway.
Any process that modulates the frequency, rate or extent of non-canonical Wnt signaling pathway.
Any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway.
Any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway.
Any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway.
Any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway.
Any process that activates or increases the frequency, rate or extent of non-canonical Wnt-activated signaling pathway.
Any process that activates or increases the frequency, rate or extent of non-canonical Wnt-activated signaling pathway.
Any process that activates or increases the frequency, rate or extent of non-canonical Wnt-activated signaling pathway.
Any process that activates or increases the frequency, rate or extent of non-canonical Wnt-activated signaling pathway.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway involved in dorsal/ventral axis specification.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway involved in digestive tract morphogenesis.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway involved in digestive tract morphogenesis.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway involved in digestive tract morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in digestive tract morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in digestive tract morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of Wnt signaling pathway involved in digestive tract morphogenesis.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-dependent protein catabolic process
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent protein catabolic process.
Any process that modulates the frequency, rate or extent of ureter smooth muscle cell differentiation.
Any process that stops, prevents, or reduces the frequency, rate or extent of ureter smooth muscle cell differentiation.
Any process that activates or increases the frequency, rate or extent of ureter smooth muscle cell differentiation.
Any process that modulates the frequency, rate or extent of cortisol biosynthetic process.
Any process that modulates the frequency, rate or extent of cortisol biosynthetic process.
Any process that modulates the frequency, rate or extent of cortisol biosynthetic process.
Any process that modulates the frequency, rate or extent of cortisol biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of cortisol biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of cortisol biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of cortisol biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of cortisol biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cortisol biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cortisol biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cortisol biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cortisol biosynthetic process.
Any process that modulates the frequency, rate or extent of root morphogenesis.
Any process that modulates the frequency, rate or extent of defense response to insect.
Any process that modulates the frequency, rate or extent of post-embryonic root development.
Any process that modulates the frequency, rate or extent of response to water deprivation.
Any process that modulates the frequency, rate or extent of response to water deprivation.
Any process that modulates the frequency, rate or extent of response to water deprivation.
Any process that modulates the frequency, rate or extent of response to water deprivation.
Any process that modulates the frequency, rate or extent of defense response by callose deposition.
Any process that modulates the frequency, rate or extent of defense response by callose deposition.
Any process that modulates the frequency, rate or extent of defense response to fungus, incompatible interaction.
Any process that modulates the frequency, rate or extent of defense response to fungus, incompatible interaction.
Any process that modulates the frequency, rate or extent of defense response to fungus, incompatible interaction.
Any process that modulates the frequency, rate or extent of defense response to fungus, incompatible interaction.
Any process that modulates the frequency, rate or extent of defense response to fungus, incompatible interaction.
Any process that modulates the frequency, rate or extent of defense response to fungus, incompatible interaction.
Any process that modulates the frequency, rate or extent of defense response to fungus, incompatible interaction.
Any process that modulates the frequency, rate or extent of defense response to fungus, incompatible interaction.
Any process that modulates the frequency, rate or extent of site selection that occurs as part of cytokinesis.
Any process that modulates the frequency, rate or extent of pancreatic B cell development.
Any process that modulates the frequency, rate or extent of pancreatic B cell development.
Any process that stops, prevents, or reduces the frequency, rate or extent of site selection that occurs as part of cytokinesis.
Any process that activates or increases the frequency, rate or extent of site selection that occurs as part of cytokinesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic B cell development.
Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic B cell development.
Any process that activates or increases the frequency, rate or extent of pancreatic B cell development.
Any process that activates or increases the frequency, rate or extent of pancreatic B cell development.
Any process that modulates the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that modulates the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that modulates the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that modulates the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that modulates the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that modulates the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that activates or increases the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that activates or increases the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that activates or increases the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that activates or increases the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that activates or increases the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that activates or increases the frequency, rate or extent of canonical Wnt signaling pathway modulating the rate or frequency of pancreatic B cell proliferation.
Any process that modulates the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of L-ascorbic acid biosynthetic process.
Any process that modulates the frequency, rate or extent of mesenchymal to epithelial transition involved in mesonephros morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of mesenchymal to epithelial transition involved in mesonephros morphogenesis.
Any process that activates or increases the frequency, rate or extent of mesenchymal to epithelial transition involved in mesonephros morphogenesis.
Any process that modulates the frequency, rate or extent of mesonephric glomerulus development.
Any process that stops, prevents, or reduces the frequency, rate or extent of mesonephric glomerulus development.
Any process that activates or increases the frequency, rate or extent of mesonephric glomerulus development.
Any process that modulates the frequency, rate or extent of mesonephric glomerular mesangial cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of mesonephric glomerular mesangial cell proliferation.
Any process that activates or increases the frequency, rate or extent of mesonephric glomerular mesangial cell proliferation.
Any process that modulates the frequency, rate or extent of mesonephric nephron tubule epithelial cell differentiation.
Any process that stops, prevents, or reduces the frequency, rate or extent of mesonephric nephron tubule epithelial cell differentiation.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that modulates the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.
Any process that modulates the frequency, rate or extent of smooth muscle cell-matrix adhesion.
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell-matrix adhesion.
Any process that modulates the frequency, rate or extent of establishment or maintenance of bipolar cell polarity.
Any process that modulates the frequency, rate or extent of establishment or maintenance of bipolar cell polarity regulating cell shape.
Any process that modulates the frequency, rate or extent of mammary stem cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of mammary stem cell proliferation.
Any process that activates or increases the frequency, rate or extent of mammary stem cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA-dependent DNA replication.
Any process that activates or increases the frequency, rate or extent of DNA-dependent DNA replication.
Any process that modulates the frequency, rate or extent of leukocyte apoptotic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte apoptotic process.
Any process that activates or increases the frequency, rate or extent of leukocyte apoptotic process.
Any process that modulates the frequency, rate or extent of macrophage apoptotic process.
Any process that modulates the frequency, rate or extent of macrophage apoptotic process.
Any process that modulates the frequency, rate or extent of macrophage apoptotic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage apoptotic process.
Any process that activates or increases the frequency, rate or extent of macrophage apoptotic process.
Any process that activates or increases the frequency, rate or extent of macrophage apoptotic process.
Any process that activates or increases the frequency, rate or extent of macrophage apoptotic process.
Any process that modulates the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that modulates the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that modulates the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that modulates the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that modulates the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular macromolecule biosynthetic process.
Any process that modulates the frequency, rate or extent of establishment of cell polarity.
Any process that modulates the frequency, rate or extent of establishment of cell polarity.
Any process that modulates the frequency, rate or extent of maintenance of bipolar cell polarity regulating in cell shape.
Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity.
Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity.
Any process that stops, prevents, or reduces the frequency, rate or extent of cysteine-type endopeptidase activity.
Any process that stops, prevents, or reduces the frequency, rate or extent of cysteine-type endopeptidase activity.
Any process that modulates the frequency, rate or extent of sodium-dependent phosphate transport.
Any process that stops, prevents, or reduces the frequency, rate or extent of sodium-dependent phosphate transport.
Any process that activates or increases the frequency, rate or extent of sodium-dependent phosphate transport.
Any process that modulates the frequency, rate or extent of removal of superoxide radicals.
Any process that modulates the frequency, rate or extent of removal of superoxide radicals.
Any process that stops, prevents, or reduces the frequency, rate or extent of stomatal complex development.
Any process that activates or increases the frequency, rate or extent of stomatal complex development.
Any process that modulates the frequency, rate or extent of endocannabinoid signaling pathway.
Any process that modulates the frequency, rate or extent of octopamine or tyramine signaling pathway.
Any process that modulates the frequency, rate or extent of octopamine or tyramine signaling pathway.
Any process that stops, prevents, or reduces the frequency, rate or extent of octopamine or tyramine signaling pathway.
Any process that stops, prevents, or reduces the frequency, rate or extent of octopamine or tyramine signaling pathway.
Any process that activates or increases the frequency, rate or extent of octopamine or tyramine signaling pathway.
Any process that activates or increases the frequency, rate or extent of octopamine or tyramine signaling pathway.
Any process that modulates the frequency, rate or extent of octopamine signaling pathway.
Any process that stops, prevents, or reduces the frequency, rate or extent of octopamine signaling pathway.
Any process that activates or increases the frequency, rate or extent of octopamine signaling pathway.
Any process that modulates the frequency, rate or extent of tyramine signaling pathway.
Any process that stops, prevents, or reduces the frequency, rate or extent of tyramine signaling pathway.
Any process that activates or increases the frequency, rate or extent of tyramine signaling pathway.
Any cell cycle regulatory process that prevents the commitment of a cell from G1 to S phase of the mitotic cell cycle.
Any process that modulates the frequency, rate or extent of cell proliferation involved in heart morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of cell proliferation involved in heart morphogenesis.
Any process that activates or increases the frequency, rate or extent of cell proliferation involved in heart morphogenesis.
Any process that modulates the frequency, rate or extent of octopamine signaling pathway involved in response to food.
Any process that stops, prevents, or reduces the frequency, rate or extent of octopamine signaling pathway involved in response to food.
Any process that activates or increases the frequency, rate or extent of octopamine signaling pathway involved in response to food.
Any process that modulates the frequency, rate or extent of DNA-templated transcription initiation.
Any process that modulates the frequency, rate or extent of DNA-templated transcription initiation.
Any process that modulates the frequency, rate or extent of DNA-templated transcription initiation.
Any process that modulates the frequency, rate or extent of DNA-templated transcription initiation.
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA-templated transcription initiation.
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA-templated transcription initiation.
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA-templated transcription initiation.
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA-templated transcription initiation.
Any process that activates or increases the frequency, rate or extent of DNA-templated transcription initiation.
Any process that activates or increases the frequency, rate or extent of DNA-templated transcription initiation.
Any process that activates or increases the frequency, rate or extent of DNA-templated transcription initiation.
Any process that activates or increases the frequency, rate or extent of DNA-templated transcription initiation.
Any process that activates or increases the frequency, rate or extent of DNA-templated transcription initiation.
Any process that activates or increases the frequency, rate or extent of DNA-templated transcription initiation.
Any process that modulates the frequency, rate or extent of cell motility.
Any process that modulates the frequency, rate or extent of cell motility.
Any process that modulates the frequency, rate or extent of cell motility.
Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
Any process that activates or increases the frequency, rate or extent of cell motility.
Any process that activates or increases the frequency, rate or extent of cell motility.
Any process that activates or increases the frequency, rate or extent of cell motility.
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in ventricular septum morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in ventricular septum morphogenesis.
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis.
Any process that modulates the frequency, rate or extent of regulation of ubiquitin-specific protease activity (deubiquitinase) activity.
Any process that modulates the frequency, rate or extent of regulation of ubiquitin-specific protease activity (deubiquitinase) activity.
Any process that modulates the frequency, rate or extent of regulation of ubiquitin-specific protease activity (deubiquitinase) activity.
Any process that activates or increases the frequency, rate or extent of cilium-dependent cell motility.
Any process that modulates the frequency, rate or extent of retrograde vesicle-mediated transport, Golgi to ER.
Any process that modulates the frequency, rate or extent of retrograde vesicle-mediated transport, Golgi to ER.
Any process that modulates the frequency, rate or extent of retrograde vesicle-mediated transport, Golgi to ER.
Any process that modulates the frequency, rate or extent of retrograde vesicle-mediated transport, Golgi to ER.
Any process that modulates the frequency, rate or extent of retrograde vesicle-mediated transport, Golgi to ER.
Any process that modulates the frequency, rate or extent of retrograde vesicle-mediated transport, Golgi to ER.
Any process that modulates the frequency, rate or extent of retrograde vesicle-mediated transport, Golgi to ER.
Any process that modulates the frequency, rate or extent of retrograde vesicle-mediated transport, Golgi to ER.
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
Any process that activates or increases the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
Any process that activates or increases the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
Any process that activates or increases the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
Any process that activates or increases the frequency, rate or extent of ubiquitin-specific protease (deubiquitinase) activity.
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in heart morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in heart morphogenesis.
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in cardiac right atrium morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac right atrium morphogenesis.
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in outflow tract morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in outflow tract morphogenesis.
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in pericardium morphogenesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in pericardium morphogenesis.
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in neural tube closure.
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in neural tube closure.
Any process that modulates the frequency, rate or extent of peptidyl-cysteine S-nitrosylation.
Any process that activates or increases the frequency, rate or extent of peptidyl-cysteine S-nitrosylation.
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
Any process that modulates the frequency, rate or extent of branching morphogenesis of a nerve.
Any process that stops, prevents, or reduces the frequency, rate or extent of branching morphogenesis of a nerve.
Any process that modulates the frequency, rate or extent of pro-T cell differentiation.
Any process that stops, prevents, or reduces the frequency, rate or extent of pro-T cell differentiation.
Any process that activates or increases the frequency, rate or extent of pro-T cell differentiation.
Any process that modulates the frequency, rate or extent of neural precursor cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of neural precursor cell proliferation.
Any process that activates or increases the frequency, rate or extent of neural precursor cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of androgen biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of androgen biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of androgen biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of androgen biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis.
Any process that modulates the frequency, rate or extent of progesterone biosynthetic process.
Any process that modulates the frequency, rate or extent of progesterone biosynthetic process.
Any process that modulates the frequency, rate or extent of progesterone biosynthetic process.
Any process that modulates the frequency, rate or extent of progesterone biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of progesterone biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of progesterone biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of progesterone biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of progesterone biosynthetic process.
Any process that activates or increases the frequency, rate or extent of progesterone biosynthetic process.
Any process that activates or increases the frequency, rate or extent of progesterone biosynthetic process.
Any process that activates or increases the frequency, rate or extent of progesterone biosynthetic process.
Any process that activates or increases the frequency, rate or extent of progesterone biosynthetic process.
Any process that modulates the frequency, rate or extent of phosphate transmembrane transport.
Any process that stops, prevents, or reduces the frequency, rate or extent of phosphate transmembrane transport.
Any process that activates or increases the frequency, rate or extent of phosphate transmembrane transport.
Any process that modulates the frequency, rate or extent of fatty acid transport.
Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid transport.
Any process that activates or increases the frequency, rate or extent of fatty acid transport.
Any process that modulates the frequency, rate or extent of female gonad development.
Any process that modulates the frequency, rate or extent of female gonad development.
Any process that stops, prevents, or reduces the frequency, rate or extent of female gonad development.
Any process that stops, prevents, or reduces the frequency, rate or extent of female gonad development.
Any process that activates or increases the frequency, rate or extent of female gonad development.
Any process that activates or increases the frequency, rate or extent of female gonad development.
Any process that modulates the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that modulates the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that modulates the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that modulates the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that activates or increases the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that activates or increases the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that activates or increases the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that activates or increases the frequency, rate or extent of ribonucleoprotein complex localization.
Any process that modulates the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal large subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that modulates the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that activates or increases the frequency, rate or extent of ribosomal small subunit export from nucleus.
Any process that modulates the frequency, rate or extent of anoikis.
Any process that modulates the frequency, rate or extent of anoikis.
Any process that activates or increases the frequency, rate or extent of anoikis.
Any process that activates or increases the frequency, rate or extent of anoikis.
Any process that modulates the frequency, rate or extent of glutamate metabolic process.
Any process that modulates the frequency, rate or extent of glutamate metabolic process.
Any process that modulates the frequency, rate or extent of glutamate metabolic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of glutamate metabolic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of glutamate metabolic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of glutamate metabolic process.
Any process that activates or increases the frequency, rate or extent of glutamate metabolic process.
Any process that activates or increases the frequency, rate or extent of glutamate metabolic process.
Any process that activates or increases the frequency, rate or extent of glutamate metabolic process.
Any process that modulates the frequency, rate or extent of proline metabolic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of proline metabolic process.
Any process that activates or increases the frequency, rate or extent of proline metabolic process.
Any process that modulates the frequency, rate or extent of invasive growth in response to glucose limitation.
Any process that stops, prevents, or reduces the frequency, rate or extent of invasive growth in response to glucose limitation.
Any process that activates or increases the frequency, rate or extent of invasive growth in response to glucose limitation.
Any process that modulates the frequency, rate or extent of pseudohyphal growth.
Any process that stops, prevents, or reduces the frequency, rate or extent of pseudohyphal growth.
Any process that activates or increases the frequency, rate or extent of pseudohyphal growth.
Any process that modulates the frequency, rate or extent of BMP signaling pathway involved in heart jogging.
Any process that modulates the frequency, rate or extent of testosterone biosynthetic process.
Any process that stops, prevents, or reduces the frequency, rate or extent of testosterone biosynthetic process.
Any process that modulates the frequency, rate or extent of pancreatic A cell differentiation.
Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic A cell differentiation.
Any process that activates or increases the frequency, rate or extent of pancreatic A cell differentiation.
Any process that modulates the frequency, rate or extent of pancreatic stellate cell proliferation.
Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic stellate cell proliferation.
Any process that activates or increases the frequency, rate or extent of pancreatic stellate cell proliferation.
Any process that modulates the frequency, rate or extent of rRNA processing.
Any process that stops, prevents, or reduces the frequency, rate or extent of rRNA processing.
Any process that activates or increases the frequency, rate or extent of rRNA processing.
Any process that modulates the frequency, rate or extent of tRNA processing.
Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA processing.
Any process that activates or increases the frequency, rate or extent of tRNA processing.
Any process that modulates the frequency, rate or extent of tRNA export from nucleus.
Any process that modulates the frequency, rate or extent of tRNA export from nucleus.
Any process that modulates the frequency, rate or extent of tRNA export from nucleus.
Any process that modulates the frequency, rate or extent of tRNA export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA export from nucleus.
Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA export from nucleus.
Any process that activates or increases the frequency, rate or extent of tRNA export from nucleus.
Any process that activates or increases the frequency, rate or extent of tRNA export from nucleus.
Any process that activates or increases the frequency, rate or extent of tRNA export from nucleus.
Any process that activates or increases the frequency, rate or extent of tRNA export from nucleus.
Any process that modulates the frequency, rate or extent of reproductive process.
Any process that stops, prevents, or reduces the frequency, rate or extent of reproductive process.
Any process that activates or increases the frequency, rate or extent of reproductive process.
Any process that modulates the frequency, rate or extent of FtsZ-dependent cytokinesis.
Any process that modulates the frequency, rate or extent of FtsZ-dependent cytokinesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of Ftsz-dependent cytokinesis.
Any process that stops, prevents, or reduces the frequency, rate or extent of Ftsz-dependent cytokinesis.
Any process that activates or increases the frequency, rate or extent of Ftsz-dependent cytokinesis.
Any process that activates or increases the frequency, rate or extent of Ftsz-dependent cytokinesis.
Any process that activates or increases the frequency, rate or extent of establishment or maintenance of bipolar cell polarity regulating cell shape.
Any process that stops, prevents, or reduces the frequency, rate or extent of establishment or maintenance of neuroblast polarity.
Any process that modulates the frequency, rate or extent of actin cytoskeleton reorganization.
Any process that modulates the frequency, rate or extent of actin cytoskeleton reorganization.
Any process that stops, prevents, or reduces the frequency, rate or extent of actin cytoskeleton reorganization.
Any process that stops, prevents, or reduces the frequency, rate or extent of actin cytoskeleton reorganization.
Any process that activates or increases the frequency, rate or extent of actin cytoskeleton reorganization.
Any process that activates or increases the frequency, rate or extent of actin cytoskeleton reorganization.
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
Any process that activates or increases the frequency, rate or extent of feeding behavior.
Any process that activates or increases the frequency, rate or extent of feeding behavior.
Any process that activates or increases the frequency, rate or extent of feeding behavior.
Any process that activates or increases the frequency, rate or extent of feeding behavior.
Any process that activates or increases the frequency, rate or extent of feeding behavior.
Any process that modulates the frequency, rate or extent of male germ cell proliferation.
Any process that stops, prevents or reduces the frequency, rate or extent of male germ cell proliferation.
Any process that activates or increases the frequency, rate or extent of male germ cell proliferation.
Any process that modulates the frequency, rate or extent of protein activation cascade.
Any process that modulates the frequency, rate or extent of protein activation cascade.
Any process that stops, prevents or reduces the frequency, rate or extent of protein activation cascade.
Any process that stops, prevents or reduces the frequency, rate or extent of protein activation cascade.
Any process that activates or increases the frequency, rate or extent of protein activation cascade.
Any process that activates or increases the frequency, rate or extent of protein activation cascade.
Any process that modulates the frequency, rate or extent of blood coagulation, common pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of blood coagulation, common pathway.
Any process that activates or increases the frequency, rate or extent of blood coagulation, common pathway.
Any process that modulates the frequency, rate or extent of blood coagulation, extrinsic pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of blood coagulation, extrinsic pathway.
Any process that activates or increases the frequency, rate or extent of blood coagulation, extrinsic pathway.
Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of blood coagulation, intrinsic pathway.
Any process that activates or increases the frequency, rate or extent of blood coagulation, intrinsic pathway.
Any process that modulates the frequency, rate or extent of fibroblast apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast apoptotic process.
Any process that activates or increases the frequency, rate or extent of fibroblast apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of a signaling receptor activity.
Any process that activates or increases the frequency, rate or extent of signaling receptor activity.
Any process that modulates the frequency, rate or extent of epithelial cell migration, open tracheal system.
Any process that modulates the frequency, rate or extent of epithelial cell migration, open tracheal system.
Any process that modulates the frequency, rate or extent of oxidative phosphorylation uncoupler activity.
Any process that modulates the frequency, rate or extent of oxidative phosphorylation uncoupler activity.
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative phosphorylation uncoupler activity.
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative phosphorylation uncoupler activity.
Any process that activates or increases the frequency, rate or extent of oxidative phosphorylation uncoupler activity.
Any process that activates or increases the frequency, rate or extent of oxidative phosphorylation uncoupler activity.
Any process that modulates the frequency, rate or extent of DNA biosynthetic process.
Any process that modulates the frequency, rate or extent of DNA biosynthetic process.
Any process that modulates the frequency, rate or extent of DNA biosynthetic process.
Any process that modulates the frequency, rate or extent of DNA biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA biosynthetic process.
Any process that modulates the frequency, rate or extent of root development.
Any process that modulates the frequency, rate or extent of histone H3-T3 phosphorylation.
Any process that modulates the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that modulates the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that modulates the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that modulates the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that modulates the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cellular amino acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cellular amino acid biosynthetic process.
A receptor internalization process that contributes to canonical Wnt signaling pathway.
A receptor internalization process that contributes to canonical Wnt signaling pathway.
A receptor internalization process that contributes to canonical Wnt signaling pathway.
A receptor internalization process that contributes to canonical Wnt signaling pathway.
A receptor internalization process that contributes to canonical Wnt signaling pathway.
A receptor internalization process that contributes to canonical Wnt signaling pathway.
A receptor internalization process that contributes to canonical Wnt signaling pathway.
Any process that activates or increases the frequency, rate or extent of myotome development.
Any process that activates or increases the frequency, rate or extent of myoblast proliferation.
Any process that modulates the frequency, rate or extent of photoreceptor cell axon guidance.
Any process that modulates the frequency, rate or extent of myotome development.
Any process that modulates the frequency, rate or extent of myoblast proliferation.
Any process that modulates the frequency, rate or extent of defecation.
Any process that stops, prevents or reduces the frequency, rate or extent of defecation.
Any process that activates or increases the frequency, rate or extent of defecation.
Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that modulates the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of synapse maturation.
Any process that modulates the frequency, rate or extent of Rho-dependent protein serine/threonine kinase activity.
Any process that modulates the frequency, rate or extent of Rho-dependent protein serine/threonine kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of Rho-dependent protein serine/threonine kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of Rho-dependent protein serine/threonine kinase activity.
Any process that modulates the frequency, rate or extent of synaptic vesicle exocytosis.
Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle exocytosis.
Any process that activates or increases the frequency, rate or extent of synaptic vesicle exocytosis.
Any process that modulates the frequency, rate or extent of a ceramide biosynthetic process.
Any process that modulates the frequency, rate or extent of a ceramide biosynthetic process.
Any process that modulates the frequency, rate or extent of a ceramide biosynthetic process.
Any process that modulates the frequency, rate or extent of a ceramide biosynthetic process.
Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.
Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.
Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.
Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.
Any semaphorin-plexin signaling pathway that is involved in regulation of photoreceptor cell axon guidance.
Any semaphorin-plexin signaling pathway that is involved in regulation of photoreceptor cell axon guidance.
Any semaphorin-plexin signaling pathway that is involved in regulation of photoreceptor cell axon guidance.
Any semaphorin-plexin signaling pathway that is involved in regulation of photoreceptor cell axon guidance.
Any process that activates or increases the frequency, rate or extent of photomorphogenesis.
Any process that modulates the frequency, rate or extent of tumor necrosis factor (ligand) superfamily member 11 production.
Any process that modulates the frequency, rate or extent of tumor necrosis factor (ligand) superfamily member 11 production.
Any process that stops, prevents or reduces the frequency, rate or extent of tumor necrosis factor (ligand) superfamily member 11 production.
Any process that stops, prevents or reduces the frequency, rate or extent of tumor necrosis factor (ligand) superfamily member 11 production.
Any process that activates or increases the frequency, rate or extent of tumor necrosis factor (ligand) superfamily member 11 production.
Any process that activates or increases the frequency, rate or extent of tumor necrosis factor (ligand) superfamily member 11 production.
Any process that modulates the frequency, rate or extent of N-methyl-D-aspartate selective glutamate receptor activity.
Any process that modulates the frequency, rate or extent of AMPA selective glutamate receptor activity.
Any process that modulates the frequency, rate or extent of kainate selective glutamate receptor activity.
Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation.
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation.
Any process that activates or increases the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation.
Any process that modulates the frequency, rate or extent of T-helper 17 type immune response.
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 type immune response.
Any process that activates or increases the frequency, rate or extent of T-helper 17 type immune response.
Any process that modulates the frequency, rate or extent of T-helper 17 cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 cell differentiation.
Any process that activates or increases the frequency, rate or extent of T-helper 17 cell differentiation.
Any process that modulates the frequency, rate or extent of glucocorticoid receptor signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of glucocorticoid receptor signaling pathway.
Any process that activates or increases the frequency, rate or extent of glucocorticoid receptor signaling pathway.
Any process that modulates the frequency, rate or extent of ligand-dependent nuclear receptor transcription coactivator activity.
Any process that modulates the frequency, rate or extent of ligand-dependent nuclear receptor transcription coactivator activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ligand-dependent nuclear receptor transcription coactivator activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ligand-dependent nuclear receptor transcription coactivator activity.
Any process that activates or increases the frequency, rate or extent of ligand-dependent nuclear receptor transcription coactivator activity.
Any process that activates or increases the frequency, rate or extent of ligand-dependent nuclear receptor transcription coactivator activity.
Any process that modulates the frequency, rate or extent of T-helper 17 cell lineage commitment.
Any process that modulates the frequency, rate or extent of T-helper 17 cell lineage commitment.
Any process that modulates the frequency, rate or extent of T-helper 17 cell lineage commitment.
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 cell lineage commitment.
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 cell lineage commitment.
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 cell lineage commitment.
Any process that activates or increases the frequency, rate or extent of T-helper 17 cell lineage commitment.
Any process that activates or increases the frequency, rate or extent of T-helper 17 cell lineage commitment.
Any process that activates or increases the frequency, rate or extent of T-helper 17 cell lineage commitment.
Any process that modulates the frequency, rate or extent of terminal button organization.
Any process that modulates the frequency, rate or extent of terminal button organization.
Any process that modulates the frequency, rate or extent of terminal button organization.
Any process that modulates the frequency, rate or extent of terminal button organization.
Any process that modulates the frequency, rate or extent of terminal button organization.
Any process that modulates the frequency, rate or extent of blood microparticle formation.
Any process that modulates the frequency, rate or extent of blood microparticle formation.
Any process that stops, prevents or reduces the frequency, rate or extent of blood microparticle formation.
Any process that stops, prevents or reduces the frequency, rate or extent of blood microparticle formation.
Any process that activates or increases the frequency, rate or extent of blood microparticle formation.
Any process that activates or increases the frequency, rate or extent of blood microparticle formation.
Any process that modulates the frequency, rate or extent of endothelial microparticle formation.
Any process that modulates the frequency, rate or extent of endothelial microparticle formation.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial microparticle formation.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial microparticle formation.
Any process that activates or increases the frequency, rate or extent of endothelial microparticle formation.
Any process that activates or increases the frequency, rate or extent of endothelial microparticle formation.
Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.
Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that modulates the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
Any process that activates or increases the frequency, rate or extent of the acrosome reaction.
Any process that modulates the frequency, rate or extent of hepatocyte proliferation.
Any process that stops, prevents or reduces the frequency, rate or extent of hepatocyte proliferation.
Any process that activates or increases the frequency, rate or extent of hepatocyte proliferation.
Any process that modulates the frequency, rate or extent of signaling via the CD40 signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of signaling via the CD40 signaling pathway.
Any process that activates or increases the frequency, rate or extent of signaling via the CD40 signaling pathway.
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
Any process that modulates the frequency, rate or extent of ovarian follicle development.
Any process that stops, prevents or reduces the frequency, rate or extent of ovarian follicle development.
Any process that modulates the frequency, rate or extent of kidney smooth muscle cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of kidney smooth muscle cell differentiation.
Any process that activates or increases the frequency, rate or extent of kidney smooth muscle cell differentiation.
Any process that modulates the frequency, rate or extent of binding of sperm to the zona pellucida.
Any process that stops, prevents or reduces the frequency, rate or extent of binding of sperm to the zona pellucida.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that activates or increases the frequency, rate or extent of prostaglandin-E synthase activity.
Any process that modulates the frequency, rate or extent of acrosomal vesicle exocytosis.
Any process that modulates the frequency, rate or extent of acrosomal vesicle exocytosis.
Any process that activates or increases the frequency, rate or extent of acrosomal vesicle exocytosis.
Any process that activates or increases the frequency, rate or extent of acrosomal vesicle exocytosis.
Any process that modulates the frequency, rate or extent of clathrin-mediated endocytosis.
Any process that modulates the frequency, rate or extent of clathrin-mediated endocytosis.
Any process that modulates the frequency, rate or extent of clathrin-mediated endocytosis.
Any process that activates or increases the frequency, rate or extent of clathrin-mediated endocytosis.
Any process that activates or increases the frequency, rate or extent of clathrin-mediated endocytosis.
Any process that activates or increases the frequency, rate or extent of clathrin-mediated endocytosis.
Any process that modulates the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that modulates the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that modulates the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that modulates the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that modulates the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that modulates the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that modulates the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that modulates the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that modulates the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that activates or increases the frequency, rate or extent of DNA topoisomerase (ATP-hydrolyzing) activity.
Any process that modulates the frequency, rate or extent of mesoderm development.
Any process that stops, prevents or reduces the frequency, rate or extent of mesoderm development.
Any process that activates or increases the frequency, rate or extent of mesoderm development.
Any process that modulates the frequency, rate or extent of ectoderm development.
Any process that stops, prevents or reduces the frequency, rate or extent of ectoderm development.
Any process that activates or increases the frequency, rate or extent of ectoderm development.
Any process that activates or increases the frequency, rate or extent of ovarian follicle development.
Any process that modulates the frequency, rate or extent of antral ovarian follicle growth.
Any process that activates or increases the frequency, rate or extent of antral ovarian follicle growth.
Any process that modulates the frequency, rate or extent of neutrophil extravasation.
Any process that stops, prevents or reduces the frequency, rate or extent of neutrophil extravasation.
Any process that activates or increases the frequency, rate or extent of neutrophil extravasation.
Any process that modulates the frequency, rate or extent of lamellipodium morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of lamellipodium morphogenesis.
Any process that activates or increases the frequency, rate or extent of lamellipodium morphogenesis.
Any process that modulates the frequency, rate or extent of ubiquitin-dependent endocytosis.
Any process that stops, prevents or reduces the frequency, rate or extent of ubiquitin-dependent endocytosis.
Any process that activates or increases the frequency, rate or extent of ubiquitin-dependent endocytosis.
Any process that modulates the frequency, rate or extent of thymocyte aggregation.
Any process that modulates the frequency, rate or extent of thymocyte aggregation.
Any process that modulates the frequency, rate or extent of thymocyte aggregation.
Any process that modulates the frequency, rate or extent of thymocyte aggregation.
Any process that modulates the frequency, rate or extent of thymocyte aggregation.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte aggregation.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte aggregation.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte aggregation.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte aggregation.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte aggregation.
Any process that activates or increases the frequency, rate or extent of thymocyte aggregation.
Any process that activates or increases the frequency, rate or extent of thymocyte aggregation.
Any process that activates or increases the frequency, rate or extent of thymocyte aggregation.
Any process that activates or increases the frequency, rate or extent of thymocyte aggregation.
Any process that activates or increases the frequency, rate or extent of thymocyte aggregation.
Any process that modulates the frequency, rate or extent of lymphocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of lymphocyte migration.
Any process that activates or increases the frequency, rate or extent of lymphocyte migration.
Any process that modulates the frequency, rate or extent of T cell migration.
Any process that modulates the frequency, rate or extent of T cell migration.
Any process that modulates the frequency, rate or extent of T cell migration.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell migration.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell migration.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell migration.
Any process that activates or increases the frequency, rate or extent of T cell migration.
Any process that activates or increases the frequency, rate or extent of T cell migration.
Any process that activates or increases the frequency, rate or extent of T cell migration.
Any process that modulates the frequency, rate or extent of T cell extravasation.
Any process that modulates the frequency, rate or extent of T cell extravasation.
Any process that modulates the frequency, rate or extent of T cell extravasation.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell extravasation.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell extravasation.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell extravasation.
Any process that activates or increases the frequency, rate or extent of T cell extravasation.
Any process that activates or increases the frequency, rate or extent of T cell extravasation.
Any process that activates or increases the frequency, rate or extent of T cell extravasation.
Any process that modulates the frequency, rate or extent of thymocyte migration.
Any process that modulates the frequency, rate or extent of thymocyte migration.
Any process that modulates the frequency, rate or extent of thymocyte migration.
Any process that modulates the frequency, rate or extent of thymocyte migration.
Any process that modulates the frequency, rate or extent of thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of thymocyte migration.
Any process that activates or increases the frequency, rate or extent of thymocyte migration.
Any process that activates or increases the frequency, rate or extent of thymocyte migration.
Any process that activates or increases the frequency, rate or extent of thymocyte migration.
Any process that activates or increases the frequency, rate or extent of thymocyte migration.
Any process that activates or increases the frequency, rate or extent of thymocyte migration.
Any process that modulates the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that modulates the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that modulates the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that modulates the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that modulates the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that stops, prevents or reduces the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that activates or increases the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that activates or increases the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that activates or increases the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that activates or increases the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that activates or increases the frequency, rate or extent of fibronectin-dependent thymocyte migration.
Any process that modulates the frequency, rate or extent of eosinophil migration.
Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil migration.
Any process that activates or increases the frequency, rate or extent of eosinophil migration.
Any process that modulates the frequency, rate or extent of eosinophil extravasation.
Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil extravasation.
Any process that activates or increases the frequency, rate or extent of eosinophil extravasation.
Any process that modulates the frequency, rate or extent of eosinophil chemotaxis.
Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil chemotaxis.
Any process that activates or increases the frequency, rate or extent of eosinophil chemotaxis.
Any process that modulates the frequency, rate or extent of apoptotic cell clearance.
Any process that modulates the frequency, rate or extent of apoptotic cell clearance.
Any process that modulates the frequency, rate or extent of apoptotic cell clearance.
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic cell clearance.
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic cell clearance.
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic cell clearance.
Any process that activates or increases the frequency, rate or extent of apoptotic cell clearance.
Any process that activates or increases the frequency, rate or extent of apoptotic cell clearance.
Any process that activates or increases the frequency, rate or extent of apoptotic cell clearance.
Any process that modulates the frequency, rate or extent of neutrophil aggregation.
Any process that modulates the frequency, rate or extent of neutrophil aggregation.
Any process that modulates the frequency, rate or extent of neutrophil aggregation.
Any process that stops, prevents or reduces the frequency, rate or extent of neutrophil aggregation.
Any process that stops, prevents or reduces the frequency, rate or extent of neutrophil aggregation.
Any process that stops, prevents or reduces the frequency, rate or extent of neutrophil aggregation.
Any process that activates or increases the frequency, rate or extent of neutrophil aggregation.
Any process that activates or increases the frequency, rate or extent of neutrophil aggregation.
Any process that activates or increases the frequency, rate or extent of neutrophil aggregation.
Any process that modulates the frequency, rate or extent of cytokinesis, actomyosin contractile ring assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of cytokinesis, actomyosin contractile ring assembly.
Any process that activates or increases the frequency, rate or extent of cytokinesis, actomyosin contractile ring assembly.
Any process that modulates the frequency, rate or extent of protein neddylation.
Any process that stops, prevents or reduces the frequency, rate or extent of protein neddylation.
Any process that activates or increases the frequency, rate or extent of protein neddylation.
Any process that modulates the frequency, rate or extent of monocyte extravasation.
Any process that stops, prevents or reduces the frequency, rate or extent of monocyte extravasation.
Any process that activates or increases the frequency, rate or extent of monocyte extravasation.
Any process that modulates the frequency, rate or extent of toll-like receptor 15 signaling pathway.
Any process that modulates the frequency, rate or extent of toll-like receptor 15 signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of toll-like receptor 15 signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of toll-like receptor 15 signaling pathway.
Any process that activates or increases the frequency, rate or extent of toll-like receptor 15 signaling pathway.
Any process that activates or increases the frequency, rate or extent of toll-like receptor 15 signaling pathway.
Any process that modulates the frequency, rate or extent of toll-like receptor 21 signaling pathway.
Any process that modulates the frequency, rate or extent of toll-like receptor 21 signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of toll-like receptor 21 signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of toll-like receptor 21 signaling pathway.
Any process that activates or increases the frequency, rate or extent of toll-like receptor 21 signaling pathway.
Any process that activates or increases the frequency, rate or extent of toll-like receptor 21 signaling pathway.
Any process that modulates the frequency, rate or extent of macrophage migration inhibitory factor signaling pathway.
Any process that modulates the frequency, rate or extent of macrophage migration inhibitory factor signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of macrophage migration inhibitory factor signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of macrophage migration inhibitory factor signaling pathway.
Any process that activates or increases the frequency, rate or extent of macrophage migration inhibitory factor signaling pathway.
Any process that activates or increases the frequency, rate or extent of macrophage migration inhibitory factor signaling pathway.
Any process that modulates the frequency, rate or extent of CD8-positive, alpha-beta T cell extravasation.
Any process that stops, prevents or reduces the frequency, rate or extent of CD8-positive, alpha-beta T cell extravasation.
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell extravasation.
Any process that modulates the frequency, rate or extent of CD8-positive, alpha-beta cytotoxic T cell extravasation.
Any process that stops, prevents or reduces the frequency, rate or extent of CD8-positive, alpha-beta cytotoxic T cell extravasation.
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta cytotoxic T cell extravasation.
Any process that modulates the frequency, rate or extent of T-helper 17 cell extravasation.
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 cell extravasation.
Any process that activates or increases the frequency, rate or extent of T-helper 17 cell extravasation.
Any process that modulates the frequency, rate or extent of astrocyte chemotaxis.
Any process that stops, prevents or reduces the frequency, rate or extent of astrocyte chemotaxis.
Any process that enhances the establishment or increases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
Any process that enhances the establishment or increases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
Any process that activates or increases the frequency, rate or extent of astrocyte chemotaxis.
Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that modulates the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity.
Any process that modulates the frequency, rate or extent of peroxidase activity.
Any process that modulates the frequency, rate or extent of peroxidase activity.
Any process that modulates the frequency, rate or extent of peroxidase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of peroxidase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of peroxidase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of peroxidase activity.
Any process that activates or increases the frequency, rate or extent of peroxidase activity.
Any process that activates or increases the frequency, rate or extent of peroxidase activity.
Any process that activates or increases the frequency, rate or extent of peroxidase activity.
Any process that modulates the frequency, rate or extent of hematopoietic stem cell migration.
Any process that stops, prevents or reduces the frequency, rate or extent of hematopoietic stem cell migration.
Any process that activates or increases the frequency, rate or extent of hematopoietic stem cell migration.
Any process that modulates the frequency, rate or extent of opioid receptor signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of opioid receptor signaling pathway.
Any process that activates or increases the frequency, rate or extent of opioid receptor signaling pathway.
Any process that modulates the frequency, rate or extent of metanephric glomerular visceral epithelial cell development.
Any process that activates or increases the frequency, rate or extent of metanephric glomerular visceral epithelial cell development.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that activates or increases the frequency, rate or extent of cAMP-dependent protein kinase activity.
Any process that modulates the frequency, rate or extent of interleukin-8 secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-8 secretion.
Any process that activates or increases the frequency, rate or extent of interleukin-8 secretion.
Any process that modulates the frequency, rate or extent of glutamine transport.
Any process that stops, prevents or reduces the frequency, rate or extent of glutamine transport.
Any process that activates or increases the frequency, rate or extent of glutamine transport.
Any process that activates or increases the frequency, rate or extent of brassinosteroid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of brassinosteroid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of brassinosteroid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of brassinosteroid biosynthetic process.
Any process that modulates the frequency, rate or extent of hepatic stellate cell activation.
Any process that stops, prevents or reduces the frequency, rate or extent of hepatic stellate cell activation.
Any process that activates or increases the frequency, rate or extent of hepatic stellate cell activation.
Any process that modulates the frequency, rate or extent of interleukin-18-mediated signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-18-mediated signaling pathway.
Any process that activates or increases the frequency, rate or extent of interleukin-18-mediated signaling pathway.
Any process that modulates the frequency, rate or extent of cell proliferation involved in compound eye morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation involved in compound eye morphogenesis.
Any process that activates or increases the frequency, rate or extent of cell proliferation involved in compound eye morphogenesis.
Any process that modulates the frequency, rate or extent of natural killer cell chemotaxis.
Any process that stops, prevents or reduces the frequency, rate or extent of natural killer cell chemotaxis.
Any process that activates or increases the frequency, rate or extent of natural killer cell chemotaxis.
Any process that activates or increases the frequency, rate or extent of blood vessel remodeling.
Any process that modulates the frequency, rate or extent of dendritic cell chemotaxis.
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell chemotaxis.
Any process that activates or increases the frequency, rate or extent of dendritic cell chemotaxis.
Any process that modulates the frequency, rate or extent of granzyme A production.
Any process that stops, prevents or reduces the frequency, rate or extent of granzyme A production.
Any process that activates or increases the frequency, rate or extent of granzyme A production.
Any process that modulates the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.
Any process that stops, prevents or reduces the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.
Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell activation.
Any process that modulates the frequency, rate or extent of T-helper 1 cell activation.
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 1 cell activation.
Any process that activates or increases the frequency, rate or extent of T-helper 1 cell activation.
Any process that modulates the frequency, rate or extent of immunological synapse formation.
Any process that stops, prevents or reduces the frequency, rate or extent of immunological synapse formation.
Any process that activates or increases the frequency, rate or extent of immunological synapse formation.
Any process that modulates the frequency, rate or extent of T cell costimulation.
Any process that modulates the frequency, rate or extent of T cell costimulation.
Any process that modulates the frequency, rate or extent of T cell costimulation.
Any process that modulates the frequency, rate or extent of T cell costimulation.
Any process that modulates the frequency, rate or extent of T cell costimulation.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell costimulation.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell costimulation.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell costimulation.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell costimulation.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell costimulation.
Any process that activates or increases the frequency, rate or extent of T cell costimulation.
Any process that activates or increases the frequency, rate or extent of T cell costimulation.
Any process that activates or increases the frequency, rate or extent of T cell costimulation.
Any process that activates or increases the frequency, rate or extent of T cell costimulation.
Any process that activates or increases the frequency, rate or extent of T cell costimulation.
Any positive regulation of glycoprotein biosynthetic process that is involved in immunological synapse formation.
Any positive regulation of glycoprotein biosynthetic process that is involved in immunological synapse formation.
Any process that modulates the frequency, rate or extent of myeloid dendritic cell chemotaxis.
Any process that stops, prevents or reduces the frequency, rate or extent of myeloid dendritic cell chemotaxis.
Any process that activates or increases the frequency, rate or extent of myeloid dendritic cell chemotaxis.
Any process that modulates the frequency, rate or extent of the biosynthesis of fatty acids, by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.
Any process that modulates the frequency, rate or extent of renal albumin absorption.
Any process that stops, prevents or reduces the frequency, rate or extent of renal albumin absorption.
Any process that activates or increases the frequency, rate or extent of renal albumin absorption.
Any process that modulates the frequency, rate or extent of entry of bacterium into host cell.
Any process that modulates the frequency, rate or extent of entry of bacterium into host cell.
Any process that stops, prevents or reduces the frequency, rate or extent of entry of bacterium into host cell.
Any process that stops, prevents or reduces the frequency, rate or extent of entry of bacterium into host cell.
Any process that modulates the frequency, rate or extent of B cell chemotaxis.
Any process that activates or increases the frequency, rate or extent of B cell chemotaxis.
Any process that modulates the frequency, rate or extent of protein geranylgeranylation.
Any process that modulates the frequency, rate or extent of protein geranylgeranylation.
Any process that stops, prevents or reduces the frequency, rate or extent of protein geranylgeranylation.
Any process that stops, prevents or reduces the frequency, rate or extent of protein geranylgeranylation.
Any process that activates or increases the frequency, rate or extent of protein geranylgeranylation.
Any process that activates or increases the frequency, rate or extent of protein geranylgeranylation.
Any process that stops, prevents or reduces the frequency, rate or extent of gastrulation.
Any process that activates or increases the frequency, rate or extent of gastrulation.
Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
Any process that modulates the frequency, rate or extent of dendritic cell dendrite assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell dendrite assembly.
Any process that activates or increases the frequency, rate or extent of dendritic cell dendrite assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of B cell chemotaxis.
Any process that modulates the frequency, rate or extent of T-helper 2 cell cytokine production.
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 2 cell cytokine production.
Any process that activates or increases the frequency, rate or extent of T-helper 2 cell cytokine production.
Any process that modulates the frequency, rate or extent of T-helper 1 cell cytokine production.
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 1 cell cytokine production.
Any process that activates or increases the frequency, rate or extent of T-helper 1 cell cytokine production.
Any process that modulates the frequency, rate or extent of immunoglobulin production in mucosal tissue.
Any process that activates or increases the frequency, rate or extent of immunoglobulin production in mucosal tissue.
Any process that modulates the frequency, rate or extent of CD24 biosynthetic process.
Any process that modulates the frequency, rate or extent of CD24 biosynthetic process.
Any process that modulates the frequency, rate or extent of CD24 biosynthetic process.
Any process that modulates the frequency, rate or extent of CD24 biosynthetic process.
Any process that activates or increases the frequency, rate or extent of CD24 biosynthetic process.
Any process that activates or increases the frequency, rate or extent of CD24 biosynthetic process.
Any process that activates or increases the frequency, rate or extent of CD24 biosynthetic process.
Any process that activates or increases the frequency, rate or extent of CD24 biosynthetic process.
Any process that modulates the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation.
Any process that stops, prevents or reduces the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation.
Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation.
Any process that modulates the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.
Any process that stops, prevents or reduces the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.
Any process that modulates the frequency, rate or extent of memory T cell activation.
Any process that activates or increases the frequency, rate or extent of memory T cell activation.
Any process that modulates the frequency, rate or extent of T-helper 2 cell activation.
Any process that activates or increases the frequency, rate or extent of T-helper 2 cell activation.
Any process that modulates the frequency, rate or extent of interleukin-4-dependent isotype switching to IgE isotypes.
Any process that activates or increases the frequency, rate or extent of interleukin-4-dependent isotype switching to IgE isotypes.
Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
Any process that modulates the frequency, rate or extent of microtubule motor activity.
Any process that modulates the frequency, rate or extent of microtubule motor activity.
Any process that modulates the frequency, rate or extent of microtubule motor activity.
Any process that modulates the frequency, rate or extent of microtubule motor activity.
Any process that modulates the frequency, rate or extent of microtubule motor activity.
Any process that modulates the frequency, rate or extent of microtubule motor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule motor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule motor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule motor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule motor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule motor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of microtubule motor activity.
Any process that activates or increases the frequency, rate or extent of microtubule motor activity.
Any process that activates or increases the frequency, rate or extent of microtubule motor activity.
Any process that activates or increases the frequency, rate or extent of microtubule motor activity.
Any process that activates or increases the frequency, rate or extent of microtubule motor activity.
Any process that activates or increases the frequency, rate or extent of microtubule motor activity.
Any process that activates or increases the frequency, rate or extent of microtubule motor activity.
Any process that modulates the frequency, rate or extent of ATP-dependent microtubule motor activity, minus-end-directed.
Any process that modulates the frequency, rate or extent of ATP-dependent microtubule motor activity, minus-end-directed.
Any process that modulates the frequency, rate or extent of ATP-dependent microtubule motor activity, minus-end-directed.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP-dependent microtubule motor activity, minus-end-directed.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP-dependent microtubule motor activity, minus-end-directed.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP-dependent microtubule motor activity, minus-end-directed.
Any process that activates or increases the frequency, rate or extent of ATP-dependent microtubule motor activity, minus-end-directed.
Any process that activates or increases the frequency, rate or extent of ATP-dependent microtubule motor activity, minus-end-directed.
Any process that activates or increases the frequency, rate or extent of ATP-dependent microtubule motor activity, minus-end-directed.
Any process that modulates the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that modulates the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that modulates the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that modulates the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that activates or increases the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that activates or increases the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that activates or increases the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that activates or increases the frequency, rate or extent of ATP-dependent microtubule motor activity, plus-end-directed.
Any process that modulates the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that modulates the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that modulates the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that modulates the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that activates or increases the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that activates or increases the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that activates or increases the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that activates or increases the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Any process that modulates the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that modulates the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that modulates the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that modulates the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that activates or increases the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that activates or increases the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that activates or increases the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that activates or increases the frequency, rate or extent of platelet-derived growth factor receptor-beta signaling pathway.
Any process that modulates the frequency, rate or extent of metanephric mesenchymal cell migration.
Any process that stops, prevents or reduces the frequency, rate or extent of metanephric mesenchymal cell migration.
Any process that activates or increases the frequency, rate or extent of metanephric mesenchymal cell migration.
Any process that modulates the frequency, rate or extent of metanephric DCT cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of metanephric DCT cell differentiation.
Any process that activates or increases the frequency, rate or extent of metanephric DCT cell differentiation.
Any process that modulates the frequency, rate or extent of optic nerve formation.
Any process that modulates the frequency, rate or extent of optic nerve formation.
Any process that stops, prevents or reduces the frequency, rate or extent of optic nerve formation.
Any process that stops, prevents or reduces the frequency, rate or extent of optic nerve formation.
Any process that activates or increases the frequency, rate or extent of optic nerve formation.
Any process that activates or increases the frequency, rate or extent of optic nerve formation.
Any process that activates or increases the frequency, rate or extent of Arp2/3 complex-mediated actin nucleation.
Any process that activates or increases the frequency, rate or extent of Arp2/3 complex-mediated actin nucleation.
Any process that modulates the frequency, rate or extent of secondary growth.
Any process that stops, prevents or reduces the frequency, rate or extent of secondary growth.
Any process that activates or increases the frequency, rate or extent of secondary growth.
Any process that modulates the frequency, rate or extent of cell proliferation involved in mesonephros development.
Any process that stops, prevents or reduces the frequency, rate or extent of cell proliferation involved in mesonephros development.
Any process that activates or increases the frequency, rate or extent of cell proliferation involved in mesonephros development.
Any process that modulates the frequency, rate or extent of thyroid hormone generation.
Any process that stops, prevents or reduces the frequency, rate or extent of thyroid hormone generation.
Any process that activates or increases the frequency, rate or extent of thyroid hormone generation.
Any process that modulates the frequency, rate or extent of thyroid-stimulating hormone secretion.
Any process that modulates the frequency, rate or extent of thyroid-stimulating hormone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of thyroid-stimulating hormone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of thyroid-stimulating hormone secretion.
Any process that activates or increases the frequency, rate or extent of thyroid-stimulating hormone secretion.
Any process that activates or increases the frequency, rate or extent of thyroid-stimulating hormone secretion.
Any process that modulates the frequency, rate or extent of histone H3-K9 acetylation.
Any process that modulates the frequency, rate or extent of histone H3-K9 acetylation.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 acetylation.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 acetylation.
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
Any process that modulates the frequency, rate or extent of histone H4-K16 acetylation.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H4-K16 acetylation.
Any process that activates or increases the frequency, rate or extent of histone H4-K16 acetylation.
Any process that modulates the frequency, rate or extent of DNA replication termination.
Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.
Any process that modulates the frequency, rate or extent of miRNA catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA catabolic process.
Any process that activates or increases the frequency, rate or extent of miRNA catabolic process.
Any process that modulates the frequency, rate or extent of miRNA metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of miRNA metabolic process.
Any process that activates or increases the frequency, rate or extent of miRNA metabolic process.
Any process that modulates the frequency, rate or extent of pre-microRNA processing.
Any process that stops, prevents or reduces the frequency, rate or extent of pre-microRNA processing.
Any process that activates or increases the frequency, rate or extent of pre-microRNA processing.
Any process that modulates the frequency, rate or extent of primary microRNA processing.
Any process that modulates the frequency, rate or extent of primary microRNA processing.
Any process that stops, prevents or reduces the frequency, rate or extent of primary microRNA processing.
Any process that stops, prevents or reduces the frequency, rate or extent of primary microRNA processing.
Any process that activates or increases the frequency, rate or extent of primary microRNA processing.
Any process that activates or increases the frequency, rate or extent of primary microRNA processing.
Any process that activates or increases the frequency, rate or extent of gene silencing by miRNA.
Any process that activates or increases the frequency, rate or extent of gene silencing by miRNA.
Any process that activates or increases the frequency, rate or extent of gene silencing by miRNA.
Any process that modulates the frequency, rate or extent of the SREBP signaling pathway.
Any process that modulates the frequency, rate or extent of the SREBP signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of the SREBP signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of the SREBP signaling pathway.
Any process that activates or increases the frequency, rate or extent of the SREBP signaling pathway.
Any process that activates or increases the frequency, rate or extent of the SREBP signaling pathway.
Any process that modulates the frequency, rate or extent of early endosome to late endosome transport.
Any process that stops, prevents or reduces the frequency, rate or extent of early endosome to late endosome transport.
Any process that activates or increases the frequency, rate or extent of early endosome to late endosome transport.
Any process that modulates the frequency, rate or extent of receptor catabolic process.
Any process that modulates the frequency, rate or extent of receptor catabolic process.
Any process that modulates the frequency, rate or extent of receptor catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of receptor catabolic process.
Any process that activates or increases the frequency, rate or extent of receptor catabolic process.
Any process that activates or increases the frequency, rate or extent of receptor catabolic process.
Any process that activates or increases the frequency, rate or extent of receptor catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of stem cell proliferation.
Any process that activates or increases the frequency, rate or extent of stem cell proliferation.
Any process that modulates the frequency, rate or extent of sodium ion transmembrane transporter activity.
Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transporter activity.
Any process that activates or increases the frequency, rate or extent of sodium ion transmembrane transporter activity.
Any process that modulates the frequency, rate or extent of secondary cell wall biogenesis.
Any process that modulates the frequency, rate or extent of secondary cell wall biogenesis.
Any process that modulates the frequency, rate or extent of secondary cell wall biogenesis.
Any process that modulates the frequency, rate or extent of secondary cell wall biogenesis.
Any process that modulates the frequency, rate or extent of secondary cell wall biogenesis.
Any process that modulates the frequency, rate or extent of secondary cell wall biogenesis.
Any process that modulates the frequency, rate or extent of genetic imprinting.
Any process that modulates the frequency, rate or extent of cellular response to testosterone stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to testosterone stimulus.
Any process that modulates the frequency, rate or extent of apolipoprotein binding.
Any process that stops, prevents or reduces the frequency, rate or extent of apolipoprotein binding.
Any process that activates or increases the frequency, rate or extent of apolipoprotein binding.
Any process that modulates the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that modulates the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that modulates the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that modulates the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that modulates the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that modulates the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that activates or increases the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that activates or increases the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that activates or increases the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that activates or increases the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that activates or increases the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that activates or increases the frequency, rate or extent of interleukin-1-mediated signaling pathway.
Any process that modulates the frequency, rate or extent of interleukin-5 secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-5 secretion.
Any process that activates or increases the frequency, rate or extent of interleukin-5 secretion.
Any process that modulates the frequency, rate or extent of interleukin-13 secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-13 secretion.
Any process that activates or increases the frequency, rate or extent of interleukin-13 secretion.
Any process that modulates the frequency, rate or extent of dendritic cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of dendritic cell apoptotic process.
Any process that modulates the frequency, rate or extent of motor neuron apoptotic process.
Any process that modulates the frequency, rate or extent of motor neuron apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron apoptotic process.
Any process that activates or increases the frequency, rate or extent of motor neuron apoptotic process.
Any process that activates or increases the frequency, rate or extent of motor neuron apoptotic process.
Any process that modulates the frequency, rate or extent of type B pancreatic cell apoptotic process.
Any process that modulates the frequency, rate or extent of type B pancreatic cell apoptotic process.
Any process that modulates the frequency, rate or extent of type B pancreatic cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of type B pancreatic cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of type B pancreatic cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of type B pancreatic cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of type B pancreatic cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of type B pancreatic cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of type B pancreatic cell apoptotic process.
Any process that modulates the frequency, rate or extent of transcription regulatory region DNA binding.
Any process that stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding.
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
Any process that modulates the frequency, rate or extent of cellular response to X-ray.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to X-ray.
Any process that activates or increases the frequency, rate or extent of cellular response to X-ray.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
An actin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
Any process that modulates the frequency, rate or extent of cardiac muscle cell myoblast differentiation.
Any process that modulates the frequency, rate or extent of cardiac muscle cell myoblast differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell myoblast differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell myoblast differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of seed maturation.
Any process that activates or increases the frequency, rate or extent of seed maturation.
Any process that modulates the frequency, rate or extent of phragmoplast microtubule organization.
Any process that modulates the frequency, rate or extent of phragmoplast microtubule organization.
Any process that modulates the frequency, rate or extent of epithelial cell differentiation involved in kidney development.
Any process that stops, prevents or reduces the frequency, rate or extent of epithelial cell differentiation involved in kidney development.
Any process that activates or increases the frequency, rate or extent of epithelial cell differentiation involved in kidney development.
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell myoblast differentiation.
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell myoblast differentiation.
The series of molecular signals generated as a consequence of a glial cell-derived neurotrophic factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
The series of molecular signals generated as a consequence of a glial cell-derived neurotrophic factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
The series of molecular signals generated as a consequence of a glial cell-derived neurotrophic factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
The series of molecular signals generated as a consequence of a glial cell-derived neurotrophic factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
The series of molecular signals generated as a consequence of a glial cell-derived neurotrophic factor receptor binding to one of its physiological ligands that contributes to the formation of the ureteric bud from the Wolffian duct.
Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of dense core granule biogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of dense core granule biogenesis.
Any process that activates or increases the frequency, rate or extent of dense core granule biogenesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
A myosin filament organization process that contributes to actomyosin contractile ring assembly during cytokinesis.
Any process that modulates the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion in the centromeric region.
Any process that modulates the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion in the centromeric region.
Any process that modulates the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion in the centromeric region.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion in the centromeric region.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion in the centromeric region.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion in the centromeric region.
Any process that activates or increases the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion in the centromeric region.
Any process that activates or increases the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion in the centromeric region.
Any process that activates or increases the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion in the centromeric region.
Any process that modulates the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion along the chromosome arms.
Any process that modulates the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion along the chromosome arms.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion along the chromosome arms.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion along the chromosome arms.
Any process that activates or increases the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion along the chromosome arms.
Any process that activates or increases the frequency, rate or extent of maintenance of meiotic sister chromatid cohesion along the chromosome arms.
Any process that modulates the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion along the chromosome arms.
Any process that modulates the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion along the chromosome arms.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion along the chromosome arms.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion along the chromosome arms.
Any process that activates or increases the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion along the chromosome arms.
Any process that activates or increases the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion along the chromosome arms.
Any process that modulates the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion in the centromeric region.
Any process that modulates the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion in the centromeric region.
Any process that modulates the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion in the centromeric region.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion in the centromeric region.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion in the centromeric region.
Any process that stops, prevents or reduces the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion in the centromeric region.
Any process that activates or increases the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion in the centromeric region.
Any process that activates or increases the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion in the centromeric region.
Any process that activates or increases the frequency, rate or extent of maintenance of mitotic sister chromatid cohesion in the centromeric region.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any process that modulates the frequency, rate or extent of cardiac vascular smooth muscle cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac vascular smooth muscle cell differentiation.
Any process that activates or increases the frequency, rate or extent of cardiac vascular smooth muscle cell differentiation.
Any process that modulates the frequency, rate or extent of cardiac muscle cell differentiation.
Any process that modulates the frequency, rate or extent of cardiac muscle cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell differentiation.
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation.
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation.
Any process that modulates the frequency, rate or extent of mRNA export from nucleus in response to heat stress.
Any process that modulates the frequency, rate or extent of mRNA export from nucleus in response to heat stress.
Any process that activates or increases the frequency, rate or extent of mesenchymal cell proliferation involved in ureter development.
Any process that activates or increases the frequency, rate or extent of mesenchymal cell proliferation involved in ureter development.
Any process that modulates the frequency, rate or extent of termination of RNA polymerase I transcription.
Any process that modulates the frequency, rate or extent of termination of RNA polymerase I transcription.
Any process that modulates the frequency, rate or extent of termination of RNA polymerase I transcription.
Any process that stops, prevents or reduces the frequency, rate or extent of termination of RNA polymerase I transcription.
Any process that stops, prevents or reduces the frequency, rate or extent of termination of RNA polymerase I transcription.
Any process that stops, prevents or reduces the frequency, rate or extent of termination of RNA polymerase I transcription.
Any process that activates or increases the frequency, rate or extent of termination of RNA polymerase I transcription.
Any process that activates or increases the frequency, rate or extent of termination of RNA polymerase I transcription.
Any process that activates or increases the frequency, rate or extent of termination of RNA polymerase I transcription.
Any process that modulates the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that stops, prevents or reduces the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that activates or increases the frequency, rate or extent of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation.
Any process that modulates the frequency, rate or extent of stem cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of stem cell differentiation.
Any process that activates or increases the frequency, rate or extent of stem cell differentiation.
Any process that modulates the frequency, rate or extent of mesenchymal stem cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal stem cell differentiation.
Any process that activates or increases the frequency, rate or extent of mesenchymal stem cell differentiation.
Any process that modulates the frequency, rate or extent of anterior head development.
Any process that stops, prevents or reduces the frequency, rate or extent of anterior head development.
Any process that activates or increases the frequency, rate or extent of anterior head development.
Any process that modulates the frequency, rate or extent of defecation rhythm.
Any process that modulates the frequency, rate or extent of defecation rhythm.
Any process that modulates the frequency, rate or extent of defecation rhythm.
Any process that modulates the frequency, rate or extent of defecation rhythm.
Any process that stops, prevents or reduces the frequency, rate or extent of defecation rhythm.
Any process that stops, prevents or reduces the frequency, rate or extent of defecation rhythm.
Any process that stops, prevents or reduces the frequency, rate or extent of defecation rhythm.
Any process that stops, prevents or reduces the frequency, rate or extent of defecation rhythm.
Any process that activates or increases the frequency, rate or extent of defecation rhythm.
Any process that activates or increases the frequency, rate or extent of defecation rhythm.
Any process that activates or increases the frequency, rate or extent of defecation rhythm.
Any process that activates or increases the frequency, rate or extent of defecation rhythm.
Any process that activates or increases the frequency, rate or extent of chromatin silencing at rDNA.
Any process that activates or increases the frequency, rate or extent of chromatin silencing at rDNA.
Any process that activates or increases the frequency, rate or extent of chromatin silencing at rDNA.
Any process that stops, prevents or reduces the frequency, rate or extent of establishment or maintenance of bipolar cell polarity regulating cell shape.
Any histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
Any histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
Any histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
Any histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
Any histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
Any process that modulates the frequency, rate or extent of glucosylceramide catabolic process.
Any process that modulates the frequency, rate or extent of glucosylceramide catabolic process.
Any process that modulates the frequency, rate or extent of glucosylceramide catabolic process.
Any process that activates or increases the frequency, rate or extent of glucosylceramide catabolic process.
Any process that activates or increases the frequency, rate or extent of glucosylceramide catabolic process.
Any process that activates or increases the frequency, rate or extent of glucosylceramide catabolic process.
Any process that modulates the frequency, rate or extent of sphingomyelin catabolic process.
Any process that modulates the frequency, rate or extent of sphingomyelin catabolic process.
Any process that modulates the frequency, rate or extent of sphingomyelin catabolic process.
Any process that activates or increases the frequency, rate or extent of sphingomyelin catabolic process.
Any process that activates or increases the frequency, rate or extent of sphingomyelin catabolic process.
Any process that activates or increases the frequency, rate or extent of sphingomyelin catabolic process.
Any process that modulates the frequency, rate or extent of peptidyl-lysine acetylation.
Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-lysine acetylation.
Any process that activates or increases the frequency, rate or extent of peptidyl-lysine acetylation.
Any process that modulates the frequency, rate or extent of N-terminal peptidyl-lysine acetylation.
Any process that stops, prevents or reduces the frequency, rate or extent of N-terminal peptidyl-lysine acetylation.
Any process that activates or increases the frequency, rate or extent of N-terminal peptidyl-lysine acetylation.
Any process that modulates the frequency, rate or extent of phenylpropanoid metabolic process.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in norepinephrine biosynthetic process.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in norepinephrine biosynthetic process.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in norepinephrine biosynthetic process.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in norepinephrine biosynthetic process.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in norepinephrine biosynthetic process.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in norepinephrine biosynthetic process.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in norepinephrine biosynthetic process.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in norepinephrine biosynthetic process.
Any positive regulation of transcription from RNA polymerase II promoter that is involved in norepinephrine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis.
Any process that modulates the frequency, rate or extent of cytoplasmic translation.
Any process that stops, prevents or reduces the frequency, rate or extent of cytoplasmic translation.
Any process that activates or increases the frequency, rate or extent of cytoplasmic translation.
Any process that activates or increases the frequency, rate or extent of nephron tubule epithelial cell differentiation.
Any process that modulates the frequency, rate or extent of establishment or maintenance of cell polarity regulating cell shape.
Any process that stops, prevents or reduces the frequency, rate or extent of establishment or maintenance of cell polarity regulating cell shape.
Any process that activates or increases the frequency, rate or extent of establishment or maintenance of cell polarity regulating cell shape.
Any process that modulates the frequency, rate or extent of cellular senescence.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular senescence.
Any process that activates or increases the frequency, rate or extent of cellular senescence.
Any histone H3-S10 phosphorylation that is involved in chromosome condensation.
Any histone H3-S10 phosphorylation that is involved in chromosome condensation.
Any histone H3-S10 phosphorylation that is involved in chromosome condensation.
Any histone H4 acetylation that is involved in a response to DNA damage stimulus.
Any histone H4 acetylation that is involved in a response to DNA damage stimulus.
Any histone H4 acetylation that is involved in a response to DNA damage stimulus.
Any histone H4 acetylation that is involved in a response to DNA damage stimulus.
Any histone H4 acetylation that is involved in a response to DNA damage stimulus.
Any positive regulation of proteasomal ubiquitin-dependent protein catabolic process that is involved in a cellular response to hypoxia.
Any positive regulation of proteasomal ubiquitin-dependent protein catabolic process that is involved in a cellular response to hypoxia.
Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.
Any process that modulates the frequency, rate or extent of double-strand break repair.
Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair.
Any process that activates or increases the frequency, rate or extent of double-strand break repair.
Any process that modulates the frequency, rate or extent of establishment of cell polarity regulating cell shape.
Any process that stops, prevents or reduces the frequency, rate or extent of establishment of cell polarity regulating cell shape.
Any process that activates or increases the frequency, rate or extent of establishment of cell polarity regulating cell shape.
Any process that modulates the frequency, rate or extent of autophagosome assembly.
Any process that modulates the frequency, rate or extent of autophagosome assembly.
Any process that modulates the frequency, rate or extent of autophagosome assembly.
Any process that modulates the frequency, rate or extent of autophagosome assembly.
Any process that modulates the frequency, rate or extent of autophagosome assembly.
Any process that activates or increases the frequency, rate or extent of autophagic vacuole assembly.
Any process that activates or increases the frequency, rate or extent of autophagic vacuole assembly.
Any process that activates or increases the frequency, rate or extent of autophagic vacuole assembly.
Any process that activates or increases the frequency, rate or extent of autophagic vacuole assembly.
Any process that activates or increases the frequency, rate or extent of autophagic vacuole assembly.
Any process that modulates the frequency, rate or extent of venous endothelial cell fate commitment.
Any process that stops, prevents or reduces the frequency, rate or extent of venous endothelial cell fate commitment.
Any process that activates or increases the frequency, rate or extent of venous endothelial cell fate commitment.
Any process that modulates the frequency, rate or extent of mesenchymal cell proliferation involved in lung development.
Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal cell proliferation involved in lung development.
Any process that activates or increases the frequency, rate or extent of mesenchymal cell proliferation involved in lung development.
Any cell proliferation that is involved in heart valve development.
Any cell proliferation that is involved in heart valve development.
Any process that modulates the frequency, rate or extent of epithelial cell proliferation involved in lung morphogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of epithelial cell proliferation involved in lung morphogenesis.
Any Notch signaling pathway that is involved in negative regulation of venous endothelial cell fate commitment.
Any Notch signaling pathway that is involved in negative regulation of venous endothelial cell fate commitment.
Any Notch signaling pathway that is involved in negative regulation of venous endothelial cell fate commitment.
Any Notch signaling pathway that is involved in negative regulation of venous endothelial cell fate commitment.
Any Notch signaling pathway that is involved in negative regulation of venous endothelial cell fate commitment.
Any Notch signaling pathway that is involved in negative regulation of venous endothelial cell fate commitment.
Any process that modulates the frequency, rate or extent of amniotic stem cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of amniotic stem cell differentiation.
Any process that activates or increases the frequency, rate or extent of amniotic stem cell differentiation.
Any process that modulates the frequency, rate or extent of endocardial cushion to mesenchymal transition involved in heart valve formation.
Any process that stops, prevents or reduces the frequency, rate or extent of endocardial cushion to mesenchymal transition involved in heart valve formation.
Any process that activates or increases the frequency, rate or extent of endocardial cushion to mesenchymal transition involved in heart valve formation.
The process in which a signal is passed on to downstream components located at the endosome. Endosomes can provide important intracellular signaling platforms and provide spatial and temporal control over signal transduction.
The process in which a signal is passed on to downstream components located at the endosome. Endosomes can provide important intracellular signaling platforms and provide spatial and temporal control over signal transduction.
The process in which a signal is passed on to downstream components located at the endosome. Endosomes can provide important intracellular signaling platforms and provide spatial and temporal control over signal transduction.
The process in which a signal is passed on to downstream components located at the endosome. Endosomes can provide important intracellular signaling platforms and provide spatial and temporal control over signal transduction.
The process in which a signal is passed on to downstream components located at the endosome. Endosomes can provide important intracellular signaling platforms and provide spatial and temporal control over signal transduction.
The process in which a signal is passed on to downstream components located at the endosome. Endosomes can provide important intracellular signaling platforms and provide spatial and temporal control over signal transduction.
Any process that modulates the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
Any process that modulates the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
Any process that modulates the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
Any process that stops, prevents or reduces the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
Any process that stops, prevents or reduces the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
Any process that stops, prevents or reduces the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
Any process that activates or increases the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
Any process that activates or increases the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
Any process that activates or increases the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
Any process that modulates the frequency, rate or extent of synaptic vesicle clustering.
Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle clustering.
Any process that activates or increases the frequency, rate or extent of synaptic vesicle clustering.
Any process that modulates the frequency, rate or extent of tight junction assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of anoikis.
Any process that stops, prevents or reduces the frequency, rate or extent of anoikis.
Any process that modulates the frequency, rate or extent of barbed-end actin filament capping.
Any process that modulates the frequency, rate or extent of barbed-end actin filament capping.
Any process that modulates the frequency, rate or extent of barbed-end actin filament capping.
Any process that modulates the frequency, rate or extent of barbed-end actin filament capping.
Any process that stops, prevents or reduces the frequency, rate or extent of barbed-end actin filament capping.
Any process that stops, prevents or reduces the frequency, rate or extent of barbed-end actin filament capping.
Any process that stops, prevents or reduces the frequency, rate or extent of barbed-end actin filament capping.
Any process that stops, prevents or reduces the frequency, rate or extent of barbed-end actin filament capping.
Any process that activates or increases the frequency, rate or extent of barbed-end actin filament capping.
Any process that activates or increases the frequency, rate or extent of barbed-end actin filament capping.
Any process that activates or increases the frequency, rate or extent of barbed-end actin filament capping.
Any process that activates or increases the frequency, rate or extent of barbed-end actin filament capping.
A process of regulation of mRNA stability that is involved in a response to oxidative stress.
Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid separation.
Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid separation.
Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid separation.
Any process that stops, prevents or reduces the frequency, rate or extent of mitotic sister chromatid separation.
Any regulation of histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
Any regulation of histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
Any regulation of histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
Any regulation of histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
Any process that stops, prevents or reduces the frequency, rate or extent of myoblast proliferation.
Any process that modulates the frequency, rate or extent of nucleotide-excision repair.
Any process that modulates the frequency, rate or extent of nucleotide-excision repair.
Any process that modulates the frequency, rate or extent of nucleotide-excision repair.
Any process that modulates the frequency, rate or extent of nucleotide-excision repair.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
Any process that modulates the frequency, rate or extent of grooming behavior.
Any process that modulates the frequency, rate or extent of behavioral fear response.
Any process that modulates the frequency, rate or extent of androgen receptor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of androgen receptor activity.
Any process that activates or increases the frequency, rate or extent of androgen receptor activity.
Any process that modulates the frequency, rate or extent of heart morphogenesis.
The set of processes involved in identifying and degrading defective or aberrant RNAs that takes place in the mitochondrion.
The set of processes involved in identifying and degrading defective or aberrant RNAs that takes place in the mitochondrion.
The set of processes involved in identifying and degrading defective or aberrant RNAs that takes place in the mitochondrion.
The set of processes involved in identifying and degrading defective or aberrant RNAs that takes place in the mitochondrion.
The set of processes involved in identifying and degrading defective or aberrant RNAs that takes place in the mitochondrion.
Any process that modulates the frequency, rate or extent of parathyroid hormone secretion.
Any process that modulates the frequency, rate or extent of parathyroid hormone secretion.
Any process that modulates the frequency, rate or extent of parathyroid hormone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of parathyroid hormone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of parathyroid hormone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of parathyroid hormone secretion.
Any process that activates or increases the frequency, rate or extent of parathyroid hormone secretion.
Any process that activates or increases the frequency, rate or extent of parathyroid hormone secretion.
Any process that activates or increases the frequency, rate or extent of parathyroid hormone secretion.
Any process that modulates the frequency, rate or extent of steroid hormone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of steroid hormone secretion.
Any process that activates or increases the frequency, rate or extent of steroid hormone secretion.
Any process that modulates the frequency, rate or extent of androgen secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of androgen secretion.
Any process that activates or increases the frequency, rate or extent of androgen secretion.
Any process that modulates the frequency, rate or extent of androstenedione secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of androstenedione secretion.
Any process that activates or increases the frequency, rate or extent of androstenedione secretion.
Any process that modulates the frequency, rate or extent of dehydroepiandrosterone secretion.
Any process that modulates the frequency, rate or extent of dehydroepiandrosterone secretion.
Any process that modulates the frequency, rate or extent of dehydroepiandrosterone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of dehydroepiandrosterone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of dehydroepiandrosterone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of dehydroepiandrosterone secretion.
Any process that activates or increases the frequency, rate or extent of dehydroepiandrosterone secretion.
Any process that activates or increases the frequency, rate or extent of dehydroepiandrosterone secretion.
Any process that activates or increases the frequency, rate or extent of dehydroepiandrosterone secretion.
Any process that modulates the frequency, rate or extent of testosterone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of testosterone secretion.
Any process that activates or increases the frequency, rate or extent of testosterone secretion.
Any process that modulates the frequency, rate or extent of corticosteroid hormone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of corticosteroid hormone secretion.
Any process that activates or increases the frequency, rate or extent of corticosteroid hormone secretion.
Any process that modulates the frequency, rate or extent of glucocorticoid secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of glucocorticoid secretion.
Any process that activates or increases the frequency, rate or extent of glucocorticoid secretion.
Any process that modulates the frequency, rate or extent of corticosterone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of corticosterone secretion.
Any process that activates or increases the frequency, rate or extent of corticosterone secretion.
Any process that modulates the frequency, rate or extent of mineralocorticoid secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of mineralocorticoid secretion.
Any process that activates or increases the frequency, rate or extent of mineralocorticoid secretion.
Any process that modulates the frequency, rate or extent of aldosterone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of aldosterone secretion.
Any process that activates or increases the frequency, rate or extent of aldosterone secretion.
Any process that modulates the frequency, rate or extent of estrogen secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of estrogen secretion.
Any process that activates or increases the frequency, rate or extent of estrogen secretion.
Any process that modulates the frequency, rate or extent of estradiol secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of estradiol secretion.
Any process that activates or increases the frequency, rate or extent of estradiol secretion.
Any process that modulates the frequency, rate or extent of estrone secretion.
Any process that modulates the frequency, rate or extent of estrone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of estrone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of estrone secretion.
Any process that activates or increases the frequency, rate or extent of estrone secretion.
Any process that activates or increases the frequency, rate or extent of estrone secretion.
Any process that modulates the frequency, rate or extent of progesterone secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of progesterone secretion.
Any process that activates or increases the frequency, rate or extent of progesterone secretion.
Any process that modulates the frequency, rate or extent of histone H4 acetylation involved in response to DNA damage stimulus.
Any process that modulates the frequency, rate or extent of histone H4 acetylation involved in response to DNA damage stimulus.
Any process that modulates the frequency, rate or extent of histone H4 acetylation involved in response to DNA damage stimulus.
Any process that modulates the frequency, rate or extent of histone H4 acetylation involved in response to DNA damage stimulus.
Any process that modulates the frequency, rate or extent of histone H4 acetylation involved in response to DNA damage stimulus.
Any process that modulates the frequency, rate or extent of glyoxylate cycle.
Any process that stops, prevents or reduces the frequency, rate or extent of glyoxylate cycle.
Any process that activates or increases the frequency, rate or extent of glyoxylate cycle.
Any process that stops, prevents or reduces the frequency, rate or extent of oligopeptide transport.
Any process that activates or increases the frequency, rate or extent of oligopeptide transport.
Any process that stops, prevents or reduces the frequency, rate or extent of dipeptide transport.
Any process that activates or increases the frequency, rate or extent of dipeptide transport.
Any process that modulates the frequency, rate or extent of starch catabolic process.
Any process that modulates the frequency, rate or extent of starch catabolic process.
Any process that modulates the frequency, rate or extent of starch catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of starch catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of starch catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of starch catabolic process.
Any process that activates or increases the frequency, rate or extent of starch catabolic process.
Any process that activates or increases the frequency, rate or extent of starch catabolic process.
Any process that activates or increases the frequency, rate or extent of starch catabolic process.
The chemical reactions and pathways resulting in the breakdown of a glucomannan.
The chemical reactions and pathways resulting in the breakdown of a galactoglucomannan.
The chemical reactions and pathways resulting in the breakdown of a glucuronoxylan.
The chemical reactions and pathways resulting in the breakdown of a glucuronoarabinoxylan.
The chemical reactions and pathways resulting in the breakdown of an arabinoxylan.
The chemical reactions and pathways resulting in the breakdown of an arabinoxylan.
The chemical reactions and pathways involving a cellodextrin.
The chemical reactions and pathways resulting in the breakdown of a cellodextrin.
The chemical reactions and pathways involving a cellobiose.
The chemical reactions and pathways resulting in the breakdown of a cellobiose.
The chemical reactions and pathways involving a cellotriose.
The chemical reactions and pathways resulting in the breakdown of a cellotriose.
The chemical reactions and pathways resulting in the breakdown of a hemicellulose.
The chemical reactions and pathways involving an amylopectin.
The chemical reactions and pathways resulting in the breakdown of an amylopectin.
Any process that modulates the frequency, rate or extent of glucomannan catabolic process.
The chemical reactions and pathways resulting in the breakdown of a xyloglucan.
The chemical reactions and pathways involving a cyclodextrin.
The chemical reactions and pathways resulting in the breakdown of a cyclodextrin.
The chemical reactions and pathways involving a cellooligosaccharide.
The chemical reactions and pathways resulting in the breakdown of a cellooligosaccharide.
Any process that modulates the frequency, rate or extent of starch metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of starch metabolic process.
Any process that activates or increases the frequency, rate or extent of starch metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of glucomannan catabolic process.
Any process that activates or increases the frequency, rate or extent of glucomannan catabolic process.
Any process that modulates the frequency, rate or extent of sterol import.
Any process that modulates the frequency, rate or extent of sterol import.
Any process that stops, prevents or reduces the frequency, rate or extent of sterol import.
Any process that stops, prevents or reduces the frequency, rate or extent of sterol import.
Any process that activates or increases the frequency, rate or extent of sterol import.
Any process that activates or increases the frequency, rate or extent of sterol import.
Any process that modulates the frequency, rate or extent of galactoglucomannan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of galactoglucomannan catabolic process.
Any process that activates or increases the frequency, rate or extent of galactoglucomannan catabolic process.
Any process that modulates the frequency, rate or extent of glucuronoxylan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of glucuronoxylan catabolic process.
Any process that activates or increases the frequency, rate or extent of glucuronoxylan catabolic process.
Any process that modulates the frequency, rate or extent of glucuronoarabinoxylan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of glucuronoarabinoxylan catabolic process.
Any process that activates or increases the frequency, rate or extent of glucuronoarabinoxylan catabolic process.
Any process that modulates the frequency, rate or extent of arabinoxylan-containing compound catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of arabinoxylan-containing compound catabolic process.
Any process that activates or increases the frequency, rate or extent of arabinoxylan-containing compound catabolic process.
Any process that modulates the frequency, rate or extent of cellodextrin metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellodextrin metabolic process.
Any process that activates or increases the frequency, rate or extent of cellodextrin metabolic process.
Any process that modulates the frequency, rate or extent of cellodextrin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellodextrin catabolic process.
Any process that activates or increases the frequency, rate or extent of cellodextrin catabolic process.
Any process that modulates the frequency, rate or extent of cellobiose metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellobiose metabolic process.
Any process that activates or increases the frequency, rate or extent of cellobiose metabolic process.
Any process that modulates the frequency, rate or extent of cellotriose metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellotriose metabolic process.
Any process that activates or increases the frequency, rate or extent of cellotriose metabolic process.
Any process that modulates the frequency, rate or extent of cellotriose catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellotriose catabolic process.
Any process that activates or increases the frequency, rate or extent of cellotriose catabolic process.
Any process that modulates the frequency, rate or extent of plant-type cell wall cellulose catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of plant-type cell wall cellulose catabolic process.
Any process that activates or increases the frequency, rate or extent of plant-type cell wall cellulose catabolic process.
Any process that modulates the frequency, rate or extent of amylopectin metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of amylopectin metabolic process.
Any process that activates or increases the frequency, rate or extent of amylopectin metabolic process.
Any process that modulates the frequency, rate or extent of amylopectin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of amylopectin catabolic process.
Any process that activates or increases the frequency, rate or extent of amylopectin catabolic process.
Any process that modulates the frequency, rate or extent of xyloglucan metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of xyloglucan metabolic process.
Any process that activates or increases the frequency, rate or extent of xyloglucan metabolic process.
Any process that modulates the frequency, rate or extent of xyloglucan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of xyloglucan catabolic process.
Any process that activates or increases the frequency, rate or extent of xyloglucan catabolic process.
Any process that modulates the frequency, rate or extent of cyclodextrin metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cyclodextrin metabolic process.
Any process that activates or increases the frequency, rate or extent of cyclodextrin metabolic process.
Any process that modulates the frequency, rate or extent of cyclodextrin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cyclodextrin catabolic process.
Any process that activates or increases the frequency, rate or extent of cyclodextrin catabolic process.
Any process that modulates the frequency, rate or extent of cellooligosaccharide metabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellooligosaccharide metabolic process.
Any process that activates or increases the frequency, rate or extent of cellooligosaccharide metabolic process.
Any process that modulates the frequency, rate or extent of cellooligosaccharide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellooligosaccharide catabolic process.
Any process that activates or increases the frequency, rate or extent of cellooligosaccharide catabolic process.
Any process that modulates the frequency, rate or extent of cell wall polysaccharide catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cell wall polysaccharide catabolic process.
Any process that activates or increases the frequency, rate or extent of cell wall polysaccharide catabolic process.
Any process that activates or increases the frequency, rate or extent of AMPA selective glutamate receptor activity.
Any process that modulates the frequency, rate or extent of detection of glucose.
Any process that modulates the frequency, rate or extent of detection of glucose.
Any process that modulates the frequency, rate or extent of detection of glucose.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of glucose.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of glucose.
Any process that stops, prevents or reduces the frequency, rate or extent of detection of glucose.
Any process that activates or increases the frequency, rate or extent of detection of glucose.
Any process that activates or increases the frequency, rate or extent of detection of glucose.
Any process that activates or increases the frequency, rate or extent of detection of glucose.
Any process that modulates the frequency, rate or extent of pro-B cell differentiation.
Any process that modulates the frequency, rate or extent of pro-B cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of pro-B cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of pro-B cell differentiation.
Any process that activates or increases the frequency, rate or extent of pro-B cell differentiation.
Any process that activates or increases the frequency, rate or extent of pro-B cell differentiation.
Any process that modulates the frequency, rate or extent of forebrain neuron differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of forebrain neuron differentiation.
Any process that activates or increases the frequency, rate or extent of forebrain neuron differentiation.
Any process that modulates the frequency, rate or extent of inner ear receptor cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of inner ear receptor cell differentiation.
Any process that activates or increases the frequency, rate or extent of inner ear receptor cell differentiation.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that modulates the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that activates or increases the frequency, rate or extent of ATP citrate synthase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of behavioral fear response.
Any process that activates or increases the frequency, rate or extent of behavioral fear response.
Any process that modulates the frequency, rate or extent of hemicellulose catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of hemicellulose catabolic process.
Any process that activates or increases the frequency, rate or extent of hemicellulose catabolic process.
Any process that modulates the frequency, rate or extent of galactomannan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of galactomannan catabolic process.
Any process that activates or increases the frequency, rate or extent of galactomannan catabolic process.
Any process that modulates the frequency, rate or extent of mannan catabolic process.
Any process that modulates the frequency, rate or extent of mannan catabolic process.
Any process that modulates the frequency, rate or extent of mannan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of mannan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of mannan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of mannan catabolic process.
Any process that activates or increases the frequency, rate or extent of mannan catabolic process.
Any process that activates or increases the frequency, rate or extent of mannan catabolic process.
Any process that activates or increases the frequency, rate or extent of mannan catabolic process.
Any process that modulates the frequency, rate or extent of cellulose catabolic process.
Any process that modulates the frequency, rate or extent of cellulose catabolic process.
Any process that modulates the frequency, rate or extent of cellulose catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellulose catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellulose catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellulose catabolic process.
Any process that activates or increases the frequency, rate or extent of cellulose catabolic process.
Any process that activates or increases the frequency, rate or extent of cellulose catabolic process.
Any process that activates or increases the frequency, rate or extent of cellulose catabolic process.
Any process that modulates the frequency, rate or extent of xylan catabolic process.
Any process that modulates the frequency, rate or extent of xylan catabolic process.
Any process that modulates the frequency, rate or extent of xylan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of xylan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of xylan catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of xylan catabolic process.
Any process that activates or increases the frequency, rate or extent of xylan catabolic process.
Any process that activates or increases the frequency, rate or extent of xylan catabolic process.
Any process that activates or increases the frequency, rate or extent of xylan catabolic process.
Any process that modulates the frequency, rate or extent of pectin catabolic process.
Any process that modulates the frequency, rate or extent of pectin catabolic process.
Any process that modulates the frequency, rate or extent of pectin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of pectin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of pectin catabolic process.
Any process that stops, prevents or reduces the frequency, rate or extent of pectin catabolic process.
Any process that activates or increases the frequency, rate or extent of pectin catabolic process.
Any process that activates or increases the frequency, rate or extent of pectin catabolic process.
Any process that activates or increases the frequency, rate or extent of pectin catabolic process.
Any process that modulates the frequency, rate or extent of cellulose biosynthetic process.
Any process that modulates the frequency, rate or extent of cellulose biosynthetic process.
Any process that modulates the frequency, rate or extent of cellulose biosynthetic process.
Any process that modulates the frequency, rate or extent of cellulose biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellulose biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellulose biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellulose biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of cellulose biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cellulose biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cellulose biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cellulose biosynthetic process.
Any process that activates or increases the frequency, rate or extent of cellulose biosynthetic process.
Any process that modulates the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.
Any process that modulates the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.
Any process that activates or increases the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.
Any process that activates or increases the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.
The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of the renal system as it progresses from its formation to the mature state.
The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the mesenchymal cells of the renal system as it progresses from its formation to the mature state.
Any epithelial cell proliferation that is involved in renal tubule morphogenesis.
Any process that modulates the frequency, rate or extent of skeletal muscle cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of skeletal muscle cell differentiation.
Any process that activates or increases the frequency, rate or extent of skeletal muscle cell differentiation.
Any process that modulates the frequency, rate or extent of retrograde axon cargo transport.
Any process that stops, prevents or reduces the frequency, rate or extent of retrograde axon cargo transport.
Any process that activates or increases the frequency, rate or extent of retrograde axon cargo transport.
Any process that modulates the frequency, rate or extent of response to DNA damage stimulus.
Any process that modulates the frequency, rate or extent of response to DNA damage stimulus.
Any process that modulates the frequency, rate or extent of response to DNA damage stimulus.
Any process that modulates the frequency, rate or extent of response to DNA damage stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of response to DNA damage stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of response to DNA damage stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of response to DNA damage stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of response to DNA damage stimulus.
Any process that activates or increases the frequency, rate or extent of response to DNA damage stimulus.
Any process that activates or increases the frequency, rate or extent of response to DNA damage stimulus.
Any process that activates or increases the frequency, rate or extent of response to DNA damage stimulus.
Any process that activates or increases the frequency, rate or extent of response to DNA damage stimulus.
Any process that modulates the frequency, rate or extent of response to drug.
Any process that modulates the frequency, rate or extent of response to drug.
Any process that stops, prevents or reduces the frequency, rate or extent of response to drug.
Any process that stops, prevents or reduces the frequency, rate or extent of response to drug.
Any process that activates or increases the frequency, rate or extent of response to drug.
Any process that activates or increases the frequency, rate or extent of response to drug.
Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis.
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell chemotaxis.
Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
Any process that modulates the frequency, rate or extent of cellular glucuronidation.
Any process that modulates the frequency, rate or extent of cellular glucuronidation.
Any process that modulates the frequency, rate or extent of cellular glucuronidation.
Any process that modulates the frequency, rate or extent of cellular glucuronidation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.
Any process that activates or increases the frequency, rate or extent of cellular glucuronidation.
Any process that activates or increases the frequency, rate or extent of cellular glucuronidation.
Any process that activates or increases the frequency, rate or extent of cellular glucuronidation.
Any process that activates or increases the frequency, rate or extent of cellular glucuronidation.
Any process that modulates the frequency, rate or extent of double-strand break repair via nonhomologous end joining.
Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair via nonhomologous end joining.
Any process that activates or increases the frequency, rate or extent of double-strand break repair via nonhomologous end joining.
Any process that modulates the frequency, rate or extent of tongue muscle cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of tongue muscle cell differentiation.
Any process that activates or increases the frequency, rate or extent of tongue muscle cell differentiation.
Any process that modulates the frequency, rate or extent of cellular response to drug.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to drug.
Any process that activates or increases the frequency, rate or extent of cellular response to drug.
Any process that stops, prevents or reduces the frequency, rate or extent of the process of physically separating the septal cell wall material by enzymatic digestion, that occurs after daughter cells are separated by cytokinesis.
Any process that activates or increases the frequency, rate or extent of the process of physically separating the septal cell wall material by enzymatic digestion, that occurs after daughter cells are separated by cytokinesis.
Any process that activates or increases the frequency, rate or extent of the process of physically separating the septal cell wall material by enzymatic digestion, that occurs after daughter cells are separated by cytokinesis.
Any process that modulates the frequency, rate or extent of integrin-mediated signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of integrin-mediated signaling pathway.
Any process that activates or increases the frequency, rate or extent of integrin-mediated signaling pathway.
Any process that modulates the frequency, rate or extent of tendon cell differentiation.
Any process that modulates the frequency, rate or extent of tendon cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of tendon cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of tendon cell differentiation.
Any process that activates or increases the frequency, rate or extent of tendon cell differentiation.
Any process that activates or increases the frequency, rate or extent of tendon cell differentiation.
Any process that modulates the frequency, rate or extent of mesenchymal cell apoptotic process.
Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of mesenchymal cell apoptotic process.
Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity.
Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity.
The chemical reactions and pathways involving a reactive nitrogen species.
The chemical reactions and pathways involving a reactive nitrogen species.
The chemical reactions and pathways involving a reactive nitrogen species.
The chemical reactions and pathways involving a D-tagatose 6-phosphate.
The chemical reactions and pathways resulting in the breakdown of a D-tagatose 6-phosphate.
The chemical reactions and pathways involving a D-glycero-D-manno-heptose 7-phosphate.
The chemical reactions and pathways resulting in the formation of a D-glycero-D-manno-heptose 7-phosphate.
Interacting selectively and non-covalently with xylan.
Interacting selectively and non-covalently with glucomannan.
Interacting selectively and non-covalently with cellooligosaccharide.
Interacting selectively and non-covalently with mannan.
Interacting selectively and non-covalently with amylopectin.
Interacting selectively and non-covalently with pullulan.
Interacting selectively and non-covalently with arabinoxylan.
Interacting selectively and non-covalently with glycogen.
Interacting selectively and non-covalently with glycogen.
Interacting selectively and non-covalently with starch.
Interacting selectively and non-covalently with starch.
Interacting selectively and non-covalently with maltoheptaose.
Interacting selectively and non-covalently with galactomannan.
Interacting selectively and non-covalently with cyclodextrin.
Any process that modulates the frequency, rate or extent of metanephric ureteric bud development.
Any process that stops, prevents or reduces the frequency, rate or extent of metanephric ureteric bud development.
Any process that activates or increases the frequency, rate or extent of metanephric ureteric bud development.
Interacting selectively and non-covalently with (1->3),(1->4)-beta-glucan.
Interacting selectively and non-covalently with (1->3),(1->4)-beta-glucan.
Interacting selectively and non-covalently with (1->3),(1->4)-beta-glucan.
Interacting selectively and non-covalently with (1->3),(1->4)-beta-glucan.
Interacting selectively and non-covalently with (1->3),(1->4)-beta-glucan.
Interacting selectively and non-covalently with (1->3),(1->4)-beta-glucan.
Interacting selectively and non-covalently with (1->6)-beta-D-glucan.
Interacting selectively and non-covalently with (1->6)-beta-D-glucan.
Interacting selectively and non-covalently with (1->6)-beta-D-glucan.
Interacting selectively and non-covalently with (1->6)-beta-D-glucan.
Interacting selectively and non-covalently with (1->6)-beta-D-glucan.
Interacting selectively and non-covalently with (1->6)-beta-D-glucan.
Interacting selectively and non-covalently with (1->6)-beta-D-glucan.
Interacting selectively and non-covalently with beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc.
Interacting selectively and non-covalently with chitosan.
Interacting selectively and non-covalently with (1->4)-beta-D-galactan.
Interacting selectively and non-covalently with inulin.
Interacting selectively and non-covalently with alpha-D-glucan.
Interacting selectively and non-covalently with L-arabinofuranose.
Interacting selectively and non-covalently with arabinogalactan.
The directed movement of a laminarabioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a sophoroseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a trisaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a maltotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a maltotriuloseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a nigerotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of an arabinotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a galactotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a xylotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a mannotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a cellotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a laminaritrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a tetrasaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a maltotetraoseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a pentasaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a maltopentaoseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a hexasaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a maltohexaoseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a heptasaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a maltoheptaoseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
Any process that modulates the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity.
Any process that modulates the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity.
Any process that stops, prevents or reduces the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity.
Any process that activates or increases the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity.
Any process that activates or increases the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity.
Any process that modulates the frequency, rate or extent of lens epithelial cell proliferation.
Any process that stops, prevents or reduces the frequency, rate or extent of lens epithelial cell proliferation.
Any process that activates or increases the frequency, rate or extent of lens epithelial cell proliferation.
Any process that modulates the frequency, rate or extent of cellular response to hepatocyte growth factor stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to hepatocyte growth factor stimulus.
Any process that activates or increases the frequency, rate or extent of cellular response to hepatocyte growth factor stimulus.
The chemical reactions and pathways involving a methanopterin.
The chemical reactions and pathways resulting in the formation of a methanopterin.
The chemical reactions and pathways involving a tetrahydromethanopterin.
The chemical reactions and pathways resulting in the formation of a tetrahydromethanopterin.
The chemical reactions and pathways involving a methanofuran.
The chemical reactions and pathways resulting in the formation of a methanofuran.
The chemical reactions and pathways resulting in the formation of a coenzyme gamma-F420-2.
The chemical reactions and pathways involving a maltoheptaose.
The chemical reactions and pathways resulting in the breakdown of a maltoheptaose.
Any process that modulates the frequency, rate or extent of translational frameshifting.
Any process that stops, prevents or reduces the frequency, rate or extent of translational frameshifting.
Any process that activates or increases the frequency, rate or extent of translational frameshifting.
The chemical reactions and pathways resulting in the formation of a methane from a formic acid.
The chemical reactions and pathways resulting in the formation of a methane from a methylamine.
The chemical reactions and pathways resulting in the formation of a methane from a dimethylamine.
The chemical reactions and pathways resulting in the formation of a methane from a trimethylamine.
The chemical reactions and pathways resulting in the formation of a methane from a dimethyl sulfide.
The chemical reactions and pathways resulting in the formation of a methane from a 3-(methylthio)propionic acid.
The chemical reactions and pathways resulting in the formation of a methane from a methanethiol.
The chemical reactions and pathways resulting in the formation of a methane from a carbon monoxide.
Any process that modulates the frequency, rate or extent of endocytic recycling.
Any process that stops, prevents or reduces the frequency, rate or extent of endocytic recycling.
Any process that activates or increases the frequency, rate or extent of endocytic recycling.
Any process that modulates the frequency, rate or extent of phospholipid transport.
Any process that stops, prevents or reduces the frequency, rate or extent of phospholipid transport.
Any process that activates or increases the frequency, rate or extent of phospholipid transport.
Any process that modulates the frequency, rate or extent of RNA biosynthetic process.
Any process that modulates the frequency, rate or extent of RNA biosynthetic process.
Any process that modulates the frequency, rate or extent of RNA biosynthetic process.
Any process that modulates the frequency, rate or extent of RNA biosynthetic process.
The directed movement of a nicotinateacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a N-methylnicotinateacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
Any process that modulates the frequency, rate or extent of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity.
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity.
Interacting selectively and non-covalently with camalexin.
Any process that modulates the frequency, rate or extent of dipeptide transmembrane transport.
Any process that stops, prevents or reduces the frequency, rate or extent of dipeptide transmembrane transport.
Any process that activates or increases the frequency, rate or extent of dipeptide transmembrane transport.
Any process that modulates the frequency, rate or extent of renal water transport.
Any process that stops, prevents or reduces the frequency, rate or extent of renal water transport.
Any process that activates or increases the frequency, rate or extent of renal water transport.
Any process that modulates the frequency, rate or extent of glucose catabolic process to ethanol.
Any process that modulates the frequency, rate or extent of glucose catabolic process to ethanol.
Any process that stops, prevents or reduces the frequency, rate or extent of glucose catabolic process to ethanol.
Any process that stops, prevents or reduces the frequency, rate or extent of glucose catabolic process to ethanol.
Any process that modulates the frequency, rate or extent of proline catabolic process to glutamate.
Any process that modulates the frequency, rate or extent of proline catabolic process to glutamate.
Any process that modulates the frequency, rate or extent of proline catabolic process to glutamate.
Any process that stops, prevents or reduces the frequency, rate or extent of proline catabolic process to glutamate.
Any process that stops, prevents or reduces the frequency, rate or extent of proline catabolic process to glutamate.
Any process that stops, prevents or reduces the frequency, rate or extent of proline catabolic process to glutamate.
Any process that activates or increases the frequency, rate or extent of proline catabolic process to glutamate.
Any process that activates or increases the frequency, rate or extent of proline catabolic process to glutamate.
Any process that activates or increases the frequency, rate or extent of proline catabolic process to glutamate.
Any process that modulates the frequency, rate or extent of protein localization by the Cvt pathway.
Any process that modulates the frequency, rate or extent of protein localization by the Cvt pathway.
Any process that modulates the frequency, rate or extent of histone H3-K79 methylation.
Any process that modulates the frequency, rate or extent of histone H3-K79 methylation.
Any process that modulates the frequency, rate or extent of histone H3-K79 methylation.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K79 methylation.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K79 methylation.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K79 methylation.
Any process that activates or increases the frequency, rate or extent of histone H3-K79 methylation.
Any process that activates or increases the frequency, rate or extent of histone H3-K79 methylation.
Any process that activates or increases the frequency, rate or extent of histone H3-K79 methylation.
Any process that modulates the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues.
Any process that activates or increases the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues.
Any process that modulates the frequency, rate or extent of histone H2B ubiquitination.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H2B ubiquitination.
Any process that activates or increases the frequency, rate or extent of histone H2B ubiquitination.
Any process that modulates the frequency, rate or extent of ATP biosynthetic process.
Any process that modulates the frequency, rate or extent of ATP biosynthetic process.
Any process that modulates the frequency, rate or extent of ATP biosynthetic process.
Any process that modulates the frequency, rate or extent of ATP biosynthetic process.
Any process that modulates the frequency, rate or extent of ATP biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of ATP biosynthetic process.
Any process that activates or increases the frequency, rate or extent of ATP biosynthetic process.
Any process that activates or increases the frequency, rate or extent of ATP biosynthetic process.
Any process that activates or increases the frequency, rate or extent of ATP biosynthetic process.
Any process that activates or increases the frequency, rate or extent of ATP biosynthetic process.
Any process that activates or increases the frequency, rate or extent of ATP biosynthetic process.
Any process that activates or increases the frequency, rate or extent of glucose catabolic process to ethanol.
Any process that activates or increases the frequency, rate or extent of glucose catabolic process to ethanol.
Any process that modulates the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.
Any process that modulates the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.
Any process that modulates the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.
Any process that activates or increases the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.
Any process that activates or increases the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.
Any process that activates or increases the frequency, rate or extent of histone H2B conserved C-terminal lysine ubiquitination.
Any process that modulates the frequency, rate or extent of mediator complex assembly.
Any process that stops, prevents or reduces the frequency, rate or extent of mediator complex assembly.
Any process that activates or increases the frequency, rate or extent of mediator complex assembly.
Any process that modulates the frequency, rate or extent of interleukin-10 secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-10 secretion.
Any process that activates or increases the frequency, rate or extent of interleukin-10 secretion.
Any process that modulates the frequency, rate or extent of interleukin-12 secretion.
Any process that modulates the frequency, rate or extent of interleukin-12 secretion.
Any process that modulates the frequency, rate or extent of interleukin-12 secretion.
Any process that modulates the frequency, rate or extent of interleukin-12 secretion.
Any process that modulates the frequency, rate or extent of interleukin-12 secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-12 secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-12 secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-12 secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-12 secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-12 secretion.
Any process that activates or increases the frequency, rate or extent of interleukin-12 secretion.
Any process that activates or increases the frequency, rate or extent of interleukin-12 secretion.
Any process that activates or increases the frequency, rate or extent of interleukin-12 secretion.
Any process that activates or increases the frequency, rate or extent of interleukin-12 secretion.
Any process that activates or increases the frequency, rate or extent of interleukin-12 secretion.
Any process that modulates the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
Any process that stops, prevents or reduces the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
Any process that modulates the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
Any process that modulates the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
Any process that modulates the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
Any process that stops, prevents or reduces the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
Any process that activates or increases the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
Any process that activates or increases the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
Any process that activates or increases the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell.
Any process that modulates the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that modulates the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that modulates the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that modulates the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that stops, prevents or reduces the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that stops, prevents or reduces the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that stops, prevents or reduces the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that stops, prevents or reduces the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that activates or increases the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that activates or increases the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that activates or increases the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that activates or increases the frequency, rate or extent of gamma-delta T cell activation involved in immune response.
Any process that modulates the frequency, rate or extent of lysine biosynthetic process via alpha-aminoadipate and saccharopine.
Any process that modulates the frequency, rate or extent of lysine biosynthetic process via alpha-aminoadipate and saccharopine.
Any process that stops, prevents or reduces the frequency, rate or extent of lysine biosynthetic process via alpha-aminoadipate and saccharopine.
Any process that stops, prevents or reduces the frequency, rate or extent of lysine biosynthetic process via alpha-aminoadipate and saccharopine.
Any process that activates or increases the frequency, rate or extent of lysine biosynthetic process via alpha-aminoadipate and saccharopine.
Any process that activates or increases the frequency, rate or extent of lysine biosynthetic process via alpha-aminoadipate and saccharopine.
Any basement membrane assembly that is involved in embryonic body morphogenesis.
Any process that modulates the frequency, rate or extent of dendritic cell differentiation.
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation.
Any process that activates or increases the frequency, rate or extent of dendritic cell differentiation.
Any process that modulates the frequency, rate or extent of transforming growth factor-beta secretion.
Any process that modulates the frequency, rate or extent of transforming growth factor-beta secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor-beta secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor-beta secretion.
Any process that activates or increases the frequency, rate or extent of transforming growth factor-beta secretion.
Any process that activates or increases the frequency, rate or extent of transforming growth factor-beta secretion.
Any process that modulates the frequency, rate or extent of osteoclast development.
Any process that stops, prevents or reduces the frequency, rate or extent of osteoclast development.
Any process that activates or increases the frequency, rate or extent of osteoclast development.
Any process that modulates the frequency, rate or extent of transcription elongation from RNA polymerase I promoter.
Any process that stops, prevents or reduces the frequency, rate or extent of transcription elongation mediated by RNA polymerase I.
Any process that stops, prevents or reduces the frequency, rate or extent of transcription elongation mediated by RNA polymerase I.
Any process that activates or increases the frequency, rate or extent of transcription elongation from RNA polymerase I promoter.
Any process that modulates the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that modulates the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that modulates the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that modulates the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that modulates the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.
Any process that modulates the frequency, rate or extent of vasculogenesis.
Any process that stops, prevents or reduces the frequency, rate or extent of vasculogenesis.
Any process that activates or increases the frequency, rate or extent of vasculogenesis.
Any process that modulates the frequency, rate or extent of hydroxymethylglutaryl-CoA reductase (NADPH) activity.
Any process that modulates the frequency, rate or extent of hydroxymethylglutaryl-CoA reductase (NADPH) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of hydroxymethylglutaryl-CoA reductase (NADPH) activity.
Any process that stops, prevents or reduces the frequency, rate or extent of hydroxymethylglutaryl-CoA reductase (NADPH) activity.
Any process that modulates the frequency, rate or extent of neuron migration.
Any process that modulates the frequency, rate or extent of neuron migration.
Any process that modulates the frequency, rate or extent of neuron migration.
Any process that stops, prevents or reduces the frequency, rate or extent of neuron migration.
Any process that stops, prevents or reduces the frequency, rate or extent of neuron migration.
Any process that stops, prevents or reduces the frequency, rate or extent of neuron migration.
Any process that activates or increases the frequency, rate or extent of neuron migration.
Any process that activates or increases the frequency, rate or extent of neuron migration.
Any process that activates or increases the frequency, rate or extent of neuron migration.
Any process that modulates the frequency, rate or extent of chloride transport.
Any process that stops, prevents or reduces the frequency, rate or extent of chloride transport.
Interacting selectively and non-covalently with quercitrin.
Any process that modulates the frequency, rate or extent of response to gamma radiation.
Any process that modulates the frequency, rate or extent of response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of response to gamma radiation.
Any process that stops, prevents or reduces the frequency, rate or extent of response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of response to gamma radiation.
Any process that activates or increases the frequency, rate or extent of response to gamma radiation.
Any process that modulates the frequency, rate or extent of protein localization to prospore membrane.
Any process that modulates the frequency, rate or extent of protein localization to prospore membrane.
Any process that modulates the frequency, rate or extent of protein localization to prospore membrane.
Any process that modulates the frequency, rate or extent of protein localization to prospore membrane.
Any process that modulates the frequency, rate or extent of protein localization to prospore membrane.
Any process that modulates the frequency, rate or extent of protein localization to prospore membrane.
Any process that activates or increases the frequency, rate or extent of protein localization to prospore membrane.
Any process that activates or increases the frequency, rate or extent of protein localization to prospore membrane.
Any process that activates or increases the frequency, rate or extent of protein localization to prospore membrane.
Any process that activates or increases the frequency, rate or extent of protein localization to prospore membrane.
Any process that activates or increases the frequency, rate or extent of protein localization to prospore membrane.
Any process that activates or increases the frequency, rate or extent of protein localization to prospore membrane.
Any process that modulates the frequency, rate or extent of apoptotic signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway.
Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway.
Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway.
Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway.
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway.
Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
Any process that modulates the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that modulates the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that modulates the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that modulates the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of phosphatidylcholine biosynthetic process.
Any process that modulates the frequency, rate or extent of ammonia assimilation cycle.
Any process that modulates the frequency, rate or extent of ammonia assimilation cycle.
Any process that stops, prevents or reduces the frequency, rate or extent of ammonia assimilation cycle.
Any process that stops, prevents or reduces the frequency, rate or extent of ammonia assimilation cycle.
Any process that activates or increases the frequency, rate or extent of ammonia assimilation cycle.
Any process that activates or increases the frequency, rate or extent of ammonia assimilation cycle.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome organization.
Any process that stops, prevents or reduces the frequency, rate or extent of chromosome organization.
Any process that activates or increases the frequency, rate or extent of chromosome organization.
Any process that activates or increases the frequency, rate or extent of chromosome organization.
Any process that activates or increases the frequency, rate or extent of chromosome organization.
Any process that activates or increases the frequency, rate or extent of chromosome organization.
Any process that modulates the frequency, rate or extent of histone H3-K36 trimethylation.
Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K36 trimethylation.
Any process that activates or increases the frequency, rate or extent of histone H3-K36 trimethylation.
Any process that modulates the frequency, rate or extent of store-operated calcium entry.
Any process that modulates the frequency, rate or extent of store-operated calcium entry.
Any process that modulates the frequency, rate or extent of store-operated calcium entry.
Any process that modulates the frequency, rate or extent of store-operated calcium entry.
Any process that modulates the frequency, rate or extent of cation channel activity.
Any process that modulates the frequency, rate or extent of cation channel activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity.
Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity.
Any process that activates or increases the frequency, rate or extent of cation channel activity.
Any process that activates or increases the frequency, rate or extent of cation channel activity.
Any process that modulates the frequency, rate or extent of semaphorin-plexin signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of semaphorin-plexin signaling pathway.
Any process that activates or increases the frequency, rate or extent of semaphorin-plexin signaling pathway.
Any process that modulates the frequency, rate or extent of C-C chemokine binding.
Any process that stops, prevents or reduces the frequency, rate or extent of C-C chemokine binding.
Any process that activates or increases the frequency, rate or extent of C-C chemokine binding.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any Roundabout signaling pathway that is involved in axon guidance.
Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity involved in execution phase of apoptosis.
Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in execution phase of apoptosis.
Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity involved in execution phase of apoptosis.
Any process that modulates the frequency, rate or extent of glucose import in response to insulin stimulus.
Any process that stops, prevents or reduces the frequency, rate or extent of glucose import in response to insulin stimulus.
Any process that activates or increases the frequency, rate or extent of glucose import in response to insulin stimulus.
Any process that modulates the frequency, rate or extent of leucine biosynthetic process.
Any process that modulates the frequency, rate or extent of leucine biosynthetic process.
Any process that modulates the frequency, rate or extent of leucine biosynthetic process.
Any process that modulates the frequency, rate or extent of leucine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of leucine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of leucine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of leucine biosynthetic process.
Any process that stops, prevents or reduces the frequency, rate or extent of leucine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of leucine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of leucine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of leucine biosynthetic process.
Any process that activates or increases the frequency, rate or extent of leucine biosynthetic process.
Any process that modulates the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that modulates the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that modulates the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that modulates the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that modulates the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that modulates the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that activates or increases the frequency, rate or extent of unsaturated fatty acid biosynthetic process.
Any process that modulates the frequency, rate or extent of muscle cell chemotaxis toward tendon cell.
Any process that modulates the frequency, rate or extent of muscle cell chemotaxis toward tendon cell.
Any process that stops, prevents or reduces the frequency, rate or extent of the directed movement of a muscle cell towards a tendon cell in response to an external stimulus. For example, when the muscle cell arrives at the target tendon cell, migration is arrested so that attachments can be made between the cells.
Any process that stops, prevents or reduces the frequency, rate or extent of the directed movement of a muscle cell towards a tendon cell in response to an external stimulus. For example, when the muscle cell arrives at the target tendon cell, migration is arrested so that attachments can be made between the cells.
Any process that stops, prevents or reduces the frequency, rate or extent of the directed movement of a muscle cell towards a tendon cell in response to an external stimulus. For example, when the muscle cell arrives at the target tendon cell, migration is arrested so that attachments can be made between the cells.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any Roundabout signaling pathway that is involved in the directed movement of a muscle cell towards a tendon cell in response to an external stimulus.
Any process that modulates the frequency, rate or extent of BMP secretion.
Any process that modulates the frequency, rate or extent of BMP secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of BMP secretion.
Any process that stops, prevents or reduces the frequency, rate or extent of BMP secretion.
Any process that modulates the frequency, rate or extent of caveolin-mediated endocytosis.
Any process that modulates the frequency, rate or extent of caveolin-mediated endocytosis.
Any process that modulates the frequency, rate or extent of caveolin-mediated endocytosis.
Any process that stops, prevents or reduces the frequency, rate or extent of caveolin-mediated endocytosis.
Any process that stops, prevents or reduces the frequency, rate or extent of caveolin-mediated endocytosis.
Any process that stops, prevents or reduces the frequency, rate or extent of caveolin-mediated endocytosis.
Any process that activates or increases the frequency, rate or extent of caveolin-mediated endocytosis.
Any process that activates or increases the frequency, rate or extent of caveolin-mediated endocytosis.
Any process that activates or increases the frequency, rate or extent of caveolin-mediated endocytosis.
The chemical reactions and pathways involving lipid X, 2,3-diacylglucosamine 1-phosphate.
The chemical reactions and pathways involving lipid X, 2,3-diacylglucosamine 1-phosphate.
The chemical reactions and pathways involving lipid X, 2,3-diacylglucosamine 1-phosphate.
The chemical reactions and pathways involving lipid X, 2,3-diacylglucosamine 1-phosphate.
The chemical reactions and pathways involving lipid X, 2,3-diacylglucosamine 1-phosphate.
The chemical reactions and pathways involving lipid X, 2,3-diacylglucosamine 1-phosphate.
The chemical reactions and pathways involving lipid X, 2,3-diacylglucosamine 1-phosphate.
The chemical reactions and pathways involving lipid X, 2,3-diacylglucosamine 1-phosphate.
The chemical reactions and pathways involving a hydroperoxide.
The chemical reactions and pathways involving codeine, an alkaloid found in the opium poppy, Papaver somniferum var. album. Codeine has analgesic, anti-tussive and anti-diarrhoeal properties.
The chemical reactions and pathways resulting in the breakdown of codeine, an alkaloid found in the opium poppy, Papaver somniferum var. album. Codeine has analgesic, anti-tussive and anti-diarrhoeal properties.
The chemical reactions and pathways resulting in the breakdown of codeine, an alkaloid found in the opium poppy, Papaver somniferum var. album. Codeine has analgesic, anti-tussive and anti-diarrhoeal properties.
The chemical reactions and pathways resulting in the breakdown of codeine, an alkaloid found in the opium poppy, Papaver somniferum var. album. Codeine has analgesic, anti-tussive and anti-diarrhoeal properties.
The chemical reactions and pathways involving malonyl-CoA, the S-malonyl derivative of coenzyme A.
The chemical reactions and pathways resulting in the breakdown of malonyl-CoA, the S-malonyl derivative of coenzyme A.
The chemical reactions and pathways resulting in the breakdown of malonyl-CoA, the S-malonyl derivative of coenzyme A.
The chemical reactions and pathways resulting in the breakdown of malonyl-CoA, the S-malonyl derivative of coenzyme A.
The chemical reactions and pathways resulting in the formation of malonyl-CoA, the S-malonyl derivative of coenzyme A.
The chemical reactions and pathways resulting in the formation of malonyl-CoA, the S-malonyl derivative of coenzyme A.
The chemical reactions and pathways resulting in the formation of malonyl-CoA, the S-malonyl derivative of coenzyme A.
The chemical reactions and pathways resulting in the formation of malonyl-CoA, the S-malonyl derivative of coenzyme A.
The chemical reactions and pathways involving N(omega)-methyl-L-arginine.
The chemical reactions and pathways resulting in the breakdown of N(omega)-methyl-L-arginine.
The chemical reactions and pathways resulting in the breakdown of N(omega)-methyl-L-arginine.
The chemical reactions and pathways resulting in the breakdown of N(omega)-methyl-L-arginine.
The chemical reactions and pathways involving N(omega),N(omega)-dimethyl-L-arginine, a methyl-L-arginine having two methyl groups both attached to the primary amino moiety of the guanidino group.
The chemical reactions and pathways resulting in the breakdown of N(omega),N(omega)-dimethyl-L-arginine, a methyl-L-arginine having two methyl groups both attached to the primary amino moiety of the guanidino group.
The chemical reactions and pathways resulting in the breakdown of N(omega),N(omega)-dimethyl-L-arginine, a methyl-L-arginine having two methyl groups both attached to the primary amino moiety of the guanidino group.
The chemical reactions and pathways resulting in the breakdown of N(omega),N(omega)-dimethyl-L-arginine, a methyl-L-arginine having two methyl groups both attached to the primary amino moiety of the guanidino group.
The chemical reactions and pathways involving a lipoxin. A lipoxin is a non-classic eicosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid.
The chemical reactions and pathways resulting in the formation of a lipoxin. A lipoxin is a non-classic eicosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid.
The chemical reactions and pathways resulting in the formation of a lipoxin. A lipoxin is a non-classic eicosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid.
The chemical reactions and pathways resulting in the formation of a lipoxin. A lipoxin is a non-classic eicosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid.
The chemical reactions and pathways resulting in the formation of a lipoxin. A lipoxin is a non-classic eicosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid.
The chemical reactions and pathways involving lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways involving lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways involving lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
The chemical reactions and pathways involving lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways involving lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways involving lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways involving a xanthone-containing compound.
The chemical reactions and pathways involving a xanthone-containing compound.
The chemical reactions and pathways involving a xanthone-containing compound.
The chemical reactions and pathways involving a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways resulting in the formation of a xanthone-containing compound.
The chemical reactions and pathways involving the epipolythiodioxopiperazine gliotoxin, a poisonous substance produced by some species of fungi.
The chemical reactions and pathways resulting in the breakdown of the epipolythiodioxopiperazine gliotoxin, a poisonous substance produced by some species of fungi.
The chemical reactions and pathways resulting in the breakdown of the epipolythiodioxopiperazine gliotoxin, a poisonous substance produced by some species of fungi.
The chemical reactions and pathways resulting in the breakdown of the epipolythiodioxopiperazine gliotoxin, a poisonous substance produced by some species of fungi.
The chemical reactions and pathways resulting in the formation of the epipolythiodioxopiperazine gliotoxin, a poisonous substance produced by some species of fungi.
The chemical reactions and pathways resulting in the formation of the epipolythiodioxopiperazine gliotoxin, a poisonous substance produced by some species of fungi.
The chemical reactions and pathways resulting in the formation of the epipolythiodioxopiperazine gliotoxin, a poisonous substance produced by some species of fungi.
The chemical reactions and pathways resulting in the formation of the epipolythiodioxopiperazine gliotoxin, a poisonous substance produced by some species of fungi.
The chemical reactions and pathways involving a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways involving a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways involving a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways involving a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways involving a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways involving a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways involving a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways resulting in the formation of a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.
The chemical reactions and pathways involving a UDP-4-deoxy-4-formamido-beta-L-arabinopyranose.
The chemical reactions and pathways resulting in the breakdown of a UDP-4-deoxy-4-formamido-beta-L-arabinopyranose.
The chemical reactions and pathways resulting in the breakdown of a UDP-4-deoxy-4-formamido-beta-L-arabinopyranose.
The chemical reactions and pathways resulting in the breakdown of a UDP-4-deoxy-4-formamido-beta-L-arabinopyranose.
The chemical reactions and pathways resulting in the formation of a UDP-4-deoxy-4-formamido-beta-L-arabinopyranose.
The chemical reactions and pathways resulting in the formation of a UDP-4-deoxy-4-formamido-beta-L-arabinopyranose.
The chemical reactions and pathways resulting in the formation of a UDP-4-deoxy-4-formamido-beta-L-arabinopyranose.
The chemical reactions and pathways resulting in the formation of a UDP-4-deoxy-4-formamido-beta-L-arabinopyranose.
The chemical reactions and pathways involving kojic acid.
The chemical reactions and pathways involving kojic acid.
The chemical reactions and pathways involving kojic acid.
The chemical reactions and pathways involving kojic acid.
The chemical reactions and pathways involving kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.
The chemical reactions and pathways resulting in the formation of kojic acid.